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Introdllction 
Introduction and outline of the thesis 
With his landmark paper in Nature Medicine in 1996, Shlomo Ben-Baim and coworkers 
introduced a novel technique into the clinical arena. (1) Indeed, this initiated the possibility 
of on-line, real-time, in-cathlab 3-dimensional (3-D) assessment of the function of the 
left ventricle. Through a dedicated system they were able to exactly locate a catheter in 
3-D space, to follow its excursions during ventricular contraction, and while making 
contact with the ventricular wall, also acquire electrical data. From the initial introduction 
of the technique, several investigators have shown its possibilities in assessing the quality 
of the human left ventricle, in evaluating possible recovery of diseased myocardium and in 
guiding therapies that may treat such conditions. (2-15) 
The importance of the assessment of left ventricle dysfunction, its causes and potential 
treatment strategies cannot be underestimated. Indeed, in add.ition to about 3000 people 
per million that die annually from acute myocardial infarction in industrialized countries, 
an even bigger number suffers from heart failure, mainly due to advanced coronary heart 
disease. (J6) Also, the continuous increase in life expectancy adds substantially to this 
problem. It is of uttermost importance to assess therapeutic possibilities for this patient 
group, as it has been shown that even a small gain in left ventricle ejection fraction 
(LVEF) may improve life quality and reduce mortality. One of the major therapeutic goals 
for the prevention of the consequences of ischemic heart disease should therefore be the 
preservation of LV function through the limitation of infarct size during the acute event, 
and by improvement of chronic ischemic LV dysfunction. While the prognosis of acute 
myocardial infarction has greatly improved with the advent of aggressive reperfusion 
strategies as thrombolysis and primary percutaneous coronary angioplasty (PTCA), 
chronic ischemic LV dysfunction may be more difficult to master. 
Revascularization - with both established (coronary artery bypass surgery (CABG), 
PTCA) and experimental (direct myocardial revascularization (DMR), protein or gene 
injection therapy) techniques - of myocardium in jeopardy has been advocated to reduce 
the impact of chronic ischemic heart disease on morbidity and mortality. 
As revascularization of necrotic tissue is unnecessary and may even prove to be hazardous, 
it is essential that injured myocardial tissue with potential for recovery is identified, so that 
patients who will actually benefit from the revascularization, are selected. 
Several methods to assess myocardial function and detect viability are currently available. 
Positron emission tomography (PET) with 18F-fluorodeoxyglucose uptake is currently 
the gold standard. However, this technique is expensive, and is not readily available. Other 
techniques as single photon emission computed tomography (SPECT) and dobutamine 
stress echocardiography are clinically attractive, widely available and more cost-effective 
than PET, but are confronted with varying sensibility and specificity figures in predicting 
recovery of injured myocard.ium. Also, none of these techniques can be easily performed 
on-line, inside the cathlab. 
Nonfluoroscopic electromechanical mapping with the NOGATM system (Biosense-
Webster, a Johnson&Johnson company) may fill this gap. Also, its unique 3-dimensional 
abilities to locate specific myocardial regions is able to guide local intramyocardial therapy 
with high specificity. Although very interesting research has been performed, the system 
still needs to find its place within common clinical interventional practice. 
The aim 0/ this thesis can be summarized as follows: in the first part of the thesis (chapters 
1-5) we will explain the technical background of the system, and compare the diagnostic 
introdlldion 
capacities of the system to standard accepted methods to assess baseline left ventricular 
function. In the second part (chapters 6-8) we will evaluate the ability of the system to 
detect and to define myocardial viability. In the third part (chapters 9-12), we describe the 
use of the NOGATM system as guidance for novel intramyocardial therapies. In the last 
part (chapter 13) we reflect on the future applications of nonfluoroscopic mapping. 
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INTRODUCTION 
Nonfluoroscopic electromechanical mapping is a novel technique that enables the 
investigator to acquire on-line information on electrical and mechanical endoventricular 
fimctioning of myocardial tissue. Although the system has only very recently been 
developed, it is already implied in the clinical arena in both the interventional cardiology 
(NOG-ATM) and electrophysiology (CARTO™) settings. The decision of the company 
that introduced the system (Biosense, Cordis-Webster,Johnson and Johnson) to subdivide 
NOG-ATM and CARTOTM into two separate systems was a political one, based on the fact 
that in the United States interventional cardiology and interventional electrophysiology 
are two entirely separated branches of clinical cardiology. The basic concepts of the tvvo 
systems are however the same, In this first of two parts, we shall review the NOG-ArM 
system components, the left ventricular mapping technique, the initial experimental and 
clinical data available, the ongoing trials and the future applications of this technique. In 
the second part, an overview of the CARTO™ system will be presented. 
The rationale of" new technique 
Percutaneous interventional techniques such as catheter-based ablation of cardiac 
arrhythmia's, direct myocardial revascularization (DMR) or intramyocardial gene-
injection are becoming widespread in clinical medicine. Previously these techniques 
needed surgical interventions, implying higher risks, cost and discomfort for the patient. 
The navigation of the minimally invasive tool in the body can be performed using 
standard imaging techniques such as echocardiography or fluoroscopy. This may prove 
cumbersome, as multiple views providing only two-dimensional projections are currently 
available on-line(l). A major pitfall in the methods presently used in electrophysiology is 
indeed the inability to accurately associate the intracardiac electrogram with a specific 
endocardial site. Thus, the localization of the recording sites with .fluoroscopy is 
inaccurate, cumbersome, and associated with high x-ray exposure for both the patient and 
the physicianUl . 
Although clinical application of on-line 3D echocardiography and magnetic resonance 
imaging are underway, until recently no technique for real-time 3D guiding of 
intervention tools and assessment of myocardial electromechanical functioning was 
available. Indeed, nonfluoroscopic electromechanical mapping has become the first 
navigation technique to accurately determine the trajectory of a tool inside the human 
heart, to guide the interventional device to a specific site, and to meticulously couple 
functional and anatomical propertics(j), 
The system 
The system is composed of a miniature passive magnetic field sensor incorporated in a 
catheter, an external ultralow magnetic field emitter (location pad), and a processing unit 
(NOG-ATM, I3iosense). The deflectable-tip catheter (NOGA-STAR, Cordis-Webster) 
contains both a location sensor just proxirnal to its tip, and standard electrodes that allow 
recording of unipolar (unipolar voltages, UPV) and bipolar (BPV) electrical signals (figure 
1a). 
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la. Tip 0/ mapping cathetel; showing the location 0/ the sensor and the electrodes. lb. Three coils 
origil1atingfrolll the lomtioll pad (C 1,2 a11d 3) that is placed tinder the ptltient. Every point sis 
locatable in 3D space by its reji:rence to the diffirent magnetic field strength .. (dista11ces ])}, 2 and 3). 
The locator pad placed beneath the operating table consists of three radiators that 
generate ultralow magnetic fields (5xl0·s to 5xlO-6 Tesla) (figure lb) that contain the 
information necessary to resolve the location and orientation of the sensor in 6 degrees of 
freedom. Indeed, the amplitude, phase and frequency of the emitted magnetic signals 
recorded by the location sensor allow the computer algorhitm to solve a number of 
complicated algebraic equations yielding the location (x, y and z) and orientation ( roil, 
pitch and yaw) of the sensor. The NOGATM processing unit consists of a computer that 
updates the acquired information in real-time and a Silicon Graphics workstation that 
displays the 3D left ventricular endocardial reconstruction. The operator can choose 
whatever view he wishes to work with during point acquisition, can add a second view in 
a separate window, and can change both views whenever he wishes to do so, during the 
mapping procedure. Besides electroanatomical activation maps, minimum voltage maps 
(showing uni- or bipolar voltages), local shortening maps, and bull's eyes views (figure 2), 
Figure 2 
(a) Electroal1atomical map in LAO view 
showing activation times ({the myocardium 
at the diffirent sites. Color-coding is from 
very early (blue) 10 lale (red). (b) 
MaximulII voltage map showing IIl1ipolar 
voltage .. at the diffirel1l measurement 
points. Color-coding is fi"Oll1 high (blue-
plllple) to very low voltages (red). (c) Local 
linear shortening (LLS) map, with colon 
going from aRinetic (red) to normal (bll/e-
pmple)' (d) Bulls eye view if the LLS lIlap, 
wilh baml (allier segments), mid and apiCtiI 
(il1l1er segments) regiom if A (anteri01), L 
(Ialeral). P (posteriol) tlnd S (septal) 
segments. The average value if LLS /J 
automatically given by the system. 
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a variety of other features are provided by the system. A full -length description however 
would lead us too far. 
Definitions 
Point loop stability: measures the maximum of distances between the locations of the 
selected point in two consecutive heart cycles. Low point loop stability indexes indicate a 
good point. 
Cycle length (CL) stability: the difference between the length of the current cycle and the 
average of the last 100 cycles recorded. 
Local activation time (LAT) stability: measure of how stable the LAT is between cycles. 
Reliable points show a LAT variation of dms. 
Location stahility: a measure of the variability in position of the catheter tip on the 
endoventricular wall during two consecutive cardiac cycles. 
Triangle jill threshoftl· by setting a "triangle fill threshold" value, the operator chooses the 
minimum triangle size for which the program will close a face on the reconstructed 
chamber (figures 3a and b). 
Figure J 
(a) Catheter tip while taking a third point, accurately located in .rpace through distances relative to 
the diffirent coils 0/ the location pad; (b) the triangle threshold allows the triangle between the three 
pointJ to be filled. 
This feature allows the operator to determine the degree to which the system will 
interpolate between actual data points and will ensure that a min.imallevel of point density 
w.ill be met at each mapped region. Usually an interpolation threshold of 30 mm between 
adjacent points is taken(:J). 
InnerpointsJilterillg: computer algorithm that removes points thought to be located inside 
the ventricular lumen (and not on the ventricular wall) or on a papillary muscle. The 
algorithm calculates relative position of points as compared to at least three neighboring 
ones and is therefore able to remove these contending points. 
Local linear shortening (LLS): The local linear shortening assessment is based on the 
assumption that in healthy myocardium any two points move closer to each other during 
contraction. Measurement of distances between neighboring points is therefore the basis 
Charla 1 - Nonjilloroscopic rea/-lillie endOl'elllriL'II/ar 1/IH:e-dilllell.l'iollu/llla{Jpillg 
for calculation of myocardial shortening. The computer algorithm takes into account the 
density of points around a point P, and gives a negligible weight to points too close 
(sampling noise) and points too far (of no influence as they provide non-local 
information). The algorithm for regional linear shortening is calculated as follows: for any 
two points on the map, i and j, LLS is calculated as the change in distance between these 
two points from end-diastole to end-systole, normalized for the length at end diastole: 
LLSij " (L(ED)ij - L(ES)ij)/ L(ED)ij 
For any point p LLS is calculated as a function of the LLSpj, for all points j=l to n on the 
map, so that 
where W is the weight of a certain point as a function of the distance Lij between two 
points i and j, the average distance D around point p (D is defined in the computer 
algorithm as the average distance of the ten closest points to p) (figure 4) 
Figure 4 
Local linear shorlening is dljined as 
the average distance that points 
move relative 10 each olher during 
systole. The computer algorhitm 
takes the ten most neighboring 
point.f, but discards points to close or 
to far from the pain! under study, 
thereby confining {/ region 0/ 
interest (orange ill pictllre). 
e ion of interest 
and the volume V at end-diastole. The weight is therefore n..ll1ction of the point density in 
a defined region, the volume of the heart and the distances between points at end-diastole. 
The mapping procedure 
The mapping catheter is introduced through a 7F or 8F femoral sheath. Prior to the actual 
mapping procedure, heparin is given intravenously (10,000 IU); additional heparin is 
given to maintain an activated clotting time (ACT) above 200s. A reference catheter can 
be inserted in to the coronary sinus or RV apex or can be applied to the back of the patient. 
A mapping catheter is then inserted into the mapped chamber. The location of the tip of 
the mapping catheter while inside the heart is gated to end diastole and is recorded relative 
II 
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to the fixed reference catheter, thus compensating for subject or cardiac motion{J). 
As the catheter tip is dragged over the LV endocardial surface (figure 5), 
Figure 5 
Dragging if the catheter over the endocardium, in this case of the right ventricle. 
(*) denotes the dijJerent positio1lJ r1 the catheter during the procedure. SCV:=. superior caval vein, 
lev= il1ftrior ((fvul vein, RA= right atrium, RV= right ventricle. The procedure ;n the left ventricle 
is essentially the .lame; the approach is retrograde through the aortic valve; some investigators we a 
tramseptal approach. 
the system continuously analyzes its loca tion in 3-dimensional space without the use of 
fluoroscopy. The set of points thus collected comprises an irregularly sampled data set of 
location points that are members of the endocardial surface. Chamber geometry is then 
reconstructed, in real time, using the set of sampled location points. The endocardial 
surface is presented as a set of polygons (triangles) whose ver tices are the sampled points. 
The local activation time (LAT ) at each site is determined as the time difference between 
a selected fiducial point on the body-surface ECG and the steepest negative intrinsic 
deflection in the unipolar intracardiac electrogram (filtered at 0.5 to 400 Hz) recorded 
from the tip of the mapping catheter. T he activation map is color coded and superimposed 
on the 3D chamber geometry. The center of mass of the reconstructed chamber is 
automatically calculated from the set of the surface points. The volume of the chamber can 
be calculated from the sum of the volumes of all tetrahedrons constructed when 
connecting the center of mass to all triangles forming the reconstructed surfacew. 'rhus, 
left ventricular end-diastolic (LVEDV) and end-systolic (LVESV) volumes, stroke 
volume (LVEDV-LVESV) and ejection fraction (LVEF, SV/LVEDV) can be calculated 
and displayed (figure 6). 
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J.lgure 6 
(a) Volume-lime wr-ve. Mini-
mUIII and maximum volumes 
are marked wilh blue crosses. 
(b) Eleclroanotomical map if 
the Jtlme patient. (c) Point 
displacemenl wrve. Poillt 
displacement all the ventriwlar 
wall is a function ~f the local 
wall mOlion. The displacement 
bar graph shows the maximum 
distance belween two localiom 
of each point within the 
recorded period. (d) Loop 
.flabilily graph. Shows 
maximulII distallus between 
Ihe localioll ~/a specified point 
at (/ specified time during 
dijferenl hearl qcles. 
The stability of the catheter-to-wall contact is evaluated at every site in real time, and 
points are manually deleted from the map if 1 of the following criteria is met: (1) a 
premature beat or a beat after a premature beat; (2) location stability, defined as a 
difference of >4 mm in end-diastolic location of the catheter at 2 sequential heartbeats; 
(3) loop stability, defined as an average distance of >4 mm between the location of the 
catheter at 2 consecutive beats at corresponding time intervals in the cardiac cycle; (4) 
cycle length that deviated> 10% from the median cycle length; (5) different morphologies 
of the local ECG at 2 consecutive beats, or severe ST-elevation of the intracardiac 
electrogram depicting excessive myocardial impression by the mapping catheter; (6) local 
activation time differences of >3 ms between 2 consecutive beats; (7) different QRS 
morphologies of the body surface ECG; (8) inner point location; (9) adjacent points closer 
than 5 mm (local linear shortening data proved to be unreliable if measured under these 
conditions) and (10) points not related to the left ventricle (such as atriallocationYl1• 
Experimental and clinical validation studies 
The initial validation studies of the mapping system were reported by Gepstein et al. (~) 
These authors first tested the in vitro accuracy of the locatable-catheter capabilities. By 
using a test jig with several holes at precise known distances from each other, they showed 
that repeated measurements of the location of one specific site differed 0.16 mm 
maximally, and that distances between specific points were equally highly reproducible 
(mean error 0.42 mm). Also, the intracardiac electrical signal from the locatable catheter 
was found to correlate highly with the signal acquired using a standard nonlocatable 
c1ectrophysiological catheter placed in the immediate vicinity of the mapping catheter 
(cross-correlation = 0.96 ::!: 0.01). In the same study, they tested the reproducibility of 
13 
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measurements performed on the beating pig's heart. Again, standard deviation (SD) for 
measurements at the same site were low (0.74 ± 0.13 mm), and the overall mean error of 
distances measured inside the body (through the use of a long sheath with markers every 
10 mm) proved to be low (0.73 ± 0.03 mm)!'n. Furthermore, Gepstein and colleagues found 
a consistent activation pattern of the left ventricle in pigs. During ventricular pacing, the 
earliest site of activation was at the site of pacing. During sinus rhythm, the earliest site 
of activation was on the superior part of the septum. Invariably, the latest site of activation 
in both rhythms was on the left lateral wall close to the mitral valve annulus. The total 
activation time of the left ventricle varied between 40 and 80 ms during sinus rhythm and 
between 57 and 87 ms during paced rhythm(4l . 
In a second series of validation studies by the same group, volumetric measurements of test 
jigs aml pig ventricles were analyzed(2). Phantom objects with known volumes showed that 
the measured volumes were very close to the actual volumes, with an average deviation of 
about 2.7%. Measurements of LV casts (with a more difficult anatomy) showed an average 
deviation of 9.6%. ,with a correlation r=0.94 with the actual volumes. Measurements of 
volumes in a dynamic test jig showed high accuracy with known volumes, deviating only 
1.4,0.7,6.0 and 5.2% for maximal volume, minimal volume, SV and EF rcspectivcly(2). In 
12 pigs tested in this study, the intra- and interobserver variability proved to be very low. 
Also, SV measurements acquired with the mapping system proved to be highly correlated 
with thermodilution cardiac output measurements (figure 7YJ). 
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Graph showing the correlation between 40 
NOGATM mapping derived J'troke ~ 
volumes (NFM, Non jluoroscopic ii 
mapping, calculated SV) and ~ 30 • thermodilution measured SV in pigs. A 
Vel] good correlation qf r2 = 0.93 was ~ • found S 20 •• 
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As further validation of the system as a tool for the assessment of local left ventricular 
function, Gepstein et a!. acquired the left ventricular electromechanical regional properties 
in 11 dogs with chronic infarction (4 weeks after ligation of the proximal LAD) and 6 
controls and compared them to the pathology results. Average endocardial local 
shortening (LS, measured at end systole and normalized to end diastole) and intracardiac 
bipolar electrogram amplitude were quantified at 13 LV regions. Endocardial LS was 
significantly lower at the infarcted area (1.2+/-0.9%, P<O.OI) compared with the 
noninfarctcd regions (7.2+/-1.1% to 13.5+/-1.5%) and with the same area in controls 
(;lJu/,la I - NrllljfllolO.YcO{Jic: rectl-lillll' I'lldrll'l'lIlrinc/ar Ihrl'('-di//lc'II.1'iUIJrd //Iupping 
(15,5+/-1,2%, P<O,Ol), Average bipolar amplitude was also significantly lower at the 
infarcted zone (2.3+/-0.2 m V, P<O.Ol) compared with the same region in controls 
(10.3+/-1.3 m V) and with the noninfareted regions (4. 0+/-0.7 to 10.2+/-1.5 m V, P ,0.01) 
in the infarcted group. Also, the electrical maps could accurately delineate both the 
location and extent of the infarct, as demonstrated by the high correlation with pathology 
(Pearson's correlation coefficient=O.90) and by the precise identification of the infarct 
border. T he authors concluded that chronic myocardial infarcted tissue could be accurately 
characterized and quantified by abnormal regional mechanical and electrical functioning!5) 
(figure 8). 
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Low! shortening map (left) showing a clear delineation if the inforct zone ( in red) il1 a dog, with 
four (1-4) brown tags, revealing the places where ablation was petformed. As one can clearly .lee, the 
ablation JileJ correlated pretty good with the sites if necrosiJ on allthopsia (right picture). It also 
becomes clearfi'om the picture that NOC/J'/'M can accurately delineate myocardial infarction zones. 
j<'rom Gep.ltein L, Goldin A, L eSJickJ, et 01. E!ectromechal1iw! characterization if chronic myocardial 
illjiJrctioll ill the canine CO/,OI101Y occlusion model. CirClllotioIl1998;98:2055-64. 
The first human studies with the NOCATM system were reported by Kornowski ct al.P) 
In 24 patients ( 12 patients with prior myocardial infarction (MI) and 12 control patients) 
LV endocardial mapping was performed to assess electromechanical function in infarcted 
versus healthy myocardial tissue, Tn patients with prior MI, the average voltage was 7.2+/-
2.7 In V (UP)/1.4+/-0.7 m V (BP) in MI regions, 17.8+/-4.6 m V (UP)/4.5+/-1.1 m V (BP) 
in healthy zones remote from MI, and 19.7+/-4.4 m V (UP)/5 .8+/-1.0 m V (BP) in control 
patients without prior M I (P<O.OOl for MI values versus remote zones or control 
patients). They clearly showed that both UPV and local endocardial shortening were 
significantly impaired in MI zones compared with controls. Also, concordance with 
echocardiographic wall motion analysis was goodP)(figure 9, figure 10). 
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Figure 9 
Example if a normal NGGA1M map. Both 
the voltage map (a) as well as lhe local 
shortening map (6) are predominantly 
green -b/lle-pillple-pink, showing high 
unipolar voltages and lowl shortening 
values. The respective b/lll's eye maps (c and 
d) show consistently high vallles if UPV 
and LLS, underlying the normal nature if 
this ventricle. Note again the low regional 
contractility and the low voltages in the 
vicinity 0/ the mitral valve annulus. 
Figure 10 
RAG view o/a patient that sllffired an anterose!tal 
in/arctiou 3 years ago. The red zones ill (a) and (b) 
delineate a zone with akinesia tlnd absence 0/ 
electrical activity. The respective hultr eye views 
show negative vollies for local shortening (tf) in the 
septal and (lnterobaJaI .legmen's, slfggeJtive if wall 
a- to dys/,inesia. The voltage map (c) shows UPV 
below 6 111 V in the Jame region. 
Kornowski et al. later reported on a comparison between NOGATM mapping and 
radionuclide perfusion imaging(6l. They showed that UP V (14.0+/-2.0 mY) and LLS 
values (12.5+/-2.8%) were highest when measured in myocardial segments (n=56) w.ith 
normal perfusion and lowest (7.5+/-3.4 mV and 3.4+/-3.4%) when measured in 
myocardial segments wi th fixed perfusion defects (n=20) (PO.0001) on single photon 
emission computed tomography imaging studies using 'wl'T'I at rest and 99mTc-sestamibi 
after adenosine stress. A significant difference in UPV and LLS values was found between 
groups (P<O.OOl for each comparison by ANOVA) . Myocardial segments with reversible 
perfusion defects (n=66) had intermediate UP V (12.0+/-2.8 m V, P=0.048 versus normal 
and P=0.005 versus fixed segments) and LLS values (10.3+/-3.7%, P=0.067 versus normal 
and P=O.OOl versus fixed segments). From these results it was concluded that NOGATM 
mapping might allow the detection of myocardial viability. 
Van Langenhovc et aL compared enddiastolic (EDV) and endsystolic volumes (ESV), 
stroke volume (SV) and ejection fraction in 44 patients with both LV angiogram and 
NOGATM mapping. Although a strong correlation (r=0.78, p<O.OOl) for EF measurement 
C;'flj'i," } - NOllj/llomscllpic rea/-lillie elit/oren/riot/llr Ihree-dimellsiOJIlI/lllappillg 
between the two techniques was found, the Bland-Altman analysis (figure 11) 
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Figure 11 
Bland-Altman analysis show-
ing the non interchangeability 
of NEM (n01!jluoroJcopir 
electromechanical mapping) 
derived ejection fraction (EF) 
measurements, and I,VEF cal-
eulated with LV angiogram. 
SD= Standard Deviatioll. 
demonstrates the disagreement and the absence of interchangeability between both 
methods. Indeed, on average, a difference of about 30% in LVEF was found(/). 
The same authors described moderate correlations between regional wall motion 
assessment using LV angiography as compared to I J,s data acquired in the same 
segments(p'O.OO1)''' (figure 12). 
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Figure 12 
Comparison of area change as derived from the 
biplane left ventriCl!lar angiogram derived in 7 
segmellh~ analyzed using the area-length method. 
Area change is% change of a specified segment in 
diastole versus systole. 
Finally, dobutamine stress echo was compared to LLS and UPV data for comparable 
segments in patients with a previous myocardial infarction. ROC curves showed 
significant cut-off values for myocardial viability ofUPV =9.0 m V (sens 56%, spec 81%, 
1',0.0001) and LLS"6.8% (sens 56%, spec 92%, 1',0.0001),". 
Fuchs et aL assessed in-vivo electromechanical changes following gradual coronary artery 
occlusion in a pig ameroid constrictor model using NOGATM(10). UPV and LLS were 
measured in the ischemic lateral and non-ischemic anterior zones in animals at rest (n = 9) 
and 5 weeks after the implantation of ameroid constrictors around the left circumflex 
artery. Echocardiography was used to assess regional contractility (% myocardial 
thickening), and an echo-contrast perfusion study was performed using acoustic 
densi.tometry methods. The ischemic lateral zone showed reduced myocardial perfusion at 
rest (peak intensity; 3.4 +/- 1.7 versus 20.7 +/- 14.8, P = 0.005), impaired mechanical 
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function (percentage wall thickening 22 +/- 19% versus 40 +/- 11%, P = 0.03; local 
endocardial shortening 2.9 +/- 5.5% versus 11.7 +/- 2.1%, P = 0.002), and preserved 
electrical activity (unipolar voltage 12.4 +/- 4.7 versus 14.4 +/- 1.9 mV, P '" 0.25; bipolar 
voltage 4.1 +/- 1.1 versus 3.8 +/- 1.5 mY, P = 0.62), compared with the anterior region. 
The authors concluded that gradual coronary artery occlusion resulting in regional 
reduced perfilsion and function at rest (i.e. hibernating myocardium) is characterized by 
preserved electrical activity. Electromechanical left ventricular mapping may be of 
diagnostic value for identifYing the hibernating myocardium(ID}. 
Recently, Vale et al. showed feasibility and safety of percutaneous, catheter-based, 
non fluoroscopic mapping guided myocardial gene transfer(Jl). In six pigs in which the 
injection catheter was used to deliver plasmid using cytomegalovirus promoter/enhancer, 
encoding nuclear-specific LacZ gene (pCMV-nlsLacZ) (50 microg/ml) to a single LV 
myocardial region, peak beta-galactosidase activity after five days was documented in the 
target area of myocardial injection in each pig. As all pigs survived until sacrifice, and no 
complications were observed with either the mapping or the injection procedures, the 
authors concluded that percutaneous myocardial gene transfer can be successfully achieved 
in normal and ischemic myocardium without significant morbidity or mortality(ll). It is 
furthermore important to underline the importance of the 3D mapping technique for 
gene <tpplication procedures, as exact delineation of the area to be treated seems 
mandatory. 
Ongoing clinical investigations 
Some burning questions related to the clinical usability of the NOGAfM mapping system 
in clinical practice still are unanswered: 
Is the local shortening function (LLS) really a reflection of the local wall motion? 
Does direct myocardial revascularization (DMR), for which this system seems to be an 
ideal guiding tool, really improve the clinical status of the patient? 
Is local gene application, again for which this system seems an optimal platform, going to 
be applied clinically? 
Is the system able to detect true viability? 
Is there need for this expensive technique for in-cathlab detection of viabilitylischemia-
when other techniques have already proven their value? 
Some of these questions will be answered by ongoing investigations. The DlRECf and 
EURO-DIRECT trials are currently enrolling patients in the USA and Europe; these 
trials (single blinded, randomized NOGAfM mapping without versus with DMR in 
patients not suitable for any other type of revascularization) are aiming to answer the 
question if the presumed benefit with DMR is simply a placebo effect, or docs really 
improve the patient's clinical and functional status (figure 13). 
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Figure 1.1 
Local shortening m~ps before DMR (aj, after DMR (b) and at 6 month follow-up (cj. The 
postero/ateral wall motion has clearly imprO'Ved, lIS witnessed by the increase in local shortening in the 
mid- and basal zones if both the posterior and !he Interal segments (see bllltf eye view, fI' through c'). 
Studies assessing "true viabil ity" in patients scheduled for bypass surgery will answer the 
question jf NOGA ™ can predict recuperation of myocardial segments with wall motion 
abnormalities after revascularization. A study assessing the possible additional benefit of 
low-dose dobutamine duri ng NOGATM mapping is currently performed at the 
Thoraxcenter. Future investigations will evaluate the possible value of adenosine in the 
detection of ischemic segments, the diagnostic value of NOGATM mapping as compared 
to magnetic resonance imaging (MRI) in myocardial viabil ity, the efficacy of growth 
factors to induce myocardial ,mgiogenesis and additional comparisons with radionuclide 
perfusion imaging studies(l2-1f,). 
CONCLUSIONS 
Left endoventricular 3D real- time electromechanical mapping is a new, in triguing 
technique for in-cathlab assessment of mechanical and electrical functioning of the left 
ventricle. Although initial studies have shown safety, feasibility and reproducibility of this 
technique, and have provided similar results as compared to established techniques in the 
quest for viability, data on the additional clinical value of the system are sti ll scarce. 
Ongoing trials on DMR and intramyocardial gene injection may definjtcly establish its 
place among currently lIsed techniques in intervcntional cardiology. 
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ABSTRACT 
Electromechanical properties of the normal human left ventricle: assessment with 
nonfluoroscopic 3-D real-time mapping 
Background: Nonfluoroscopic electromechanical mapping (NEM) has been introduced as 
a novel technique for the evaluation of electrical and mechanical functioning of the 
myocardium. In this system, local linear shortening (LLS) is the parameter used for 
assessment of local mechanical properties; unipolar (DPV) and bipolar (BPV) voltages 
represent the electrical properties of the left ventricle. Studies concerning the possible 
detection of viable or ischemic regions using this system are currently being performed. 
Also, the system is being used as guidance tool to direct new interventional modalities as 
direct myocardial revascularization (DMR) and injection therapy. As the normal left 
ventricle should be used as a reference model, and a paucity of data on this issue exist, we 
analyzed electromechanical maps in normallcft ventricles. 
Methods: Patients were included in this study if they met all three following criteria: 
1) Negative history of myocardial infarction or hospitalization for acute coronary 
syndrome; 2) Normal baseline ECG; 3) Absence of abnormal regional wall motion on 
contrast left ventricle angiogram and 4) Absence of objective signs of ischemia on stress 
testing. Nonfluoroscopic maps and left ventricle angiograms were analyzed by 
independent observers. Ejection fraction (LVEF), end-diastolic (LVEDV), end-systolic 
(LVESV) and stroke volumes (SV) were calculated, and compared to the same parameters 
of patients in the database that did not meet the aforementioned criteria. LLS, DPV and 
BPV were defined for the different ventricular segments. 
Results: Of the 110 patients in our database, 24 met the criteria for normal left ventricular 
function. LVEF and SV were consistently higher, LVEDV and LVESV were lower than 
in ventricles that did not match the criteria for normal function. LLS and DPV were high 
throughout all segments, except for posterior and septal basal segments, that showed 
consistently lower values. Finally, large variations in LLS, DPV and BPV for normal 
myocardial segments were noted. 
A strong correlation between angiography and NE]\.1 for the measurement of LVEF was 
found (R::::0.73). However, the Bland-Altman analysis performed elearly showed the 
clinical non-interchangeability between the two techniques. 
Conclusion: NEM is a powerful tool for invasive electromechanical assessment of 
myocardial function. Normallcft ventricles show consistently lower values for both UPV 
and L1,S for the posterior and septal basal regions, probably caused by mitral and aortic 
valve ring fibrous tissue. These facts should be taken into account in future evaluations of 
these regions. Also, underlying clinical conditions may account for the large variations 
between different normal segments in LLS, UPV and BPV. Finally, LVEF value for the 
same patients differ strongly when comparing NEM and angiographic assessments, 
despite their strong correlation. 
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list of acronyms 
NEM: 
UPV: 
BPV: 
LLS: 
LVA: 
RAO: 
LAO: 
LVEDV: 
LVESV: 
LVEF: 
SV: 
nonfiuoroscopic electromechanical mapping 
unipolar voltage 
bipolar voltage 
local linear shortening 
left ventricle angiogram 
right anterior oblique 
left anterior oblique 
left ventricle end diastolic volume 
left ventricle end systolic volume 
left ventricle ejection fraction 
stroke volume 
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INTRODUCTION 
Nonfluoroscopic mapping (NOGATM, Biosense-Webster, Waterloo, Belgium) is a new 
technique for in-cathlab on-line assessment of electromechanical properties of dle left 
ventricle(1). Research with this technique is now focusing on the future use for the in-
cathlab detection of myocardial viability(2), and as a guidance tool to direct novel 
therapeutic modalities as direct myocardial revascularization (DMR)(3) and direct 
myocardial injection.(.I,S) Although the system has shown its possibilities in distinguishing 
infarcted from normal myocardial tissue and from myocardium with reversible perfusion 
defects(6-101, there is still little information on the electromechanical properties of the 
normal human ventricle. Also, the currently available data on the normal canine and pig 
ventricle may not be easily applied to the human situation. (9) We therefore assessed the 
electrical, mechanical and volumetric properties in 24 patients -with normal left ventricles. 
METHODS 
Patients 
Patients were included in this study if they met all of the following criteria: 1) Negative 
history of myocardial infarction or hospitalization for acute coronary syndrome; 2) 
Normal baseline electrocardiogram, including the absence of left or right bundle branch 
block; 3) Absence of myocardial ischemia on stress test and 4) Normal left ventricle 
angiography as assessed by an independent investigator. All patients signed an informed 
consent. 
left ventricular angiography 
Left ventricle angiograms (LVA) in RAO 300 and lAO 600 were performed using 
standard techniques (11). LVA's were first analyzed visually. Only the angiograms with a 
normal contraction pattern were included in the study. Angiograms were then analyzed 
using the centerline method (CAAS II system, PIE Medical, Maastricht, The 
Netherlands). The 5F diagnostic pig tail catheters were used for computerized calibration. 
The left ventricle boundaries at end-diastole and end-systole were traced manually with a 
digitizing device. The frame showing the largest ventricular volume was chosen as the 
end-diastole, the frame with the smallest volume as the end-systole. Care was taken that 
measurements were not performed during or immediately after an extrasystole. The 
CAAS system algorithm automatically provides end-diastolic, end-systolic and stroke 
volumes, and left ventricle ejection fractions. Patients were excluded from the study if any 
myocardial segment showed reduced regional functioning (any value <-1.0 SD/chord). 
Nonfluoroscopic electromechanical mapping: 
The NEM system has been described previously. (1,6-8,10) In short, a reference catheter was 
taped securely to the patient's back. The mapping catheter (NOGA-STARTM, Biosense-
Webster, a Johnson &Johnson company), also with a tip sensor, was introduced through 
a femoral sheath and placed through the aortic valve in the left ventricle. The location pad 
fixed beneath the catheterization table generates a low magnetic field (5x10-1> to 5x10-1 
Tesla) which allows that at all times, the tip of the catheter can be located with six degrees 
of freedom (x, y, z, pitch, yaw and roll). The catheter was then dragged along the 
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endocardial surface of the left ventricle in order to acquire electromechanical data. When 
a stable signal was obtained a "point" was added to a three-dimensional map as shown on 
the NEM unit. Electrophysiological data (UPV, BPV, and local activation time) and 
mechanical data (LLS) were displayed three-dimensionally, while the images obtained 
could be viewed from different angles as chosen by the operator. A bull's eye view showing 
average voltages and LLS for 12 segments (basal, mid and apical parts of anterior, lateral, 
posterior and septal segments) was visualized on the NEM screen (figure 1). 
Figure 1 
Electromechanical assessment using nonjluoroscopic electromechanical mapping. Panel A shows 
unipolar voltages (UPV) o/"the left ventricle in 30· RAG view, with the color bar ill the upper right 
cornel: Color-coding goes from red «6 mV) to blue-pUiple (>14 mVj, with plflple zones being 
normal. The arrowhead~ delineate a zone 0/" low voltages in the vicinity 0/" the mitral valve area. 
Panel A 'shows a bull's eye view o/"the same UPV map, with -clockwise from upper right A (rmteriOl), 
L (lateral), P (po.rterim) and S (reptal) regio11S. EvelY region is subdivided into a basal (outel), mid 
and apical (innel) segment. The two arrows show the basal seplal and basal posterior segments thtlt 
clearly present lower voltages. Also, Ihe Il1Ige inter-segment variations can be appreciated. Panel B 
shows the linear local shortening (LLS) map 0/" the same ventricle. The arrowheads delineate the 
ventricular segment with low LLS, located in the mitral valve area. Panel B ' shows the bull's eye 
view 0/" the LLS map, with the arrows directed at the basal septal and basal posterior Jegments with 
lower vailies as compared to the other segments. Again, Il1Ige inter-segment dijJerences can be noted. 
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The LLS assessment is based on the assumption that in healthy myocardium any two 
points move closer to each other during contraction. Measurement of distances between 
neighboring points is therefore the basis for calculation of myocardial shortening. The 
computer algorithm takes into account the density of points around a point p, and gives a 
negligible weight to points too close (sampling noise) and points too far (of no influence 
as they provide non-local information). The algorithm for LLS is calculated as follows (12): 
for any two points on the map, i and j, LLS is calculated as the change in distance between 
these two points from end-diastole to end-systole, normalized for the length at end 
diastole: 
LLSij ~ (L(ED)ij - L(ES)ij)/ L(ED)ij 
For any point p LLS is calculated as a function of the LLSpj, for all points j=l to n on the 
map, so that 
LLSp~ (Sj~l..n Wpj (L(ED)pj)x LLSpj ) / Sj"l..n Wpj, 
where W is the weight of a certain point as a function of the distance Lij between two 
points i and j, the average distance D around point p (D is defined as the average distance 
of the ten closest points to p) and the volume V at end-diastole. The weight is then 
function of the point density in a defined region, the volume of the heart and the distances 
between points at end-diastole. We used the revised NOGA 4.0 software version 
(Biosense-Webster, Johnson&Johnson, June 2000) with (1) a new weight function so that 
very close neighboring points within the range of noise are not given any weight and do 
not influence the LLS value of the investigated point, and that very distant points do not 
influence LLS for a certain point, (2) changing the arithmetic mean by the geometric 
mean which is better suited for location validation because it is virtually unaffected by the 
density of points; (3) very careful determination of the apical point, either defined 
automatically by the system or manually by the user. If such a point it is not meeting the 
criteria of the various filters a "Location-only" (where its value is not used to determine 
the LLS in this particular region) comment will appear on the Point List. The user can 
then decide if another near point in the apical region should be defined as Apex. If the 
original point is kept then the LLS will not be computed but will rather represent the 
average of its neighbors. The changes in the new software have been validated (Biosense-
Webster, personal communication). 
Statistics 
Statistical analysis was performed using SPSS, version 9.0 (SPSS Inc., Chicago, Illinois, 
USA). Data arc expressed as mean ± SD. Correlations were performed using Pearson's 
test. LVEDV, LVESV, LVEF and SV were compared using an independent Student's 
t-test. LVEF values measured using NOGA and LV angiogram were compared with the 
Bland-Altman test. Means of nominal values for LLS, illV and BPV were compared 
between all segments by the Wilcoxon signed ranks test. A l<riedman nonparametric test 
was used where appropriate. A value of P<0.05 was considered statistically significant. 
Cbtli/C)" 2 - Elec/rolllechmlical proper/ie.I' of/he 1l017l1U! !mmml !eft vellfricle 
RESULTS 
Between June 1997 and April 2000, 110 patients were studied. Of these, 24 met the 
criteria for normal left ventricular function. Clinical characteristics of both groups are 
shown in the table. 
NOlmal LV ftmction Abnonnal LV function 
(n~24) (n~86) 
Age (years ± SD) 61 ± 12 57 ± 9 
Male 21 (88%) 73 (85%) 
Previous MI (n) 0 80 (93%) 
Previous PCI (n) 0 68 (79%) 
Previous CABG (n) 0 46 (53%) 
Signs of ischemia on non- 0 54 (63%) 
invasive testing (n) 
Congestive heart failure (n) 0 23 (27%) 
Hypertension (n) 6 (25%) 46 (53%) 
Diabetes (n) 1(4%) 13 (15%) 
Smoking histOlY (n) 7 (29%) 44 (51 %) 
Hypercholesterolemia (n) 8 (33%) 53 (62%) 
Family history (n) 1(4%) 21 (24%) 
Table 
Clinical parameten of patients with normal and abnormal left ventricular function. LV=ltji 
ventricle, MI=myocardial infarction, PCI=percutaneouJ coronary intervention, CABG=coronary 
m-tel] bypass grqft. 
The average procedure time for the acquisition was 49 ± 18 minutes for normal maps 
versus 44 ± 22 minutes for NEM maps of the diseased ventricles (p=OA). All 110 patients 
remained in stable hemodynamic conditions during the respective procedures, as 
confirmed by continuous in-cathlab heart rate and blood pressure monitoring data. One 
patient suffered a stroke after diagnostic catheterization, before introduction of the 
NOGA-catheter. Four patients had a pericardial effusion after the procedure, two of 
which required pericardial drainage. One patient died of a large intramyocardial effusion 
with subsequent heart arrest that could not be corrected despite urgent surgical treatment. 
No complications however occurred in the last 40 procedures, and no complications were 
seen in the "normal" group. NOGA-derived LVEDV (90±33ml versus 107±42ml, 
p=0.04), LVESV ( 51±22ml versus 77±37ml, p=O.OOl), SV (38±13ml versus 30±12ml, 
p=O.003) and LVEF (44±8% versus 29±10%, p,0.0005) differed significantly for the 
normal versus the diseased ventricles. Average LLS for all segments of the normal 
ventricles was 15.6±7.4%j average UPV was 15.1±5.6mV, average BPV was 4.5±2.9mV. 
LLS however varied consistently throughout the left ventricle: LLS of apical segments 
was higher than that in all other segments (18.0±6.5% versus 14.4±4.8%, p=O.OOl). LLS 
of the posterior basal (9.0±6.8%) and the septal basal (6.0±5.7%) segment were also 
consistently lower than all other segments (p<O.0005 for all comparisons). Average UPV 
for all segments was 15.1±5.6mV. UPV's were higher in all apical and mid-segments as 
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compared to all basal segments (17.2±5.4m V and 10.8±3.5m V respectively, p<0.0005). 
Again, values were lowest in the posterior basal and septal basal segments (9.6±3.1m V and 
8.4±3.2m V respectively, p<O.0005 for all comparisons). 
Pearson correlation graph between DPV and BPV for the same segments is shown in 
figure 2. 
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Figure 2 
Correlation graph q( unipolar (UPV) 
and bipolar voltages (BPV) for all 
segments 
Correlation was only moderate 
(R=0.59), albeit highly significant. 
BPV's were lower in the basal 
septal region as compared to all 
other regions (2.3±1.3m V versus 
4.8±2.8m V, p<0.0005 for all 
UPV (mV) all segments comparisons), but not consistently 
for the posterior basal region. 
Bipolar voltages differed importantly amongst segments, ranging from 6.3±3.8m V in the 
apical septal segment to 3.S±2.Sm V in the mid anterior segment. 
LVEF measured by NOGA mapping correlates with LVEF calculated using the LV 
angiogram (R=0.73, 1'<0.0005) (sec figure 3). 
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Correlation of left ventricular ejection 
ji'action (EF) as asse.ued by 
angiography versus nonjluoroscopic 
mapping. 
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The Bland-Altman graph however demonstrates the difference of ±2S% tn LVEF 
between the two methods (see figure 4). 
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Figure 4 
Bland-Altman comparison of left 
ventricular ff/edion fraction assessed by 
angiography versus norifluoroscopic 
mapping. The Bland-Altman analysis 
maps the dijJerences between the two 
techniques and the averages qf the 
values obtained by the two techniques. 
Ideally, all points would be on the zero 
reference line (when the two techniques 
show no dijJerence in the absolute value 
obtained). The other two refirence lines 
demonstrate the + and -1.96 standard 
deviations qfthe dijJerences. As most qf 
80 the values shown, appear outside 0/ 
these borders, if can be concluded that 
the two methods are clinically not 
interchangeable. 
Large variations for LLS, DPV and BPV between normal segments were noted. LLS 
ranged from 3.7% up to 30.4%, UPV from 3.0 up to 34.5, and BPV from 0.3 up to 16.5. 
The study however was not powered to detect possible clinical parameters predictive for 
differences in elec-tromechanical parameters. 
DISCUSSION 
The main finding of this study is that UPY and LLS are consistently high throughout the 
normal left ventricle. Regions surrounding the aortic, but mostly the mitral valve area 
(posterior and septal basal regions) however both show lower DPY as well as LLS, when 
compared to all other regions. These findings are explained by the presence of dens fibrous 
tissue in the valve region, that shows both a limited movement and a limited amount of 
functional myocardial cells, accounting for the lower voltages measured. 
The correlation between DPY and BPV was significant, albeit very moderate. Also, BPV 
did not consistently show lower values in the entire valve area, although significantly lower 
BPV was seen in the basal septal area. Although it has been shown that BPV recordings 
may be less influenced by contact stability, and far-field potentials, it is also known that 
the orientation of the catheter tip towards the mapping area may influence the magnitude 
of the BPV signal. The difficulties in mapping the area very close to valves and the 
sometimes awkwardly curled catheter profiles in these areas may therefore account for the 
lack of strong correlation of BPV with UPV in some of the basal myocardial segments. 
Only one study has previously described nonfluoroscopic mapping in normal, healthy 
myocardium in human volunteers(8). In that study, mean values for all myocardial segments 
were 19.7±4.4 mV for UPV, S.8±l.OmV for BPV and 14.3±2.7% for LLS. The findings in 
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our study are consistent with these results: DPV=15.1±5.6mV, BPV=4.5±2.9mV, 
LLS=15.6±7.4%. Although Kornowski et al. mention the trend towards lower voltages in 
the mitral annulus area, no measurements are set forward. Our study is therefore the first 
to clearly delineate areas that show physiologically altered electromechanical properties. 
When defining electromechanical properties of posterior and septal areas, these findings 
should be taken into account. 
Although not the main purpose of our study, we compared LVEF as assessed by 
electromechanical mapping using the new NOGA 4.0 software and compared these data 
with angiographically measured LVEF. We found a strong correlation, albeit with 
important absolute differences, as shown by the Bland-Altman analysis. Previously we 
have shown that in diseased ventricles, the two methods were not interchangeable for EF 
measurement (13). In that study however, the use of a previous software version and the 
limited mapping experience may in part have accounted for the large differences in EF 
found. In the present study, although the differences are still important, EF measurements 
come in the range of echocardiographic and magnetic resonance measurements, which in 
previous studies have also shown differences in EF as compared to angiography that may 
reach up to 20-30%(14,15). The differences may be caused by the differences in volume 
calculation of the two methods, the fact that the pig tail catheter is used for calibration in 
the angiography method, which may induce significant absolute faults, the possibility that 
the mapping catheter may not reach all relevant areas, and also the fact that the effects of 
a sudden contrast injection into the left ventricle are not clear(16-18). 
Limitations. The ventriculogram is a two-D reconstruction of a three-D structure, and may 
therefore not constitute the optimal technique for wall motion abnormality detection. 
Also, the computer-assisted centerline method is subject to interobserver variability, as 
choosing of the respective digitized cine frames and manual tracing of the endocardial 
border is operator-dependent. However, also a negative history and the absence of ECG 
abnormalities were necessitated to enter the study, so that it is probable that these were 
indeed normal left ventricles. The limitations concerning LV angiography may however 
influence the value of the EF measurements. Also, the importance of accurate apex 
positioning is of cornerstone importance. Indeed, the whole segmental division performed 
by the computer's algorithm is based on the initial choice of the apex by the operator. 
Although in all patients we carefully checked for defining the true apex, there is no 
absolute certainty that in all cases this was effectively accomplished. 
Last, although high values for LLS and DPV were found in these normal ventricles, there 
still arc important differences amongst patients (as there were in the study by Kornowski 
et al. (8): differences for DPV reached from as low as 3m V to as high as 34m V, and for LLS 
from as low as 0% to as high as 33%. Although we performed a regression analysis model, 
no predicting clinical factor (such as gender, age, diabetes, use of beta-blockade, use of 
anti-arrhythmic medication ... ) could be isolated. The current study was not powered to 
find such differences. It remains to be seen if certain clinical characteristics may alter 
baseline voltages and local shortening function. 
In conclusion, our study showed consistently high LLS, DPV and BPV throughout most 
of the left ventricle in patients with normal myocardial function. Only the basal septal and 
the basal posterior segments in the mitral annulus area showed lower LLS and UPV, with 
respect to the rest of the left ventricular segments. These findings have to be taken into 
account when assessing the myocardial function in this area. Secondly, NEM -derived 
e;',lf'ff'i")- Eleclromechal1ical pl¥!perlies (!fllre I!O/mal human lefllYn/ride 
LVEF differs significantly from angiographic measurements, and may therefore 
necessitate comparison with other accepted techniques. Third, large differences in LLS, 
UPV and BPV of normal myocardial segments exist between patients and between 
normal segments in the same patient. 
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STRUCTURED ABSTRACT 
Background: Recently, a novel non-fluoroscopic three-D electromechanical mapping 
technique was introduced in the clinical arena. Although initial in vitro and in vivo studies 
suggested the reliability of the system in volumetric and hemodynamic evaluation of the 
left ventricle, no validation in humans has been performed. 
Methods: A nonfluoroscopic electromechanical mapping (NOGATM, Biosense-Webster) 
procedure was performed in 44 patients. All patients received a contrast left 
ventriculogram during the same session. Volumetric ( end-diastolic (EDV) and end-
systolic volumes (ESV)) and hemodynamic ( LVEF and stroke volume (SV)) parameters 
using both systems were compared. 
Remits: Two uncomplicated pericardial effusions occurred with the first-generation 
mapping catheters. Using the new-generation mapping catheters, no procedural 
complications were noted. Significant correlations were found between mapping-derived 
and ventriculography-based measurements for both ESV (r=0.67, p<O.OOl) and LVEF 
(r=0.78, p<O.OOl). Absolute volumes, however, were only comparable for ESV (46.6 ml 
±25.3 vs 48.8±37.0 resp, p~0.13), but differed greatly for LVEF (35%±13 vs 65±19 resp, 
p,O.OOl), EDV (69.1mI±28.6 vs 125.9±53.4 resp, p'O.OOl) and SV (22.4±9.9 vs 
77.1±33.7 resp, p<O.OOl). Moreover, Bland-Altman analysis showed the clinical non-
interchangeability between these techniques for the measurement of hemodynamic 
parameters. 
Conriusion: Measurement of hemodynamic parameters using nonfluoroscopic mapping of 
the left ventricle is feasible and safe. The system provides data that strongly correlate, but 
that are in clinical disagreement with angiographic data. Therefore, the interchangeability 
of these techniques may be questioned. 
SHORT TITLE: 
Three-D mapping for evaluation of LV volumes and EF 
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INTRODUCTION 
The acquisition of hemodynamic data and the assessment of the left ventricular function 
remain of cornerstone importance in clinical cardiology. These parameters may playa role 
in the assessment of the severity of several cardiac disorders, may direct therapeutic 
options, and can evaluate the efficacy of measures taken(l-4). Changes in left ventricular 
volumes during the various stages of the cardiac cycles and hence the left ventricular 
ejection fraction, have been measured by a variety of techniques, such as two-dimensional 
(two-D) echocardiography(5,61, two-D echocardiography with automated border 
detection(7.Rl, three-D echocardiographyl9.lG1, radionuclide ventriculographyln-ul, left 
ventricular contrast angiographyl141, computed tomographyl!5) and magnetic resonance 
imaging (MRI)(l6-18). Most of these techniques however may have limitations. Two-D 
echocardiographic as well as angiographic techniques are based on geometric assumptions; 
this can be particularly hazardous when confronted with distorted ventricular anatomy. 
Three-D reconstruction ofleft ventr.icle dynamic volumes is time-consuming and can not 
be performed on-line, and -as in all echocardiographic techniques- depends on a good 
precordial image quality. Isotope-scanning techniques are expensive, while exact volume 
calculation is difficult. Furthermore computed tomography and MRI are not readily 
available. 
Recently, a novel technique using a non-fluoroscopic electromechanical mapping (NEM) 
system has been proposed(19). This technique utilizes a miniature locatable sensor that is 
incorporated in a 7 or R F (first generation) flexible catheter. Through the induction of a 
low magnetic field and with the use of a reference catheter that is placed on the back of 
the patient, the precise three-D location of the catheter-tip can be determined on-line. At 
the same time, electrodes located in the tip of the catheter measure typical 
clectrophysiological data. The use of this technique in the assessment of volumetric 
measurements and of hemodynamic parameters has recently been validated in vitro and in 
the animal model(20). In the present study we compared left ventricle (LV) volumes and 
ejection fraction (EF) measured by the NEM system to LV angiogram derived 
measurements. 
METHODS 
Definitions 
Point loop stability (1.8): measures the maximum of distances between the locations of the 
selected point in two consecutive heart cycles. Low absolute 1.S values indicate a good 
point. 
Cycle length (CI.) stability: the difference between the length of the current cycle and the 
average of the last 100 cycles recorded. 
Local activation time (UT) stability: measure of how stable the LAT is between cycles. 
Reliable points show a LKf variation of dms. 
Location stability: a measure of the variability in position of the catheter tip on the 
endoventricular wall during two consecutive cardiac cycles. 
T7-iangie jiJI threshold: this parameter, which can be altered by the operator, defines the 
minimum triangle size for which the computer algorithm will close a space between 
adjacent points, and thus will make an interpolation between actual data. For our data set 
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we used a uniform value of 40 mm. 
Inner points filtering: computer algorithm that removes points thought to be located inside 
the ventricular lumen (and not on the ventricular wall) or on a papillary muscle. The 
algorithm calculates relative position of points as compared to at least three neighboring 
ones and is therefore able to remove these contending points. 
System components and mapping technique 
The system and its var.ious components have been described previously (19-2.1). In short, a 
low magnetic field (10-' to 10-6 Tesla) is generated around the patient. A catheter securely 
taped to the patient's back serves as a reference to compensate for subject or heart motion 
during the procedure. A 7 or 8 French catheter containing a locatable sensor and recording 
electrodes in its deflectable tip is inserted through an 8 F femoral sheath and is then 
moved along the left ventricular endocardium. Acqu.ired signals are then send through the 
catheter shaft and processed by the NOGA processing unit (Biosense-Webster). The 
system can determine the location (with an accuracy of dmm) 24 and orientation of the 
catheter in six degrees of freedom (x, y, z, roli, pitch, and yaw). Electromechanical 
information is obtained using a combination of data gathered by the electrodes and the 
location sensor. T'hus unipolar and bipolar endocardial potentials and local linear 
shortening data for every contact point are acquired, and can be displayed in bull's eye 
maps. Chamber geometry can then be accurately reconstructed using three-D endocavital 
information. 
The computer algorithm directly calculates three-D volumes. Acquired points arc 
synchronized using the intracardiac electrocardiogram provided by the system. At any 
specific point in the cardiac cycle, the system is able to calculate volumes by connecting all 
available points in a three-dimensional polyhedron. The computer algorhitm addresses the 
largest volume as the enddiastolic volume (EDV), and the smallest as the endsystolic 
volume (ESV). Ejection fraction is calculated as ( EDV ~ ESV)! EDV; stroke volume 
(SV) is calculated as EDV - ESV. 
Post-processing of data was performed to eliminate points suggestive for catheter tip 
instability, as evidenced by catheter point loop stability, cycle length stability, local 
activation time and location stability data. A triangle fill threshold of 40 mm was chosen 
for our data set. This setting allows the system to fill triangles between acqu.ired points 
using an interpolation algorithm; distances between points larger than 40 mm were left 
blank until points in between were captured. 
After applying an inner point filtering by the computer algorithm, points were manually 
deleted when they did not fit standard stability criteria ( location stability <4mm, cycle 
length stability < 10% and loop stability <4mm), if they were taken during ST-segment 
elevation (suggestive for severe wall impression), if adjacent points were closer than 5 mm 
(local linear shortening data proved to be unreliable if measured under these conditions) 
and if the points were not related to the left ventricle (such as atrial location). 
Contrast left ventricular angiogram 
Prior to the electromechanical mapping, biplane left ventricular angiograms in a 30° right 
anterior oblique and 600 left anterior oblique view using 7 F pig tail catheters were 
performed. Calibration was performed using non contrast-filled catheters. Measurements 
of ventricular volumes were calculated during sinus rhythm only . Measurements of 
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ventricular volumes during or after an extrasystole were avoided. LV angiograms were 
made with the patient in a stable position and during maximal inspiration. The 
measurements were performed on the eAAS IT system (PIE medical, Maastricht, The 
Netherlands) by an independent investigator, who was blinded for the left ventricular 
mapping data. This system calculates left ventricular volumes using the area length 
method of Dodge for single plane angiography, modified by Kennedy et al(25.16). Ejection 
fraction was then calculated through the above mentioned formula EF ",(EDV-
ESV)/EDV 
Patients and mapping procedure 
T he study protocol was approved by the ethics committee of the hospital, and all patients 
signed an informed consent prior to the procedure. 
Coronary angiography was performed in all patients using standard 6F diagnostic and 7F 
pig tail catheters. A 7 or 8F mapping catheter was then introduced through an 8 F femoral 
sheath and placed in the left ventricle. The apex of the left ventricle and the aortic and 
mitral valves were located using fluoroscopic guidance, to ensure the exact location of 
these important anatomical landmarks, which could then be used as reference points. 
Further mapping was done solely using the mapping system, unless repositioning of the 
catheter in the left ventricle was necessary. 
The volume-time curves were examined to make sure that smallest and largest volumes 
along the cardiac cycle were chosen by the computer algorithm to calculate the 
hemodynamic parameters (figure 1). 
Figure 1 
Example of voilime-time wrves displayed by the l1011-j111oro, fcopic electromechanical mapping 
(NOGAJ1. I) system. The blue + marks in the lift-side picture show the points ofminimal and maximal 
volumes, respectively. Electromechal1ical mapfi fihowillg maximal and minimal volumes are shown to 
the right. 
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To ensure hemodynamic stable conditions during the mapping procedure, heart rate and 
blood pressure were monitored continuously. 
A representative map of the left ventricle in end-diastole and end-systole, and its 
corresponding RAO and LAO ventriculographic views are shown in figure 2. 
Figure 2 
Example 0/ ventriwlogrophic (A-D) and corresponding unipolar voltage (UPVj maps ming the 
NOGATM system (A'-D'). A""RAO at end-diastole with A' as i/.~ corresponding view using the 
mapping system in the same patient; B (B,) ""RAO end-.rystole; C (C,) "" LAO end-diastole; D (D') 
:=LAO end-.rystole. The color code shown in A' shows regio115 with UPV < 6 mV in red, and zones 
with high UPV in blue-pmple (>14 mV). Enddiastolic (EDV) tlnd endsystolic (ESV) volumes, 
stroke volume (SV) (lnd left ventricular ('jection fraction (LVEF) are shown for both techniques. The 
most dhtal apical part is possibly not entirely mapped, explaining in part why end diastolic 
mea.wrements may be underestimated using the mapping technique. 
Statistics 
Data are reported as mean ± SD. Means of values acquired with both techniques were 
compared using an unpaired Student's t-test. Correlation coefficients are reported as R2 
and were calculated with a Pearson test. The technjques used for volumetric data 
acquisition and ejection fraction calculation were compared using a Bland-Altman test(1). 
A value of p<O.05 was considered significant. 
RESULTS 
A mapping procedure was performed in 44 patients. Mean age of the patients (39 males, 
89%) was 59.2 ± 9.7 years. Twenty-nine patients (66%) had a previous myocardial 
infarction with wall motion abnormalities on the LV angiogram. Twenty-four patients 
(55%) had a history of coronary artery bypass surgery, 29 patients (66%) were previously 
treated with a percutaneous coronary intervention. Maps were performed with an average 
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procedure time of 45 ± 15 minutes. On average, 89 ± 42 ( range 77-165) points were taken. 
Mter editing, 62 ± 30 (range 51-113) points remained as the basis for our analysis. With 
the 8F first generation catheter there were tvvo incidents of pericardial effusion 
necessitating pericardial drainage. With the new 7F catheter (n=18) there were no 
procedural complications. Average fluoroscopy time was 3.2 ± 2.4 minutes. The catheter 
was re-introduced into the left ventricle 4 ± 2 times. 
Mean values of angiographic and endoventricular mapping EDV, ESV, SV and LVEF 
data are shown in the table. Except for the ESV values, the absolute values as measured 
by the two different methods were significantly different between individual patients. As 
the ESV values were comparable for both methods) the higher enddiastolic volumes 
measured by contrast ventriculography account for the higher values of LVEF measured 
with this technique. The Pearson test (see table) 
'Table. Comparison between LV angiogmphy and NOGATM mapping for the assessment if 
hemodynamic pammeters 
NEM- Angiographic Comparison Correlation p-value of 
I parameters parameters of the means I (Pearson) R2 correlation 
MaxVolume 69.1 EDV Angio 125.9 <0.001 0.09 0.1 
I (ml ± SD) ± 28.6 (ml ic SD) + 53.4 
MinVolume 46.6 ESV Angio 48.8 0.13 0.45 <0.001 I (ml ± SD) ± 25.3 fml ± SIl) ± 37.0 
SV 22.4 SV Angio 77.1 <0.001 0.014 0.52 
I (ml ± SO) ±9.9 ml ± SD) ± 33.7 
LVEF 35 LVEF Angio 65 <0.001 0.61 <0.001 
'(% ± SD) ± 13 I (%± SD) ± 19 
_.-
The table shows the respective volumes if the left ventricle and the derived pammeters LV.f.""'F and SV 
measured by the two methodJ; NEM =NonftuoroJcopic Electromechanical Mapping, SD=Standard 
Deviation, Max= maximum, Min =minimum, LVEfi'=Lift Ventricular Ejection Fmction, EDV 
=EnddiaJtolic Volume, ESV =Endsystolic Volume, Angio =Angiogmphic. Colun1m 5 to 7 show the p-
value for the comparison 0/ the meam, correlation R2 (Pearson) and the p-value .for correlation, 
respectively. 
shows the correlation coefficients betvveen measurement techniques. A significant 
correlation between NOGATM and angiography for ESV and EF is shown, where no such 
correlation was found for EDV and Sv. When we divided the patients in groups without 
versus with regional wall motion abnormalities, correlations for EF, EDV, ESV and SV 
were 0.08 (not significant (NS», 0.14 (NS), 0.50 (p=0.04), and 0.1 (NS) respectively for 
the normal ventricles, versus 0.69 (p=0.005), -0.38 (NS), 0.15 (NS) and 0.54 (p=O.03) 
respectively for the ventricles with wall motion abnormalities. 
The correlation between the two methods is shown in figure 3. 
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Scatterplot for the left ventricular ejection fraction (LVEF) obtained with angiographic (Angio) and 
110rifluoroscopic (NEM) measurements of LVEF 
A line 0/ equality is drawn in the picture. This line shows the optimal situation in which the values 
r::/a parameter measured by two dijJi:rent method, would 110t only correlate fmftctly, but in which the 
measurement techniques would aIm be interchangeable. The line 0/ correlation, the corre/ation 
equatioJ1 and the value r::lcorrelation are aho shown. 
Although this method of comparison may not provide a correct interpretation of the 
data(27), the figure however provides an idea of the general correlation betw'een the 
methods. The line of equality and the line of correlation approach each other in the area 
of lower ejection fractions, suggesting a better correlation between the two methods for 
patients with worse ejection fractions. 
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two techniques, with values measured by l~jt ventricular angiography being on average 31% higher. 
EF '" Ejection Fractiol1; Angio '" Angiographic; NEM = Nonjluoro.>copic Electromechanical 
Mapping; SD = Standard Deviation 
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Figure 4 shows a Bland-Altman analysis comparing angiographic measurements ofLVEF 
and nonfluoroscopic electromechanical mapping measurements. 
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figure Sa. rlland-Altman comparison 
of EDV measurements. 
Mean ditrcrenee = 43.8 ± 53.8 ml 
Figure 5b. Bland-Altman comparison 
of ESV measurements. 
Mean difference = -14.2 ± 27.7 IllI 
Figure 5e. Bland-Altman comparison 
ofSV measurements. 
Mean ditIcrenee = 33.3 ± 44.7 ml 
The dif/erent Bland-Altman plotsjor End-Diastolic Volumes (EDV), End-Systolic Volumes (ESV) 
and Stroke Volume (SV) respectively. Only measurements c:lESV are in relatively close agreement 
with one anothel: Measurements if ED Vand SV difftr on average 33 ml and 44 ml respectively, and 
therifore do not seem to be interchangeable in the clinical setting. 
Figure 5 shows Bland-Altman analyses for ESV, EDV and SV measured by the two 
techniques. These figures demonstrate the disagreement and absence of interchangeability 
betwccn all measured parameters, even for those measurements that showed the strongest 
correlations. Indeed, the average difference mounts up to 44±S4 illl, -14±28 ml, 33±4S rul 
and 31±37% for EDV, ESV, SV and LVEF respectively. 
Also, a bivariate Pearson's correlation test showed a significant correlation between the 
45 
46 
Chilph'/".} - Three-D mapping/or Cl'lt/uut;OIl of LV POll/lIle.l· (lild EF 
total amount of points acquired and of points edited, and the maximum diastolic volume 
measured by NEM (correlation R2 0.40, p,O.OOl and 0.50, p,O.OOl respectively). 
DISCUSSION 
The current study showed that the absolute values of LVEF and ESV provided by the 
mapping technique are correlated to the volumetric measurements using angiography. 
However, the Bland-Altman analysis showed an important disagreement and thus a 
clinical non-interchangeability betvveen the tvvo measuring techniques. As shown in the 
table, end-systolic volumes had a good correlation, but end-diastolic volumes differed 
greatly. Moreover, ventricles with regional wall motion abnormalities seemed to have 
better correlations for both LVEF and SV than did normal ventricles. The explanation for 
these findings is not straightforvvard. One possible explanation is that spaces betvveen 
chordae, or around the papillary muscles, are filled with contrast, but are not easily reached 
with the mapping catheter. In the end-systolic phase these spaces are cleared of contrast 
through the muscular contractions, and the end-systolic volumes recorded were indeed in 
better agreement for both techniques. Also, careful review of the angiograms acquired in 
our patients suggested a considerable movement of the apex towards the base of the 
ventricle; earlier studies using implanted markers however clearly showed the remarkable 
station;:lry behavior of the apex(2S-30). This may account for a difference of the volumetric 
changes. Thirdly, there is no certainty that at the end of a mapping procedure, all 
myocardial areas are covered. As the three-D reconstruction is based on points collected 
by the mapping catheter, the LV volumes can be underestimated if not all regions of the 
LV were covered by the catheter. It is furthermore clear that within these non-covered 
regions anatomical variations may occur. We used the area-length method for the 
angiographic measurements. Although minor differences between measuring techniques 
may exist, Kussmaul et at. recently found that all methods correlate well and do not show 
important differences in volumetric analysis. (.1.1) 
Nonfluoroscopic electromechanical mapping is a novel technique that enables the 
investigator to acquire on-line information on electrical and mechanical endoventricular 
functioning of myocardial tissue. Previously, investigators have found this technique to be 
easy, safe, reliable and reproducible(3l). Kornowski et al. showed the reliability of the system 
in differentiating normal from infarcted myocardial tissue(23). Gepstein et al. found a strong 
correlation of hemodynamic parameters in the animal model acquired with NEM and 
stroke volume measured through the Fick method(20). This study however was performed 
on only 12 pigs with a normal left ventricular fimction, so that the drawing of definite 
conclusions from this experience may be hazardous. Another issue that may interfere with 
our findings, is the inter- and intra-observer variability. Gepstein et al however showed a 
low intra- (8% for EDV, 12% for ESV, 5% for SV and 7% for EF) and inter-observer 
variability (6% for EDV, 8% for ESV, 11% for SV and 7% for EF). Again, the study refers 
to only 12 pigs(20). 
The number of points acquired and the number of points retained in the manually edited 
maps in the present study correlated strongly with the EDV measured. This finding 
confirms the first results of Gepstein et aI., where he stated that volume measurements can 
be performed accurately after acquisition of 40 points in the animal model (20). Possibly a 
much higher amount of points is needed in the ischemic and distorted left ventricle. The 
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low end diastolic volumes obtained by electromechanical mapping may indeed reflect 
incomplete endocardial sampling. 
Although the LV angiogram is considered a "gold standard", the literature on the value of 
measurements of ventricular volumes using angiography is somewhat contradictory. 
Volumes calculated by the different angiographic volume calculation methods regularly 
exceed known volumes(32).This might be explained by the fact that all current methods 
apply an ellipsoid reference, which might not be truly representative of the irregularly 
shaped LV. Previous studies have shown lower absolute values by other techniques such as 
radionuclide tomography (25% differenceY33), echocardiography (35%)<-'4)) or computed 
tomography studies(40%)<-'I)) measuring LVEF as compared to ventriculography, while 
others showed good correlations between the different methods (.lo.m. Starling et al. showed 
that standard orthogonal projections (RAO 30" and LAO 60°) as used in our study, 
provide accurate determinations ofleft ventricular volumes and hence ejection fractions(.lR). 
Rogers et al. found a highly accurate volume determination using biplane 
angiocardiography in the RAG/LAO method(39). Beier et aL recently found that manual 
contour detection for left ventricle angiographic volumetry results in an over-estimation 
of the measured volumes. These authors stated that these measurements arc case 
dependent and should only be seen as an estimate of the actual values(~n). A second 
observation is that the ancillary structures inside the left ventricle are not taken into 
account when calculating the size of the left ventricle with angiography. Indeed, structures 
as the papillary muscle are obscured by contrast on two-dimensional films, and volumes 
arc calculated as if these structures were not present. Furthermore, it has not been shown 
what the precise effect is of a sudden injection of a volume of contrast material on the left 
ventricular function. Possibly the hyperacute (i.e. within seconds) effect is negligible, as 
previously shown.(41,42) Erbel et aL however showed comprehensively that 10 minutes after 
contrast injection the ischemic ventricle shows a pronounced alteration ( increase as well 
as decrease, depending on amount and duration of injection and baseline hemodynamic 
characteristics) of the systolic and diastolic functiodH ). It is therefore possible that during 
the mapping procedure (performed immediately after the contrast ventriculogram) left 
ventricular volumes and hemodynamic properties are influenced by a previous injection of 
contrast. 
It could be of relevance that non-fluoroscopic measurements arc made during a time 
period of circa 30-40 minutes. Although hemodynamic stability was present in all patients 
during the procedure, it is possible that in this time frame, some minor changes in the LV 
function occurred. Also, as this technique is not easy to master, and has only recently been 
developed, increased operator experience may improve the agreement between the two 
methods. 
In conclusion, our study showed that LVEF measurement using nonfluoroscopic mapping 
of the left ventricle is feasible and safe. The system however provides data that are in 
strong correlation but clinical disagreement with LV angiographic data. Therefore, the 
interchangeability of these techniques may be questioned. Announced improvements of 
the computer algorithm (with smoothening of the contours detected by the mapping 
catheter) may rectify this shortcoming. 
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Two-sentence summary for the table of contents 
In 40 patients, we compared local linear shortening assessed with nonfluoroscopic 
electromechanical mapping (NEM) as a function of regional wall motion with 
echocardiographic data in a subset of patients with severe coronary artery disease and 
subsequently decreased LV-function. Our study showed that NEM mapping can 
accurately assess regional wall motion. In addition, this study showed a significant 
decrease in unipolar voltages amongst segments with declining regional function. 
Running Head: 
Nonfluoroscopic mapping for left ventricle evaluation 
Key words: 
Nonfluoroscopic mapping 
Echocardiography 
Regional wall motion 
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Text 
Recently, a novel nonfluoroscopic electromechanical (NEM) three-dimensional on-line 
in-cathlab mapping device for assessment of left ventricle electrical and mechanical 
function has been introduced(I). The mapping system has proven its accuracy in the exact 
delineation of infarcted myocardium when compared to radionuclidc and pathology 
studies(2.3l. Recent reports have suggested its value in the detection of viability in 
myocardium with reduced function.(4l The current study compared the mechanical 
properties (local linear shortening, LLS) of diffusely diseased myocardium in patients with 
severe coronary artery disease assessed with the NEM system) -with echocardiography data 
for comparable segments. In addition, unipolar voltages (UPV) for segments with 
different contractility patterns were compared. 
The NEM system has been described previously. (17) It is composed of a miniature passive 
magnetic field sensor incorporated in a catheter, an external ultralow magnetic field 
emitter (location pad), and a processing unit (NOGATM, Biosense-Webster, Cordis, 
Johnson&Johnson). The deflectable-tip catheter contains both a location sensor just 
proximal to its tip, and standard electrodes that allow recording of unipolar (UPV) and 
bipolar (BPV) electrical signals. 
The locator pad placed beneath the operating table consists of three radiators that 
generate ultralow magnetic fields ( Sx10-s to Sx10-(' Tesla) that contain the information 
necessary to resolve the location and orientation of the sensor in 6 degrees of freedomYl 
As the catheter tip is dragged over the LV endocardial surface, the system continuously 
analyzes its location in 3-dimensional space without the use of fluoroscopy. The set of 
points thus collected comprises a data set of location points that are members of the 
endocardial surface. Chamber geometry is then reconstructed) in real time) using the set 
of sampled location points. Electrical (through the incorporation of standard electrodes in 
the catheter's tip) and mechanical (through LLS measurement, see further) function of the 
myocardium can thus be assessed. (1.25,6) The LLS assessment is based on the assumption 
that in healthy myocardium any two points move closer to each other during contraction. 
Measurement of distances between neighboring points is therefore the basis for 
calculation of myocardial shortening. The computer algorithm takes into account the 
density of points around a point p) and gives a negligible weight to points too close 
(sampling noise) and points too far (of no influence as they provide non-local 
information)Yl LLS is the average of the change in distance between any point p and its 
ten closest surrounding points of interest from end-diastole to end-systole, normalized for 
the length at end diastole.(Sl 
Electrical data (UPV, BPV and local activation time) and mechanical data (LLS) can be 
displayed in a three-dimensional way, and the images obtained can be viewed from any 
angle chosen by the operator. A bull's eye view sho-wing average voltages) activation time 
or LLS for 12 segments (basal, mid and apical parts of anterior, lateral) posterior and septal 
segments) can be seen in an extra window on the NOGATM screen (figure 1). 
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l<lgure .1 
Example qf a nOI1f!lIoroscopi( electromechallical map in a patient with a IflIge apical amlllysm. 
Figl/reA shows the unipolar voltage (UPV) map il1 RAG view. The (olor bar all the right shows the 
color coding rangingfi·om red (-:;' 6.0 mV) /0 bilie-pll/ple (2 14.0 mV). Clearly, a large apical 
aneurysmal sac with very low voltages - suggesting scar tissue - can be seen (white arrowhead;). 
I'rgure B shows the lorallinear shortening (LLS) map ill the Jal11e RAO view. The color bar ranges 
.fi"om red (LLS -:;. 2.0%) /0 blue-plllple (;:::0.11.0%). Again, the extent if the api(al anell1ysm becomes 
clem: Figure C shows the bull's eye view if the unipolar voltage map as displayed by the system. FOllr 
regiollS (clockwise from top: an/erial' (A), lateral (L), posterior (P) and septal (S}) are each divided in 
3 Jegments (apical, mid and basal), thvidillg the whole map i71 /welve segments. The low UPV's if 
all apical segmenlJ are shown (white arrow). Figure D shows the bull's eye view if the LLS map. 
again with VelY low LLS values for the entire apex, with the akinesia extending towards the mid 
septal (LLS = 0.8%) and mid anterior region (LLS = 1.8%). 
Between March 1998 and November 1999, we performed nonAuoroscopic mapping on 40 
patients (34 male, 85%). Of these patients, 38 (95%) previously underwent percutaneous 
or surgical revascularization, 31 (78%) had suffered a myocardial infarction. Prior to the 
mapping procedure, an echoeardiogram was performed in all patients. Two-dimensional 
echocardiograms were obtained at rest with a commercially available system (Hewlett 
Packard Sonos 5500; HP Company, Palo Alto, Cal,USA) with the patients lying in the 
left lateral decubitus position. Standard views, including conventional parasternal short 
and long axes, and apical 2- and 4-chamber views were used. Segmental wall motion was 
visually evaluated and scored as normal, hypokinetic or akinetic. The echocardiographic 
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data were obtained by 3 experienced cardiologists who were unaware of the mapping 
results. T'o produce a comparable data set, the 16-segment division used for the 
echocardiographic analysis was reduced to 12 segments as shown in figure 2. 
r'igure 2 
Reduction of the 16- segment division if the echocardiographic images to 12 segments to jJroduce a 
data set comparable with the 12-segment di·vision if the bul/'s eye LLS map shown in colm: (A) shows 
the 3 anterior segments in the echocardiographic apical two-rhamber view with the correJjJonding 
segments 011 the huli:, eye, (B) the Jlateml segmen!J~ (C) the 3 posterior segments, and (D) the 3 septal 
segments. From (D) one cm7 appreciate the jact thatfor both the mid and basal septal segments all the 
hull:, eye, 2 echocardiographic segments were taken into account. if these segments were ill 
disagreement, the worst evaluation was chosen. 
Abbreviatiomjor earh ahocardiogmphir view (from upper right (A), clockwise): AP2C= apical two-
rhamber view, AP4C= apical Jow·-chamhel; AP/AX= apical long axiJ~ SAX=- short axis, PLAX= 
parasternal long axis. 
The study was approved by the local ethics committee, and all patients signed an informed 
consent. 
Data are presented as mean ± SD. Means of nominal values (UrV and LLS) were 
compared between segments with normal wall motion, mild or severe hypokinesia or 
akinesia by one-way analysis of variance (AN OVA). Comparison between groups was 
made by independent t-test with Bonferroni correction. A value of p <0.05 was considered 
statistically significant. 
Of 480 segments, 46 (10%) could not be assessed because less than 3 points were taken 
during the mapping procedure (n=13), or because of insufficient image quality for proper 
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echocardiographic assessment (n=33). Of the remaining 434 segments, 136 were normal, 
210 were hypokinetic, and 88 were akinetic. The average values of LLS and UPV, the 
results of the ANOVA and of the unpaired t-tests are shown in the table. 
-
Normal r-values Hypokinesia r-valucs Akinesia Overall 
ANOVA 
N 136 210 88 434 
UPV 14.86 ± 5.42 <0.0005* 9.23± 3.62 <0.0005 t 6.95 ± 3.83 <0.0005 
(mV ± SD) 
LLS 13.15±5.89 <0.0005* 7.56 ± 4.36 <0.0005 t 3.26 ± 7.16 <0.0005 
(% ± SD) 
:'lor the COmjHJl"lJOn w1th hypokmetlc and akmetlc segments; jor the companson wIth 
akinetic segments. UPV= Unipolar Voltage, I.LS= Linear Loeal Shortening; SD= Standard 
Deviation, ANO"01= Analysis O/Variance. 
Table 
Unipolar voltages and loeallinear shorteningfor normal, hypokinetic or akinetic Jegmen!J~ the results 
of the diffinmt independent t-tests with BOJ~/(:rroni correction, and the result q/the overall ANOVA. 
Our study showed highly significant differences in LLS as assessed through NEM 
mapping for segments scored as normal, hypo kinetic or akinetic on echocardiography. 
Also, UPV proved to be significantly different amongst these segments. 
Kornowski et aL recently demonstrated concordances in regional wall motion assessment 
between NEM mapping and echocardiography ranging from 58% to 100%, depending on 
the segment analyzed. The power of these findings however were hampered by the low 
number of patients included in this substudy (n=12)Y) 
The absolute values for normal and akinetic segments reported in our study are in close 
agreement with previously published data.(4) It must be stressed however that segments 
that are akinetic on echocardiography do not necessarily all reflect scarred tissue, as 
viability may be present in some of these segments. 
Limitations: Assessment of regional wall motion through echocardiography is strongly 
operator-dependent. Furthermore, although at least three points per segment were taken, 
this may not be enough to cover the complete segment. Also, the reduction of the 
echocardiographic assessment from 16 to 12 segments is not validated. 
In conclusion, our study showed that NEM mapping -through its LLS-function- can 
accurately assess regional wall motion in a subset of patients with severe coronary artery 
disease and subsequently decreased LV-function. In addition, this study shows a 
significant decrease in UPV amongst segments with declining regional function. 
(J'dj,rr -! - NOlljllloro5copic mappillgfor lefT l'elllric/e emilla/ioll 
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ABSTRACT 
Background: Nonfluoroscopic electromechanical mapping (NEM) has been proposed as a 
new technique for the evaluation of electrical and mechanical functioning of the 
myocardium. In this system, linear local shortening (LLS) is the parameter used for 
assessment oflocal mechanical properties. To validate this parameter, we compared LLS 
with regional wall motion (RWM) data derived from contrast left ventriculograms 
acquired in the same patients. 
Method~ and results: Twenty-six patients were included. Twenty patients (77%) patients 
suffered a previous myocardial infarction, 19 (73%) had undergone 1 or more 
revascularisation procedures (CABG or PTCA). The majority of the patients suffered 
stable angina (22 patients, 85%) at the time of catheterization. Angiographic left 
ventricular RWM was analyzed using the area-length method. The right anterior oblique 
view was divided in 5 segments, the left anterior oblique view in 2. Through a comparison 
of enddiastolic and endsystolic areas drawn from a computer- defined central point to the 
respective wall delineation, RVVTvI was calculated as change in area. In the first approach, 
we compared area changes to comparable NEM segments. In the second part of the study, 
LLS values for normokinetic, hypokinetic, akinetic and dyskinetic segments were 
correlated to the change in angiographic RWM. In the first approach, the overall 
comparison of segments yielded a correlation coefficient of 0.67 (p<0.0005). In the second 
part of the study, differences in LLS values between dyskinetic (LLS= -3.68% ± 8.86), 
akinetic (2.84% ± 3.96), hypokioctic (9.35% ± 4.27) and normokinetic (13.66% ± 7.98) 
segments were highly significant (overall AN OVA: p<0.0005). 
Conclusion: NEM is a powerful tool for invasive electromechanical assessment of 
myocardial function. 
C/),ljJI('( 'j - Validation of the local shortellillg/ill/ctioll (IS !I.\',\"(',\"sed by mmjluom.I'copic eicctrolllecimnicallIIappillg: 
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INTRODUCTION 
Recently, a new nonfluoroscopic electromechanical mapping (NEM) system was 
introduced into the clinical arena. Using a locatable sensor positioned in a magnetic field, 
the endocardial border can be traced and local information on electrical (unipolar and 
bipolar voltages) and mechanical (linear local shortening, LLS) properties of the 
myocardium can be assessedo 51. The local myocardial shortening function has been 
validated with techniques as radionuclide perfusion imaging and echocardiography(I-J,51, 
but clinical data remain scarce. Because left ventricle angiography remains an important 
tool in the assessment of regional wall motion.(fi.7)) we compared regional wall motion 
(R~) contractility assessed by computerized left ventricular angiography (LVA) with 
LLS data provided by the NEM system. 
METHODS 
Patients 
Patients were included if wall motion abnormalities were present on the left ventricular 
angiogram, whatever the reason for their referral for coronary angiography. Exclusion 
criteria were presence of left ventricular thrombus, unstable angina, atrial fibrillation, 
severe ventricular instability that did not allow for ensuring stable catheter positions, 
aortic valve prosthesis and severe aortic valve stenosis. The study was approved by the 
Erasmus University Hospital medical ethics committee, and all patients signed an 
informed consent. 
Left ventricular angiography 
LVks in RAO 300 and LAO 600 were performed using standard techniques(~). 
Angiograms were analyzed using the CAAS II system (PIE Medical, Maastricht, The 
Netherlands). The catheters (5- 7 French) were used for computerized calibration. The 
left ventricle boundaries at end-diastole and end-systole were traced manually with a 
digitizing device by an observer blinded for the mapping results. The frame showing the 
largest ventricular volume was chosen as the end -diastole, the frame with the smallest 
volume as the end-systole. By using a simultaneously recorded ECG signal measurements 
related to an extra-systole were eliminated prior to the analysis. Then, the R~ was 
analyzed through a comparison of end diastolic and endsystolic areas drawn from a 
computer- defined central point to the respective wall delineation. Regional wall motion 
was expressed as change in area: (enddiastolic area - endsystolic area)/enddiastolic area. 
Seven segments were identified: 5 in the RAO view (anterobasal, anterolateral, apical) 
inferior, posterobasal) and 2 in the LAO view (posterolateral, septal) (figures 1 and 2). 
C/J.I/,f,y 5 - I'nlid(l/;oll oflhe local SllOrlellillsfilllCfioll (IS (lSSCJscfl by l1o/ljltw/rJ.\·/.vpir e/c("fmlllcdlClI1icnllllappillg: 
Figure 1 
Nonftlloroscopic and 071giographic view 0/ a 1I0rmallift ventricle. Al to 4 show a nonftuoro.rcopic 
mapping- derived linear local Jhortening map in a 30 degrees RAO view (AJ). a bulls eye view of 
the same map (A2), a unipolar voltage map in RAG view (AJ), and an electroanatomical map, 
Jhowing lime to activ atiol1 relative to a refirence poinl. The same RAO view oj the left ventricle 
angiogram in end-dimtole is JhOWI1 in B. Numbers 81 10 5 show the anterobasa/, allterolateml, 
apical, inferior and posterobasal segments, respectively. C shows the lift ventricular angiogram in 
end-systole in the same RAO view. 
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Figure 2 
Angiogmphic assessment of wall motion using the area-length method (CMS 11 system, PIE 
M edical, Maastricht, Tne Netherlandr). The top lift pictllre shows the catheter calibration. Top 
middle (111(1 top right (1re the RAO views of the left ventricle at end-diastole and end-systole, 
respectively, with the manually outlined contolll; amI the [(I/culated volumes shown below the 
respective pictures. The bottom shows the calculations of ejection/raclion and stroke volume, and the 
regi01101 wall motiol1 analysis jor the diffirent segments (with segments numbered from J to 5, with 
the antero-basal segment (regmeJ1t I) beginning as first clockwise from the straight aortic valve 
delineation}, expressed (IS a percentage chauge in area. 
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Nonfluoroscopic electromechanical mapping 
The NEM system has been described previoll sly.o ·H~) In short, a reference catheter, with 
a location sensor in its tip, was taped securely to the patient's back. The mapping catheter 
(NOGA-STARfM, Biosense-Webster, Cordis,lohnson & Johnson), also with a tip sensor, 
was introduced through an 8F femoral sheath and placed retrogradely through the aortic 
valve in the left ventricle. The location of the mapping catheter was gated to end diastole 
and recorded relative to the location of the fixed reference catheter at that time, thus 
compensating for subject motion. The loca tion pad was fixed beneath the operating table 
generating an ultralow magnetic field (5xlO·6 to 5x10'~ Tesla) which codes the mapping 
space around the chest with both temporal and spatial d.istinguishing characteristics. 
Thus, at all times, the tip of the catheter could be located with six degrees of freedom (x, 
y , z, pitch, yaw and roll). The catheter was dragged along the endocardial surface of the 
left ventricle in order to acquire electromechanical data. When a stable signal was 
obtained (see definition section) a "point" was added to a three-dimensional map as shown 
on the NEM unit. Electrophysiological data (UPV, bipolar local voltages, and local 
activation time) and mechanical data (LLS) were displayed three-dimensionally, while the 
images obtained were viewed from different angles as chosen by the operator. A bull's eye 
view showing average voltages, activation time or LLS for 12 segments (basal, mid and 
apical parts of anterior, lateral, posterior and septal segments) was visualized in an extra 
window on the NEM screen (figure 3). 
Figure 3 
Nonjluoroscopic and angiogmphic image 0/ the lift ventride with buill eye view of LLS data in 
onotherpotient (th(Wfig 1). C-D show 3{}oo RAO views at ED amI ES respectively. C'-D'show the 
6(}OO LAO views at ED (ll1d ES respectively. The arrows delineate the posterobllSol (C-D) and 
posterolateml (C'-D') segments showing akinesia. ftIgures A-A' show the 3(}OO RAO (fig A) and 6{}OO 
LAO (jig A') NE!Vl- im(lges with the bull's eye II1(1P (oj course the some for both projectiol/J) (B-B') 
of the same patient, showing the linear local shortening (LLS) data. Again color coding is from low 
LLS «2%, red) to high (>11%, blue-purple). The same akinesia can be easily "ppreciated as the red 
zone in A-A' (see small arrows), and through the very low and even negative LLS values in the 
posterobosal (-0.1%, see arrowhead in B-B'), mid posterior (2.5%) and lateml (2.8%, see large 
arrow) segments seen ill the bull's eye map. 
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The LLS assessment is based on the assumption that in healthy myocardium any two 
points move closer to each other during contraction. Measurement of distances between 
neighboring points is therefore the basis for calculation of myocardial shortening. The 
computer algorithm takes into account the density of points around a point p, and gives a 
negligible weight to points too close (sampling noise) and points too far (of no influence 
as they provide non-local information). The algorithm for LLS is calculated as follows(1O): 
for any two points on the map, i and j, LLS is calculated as the change in distance between 
these two points from end-diastole to end-systole, normalized for the length at end 
diastole: 
LLSij ~ (L(ED)ij - L(ES)ij)/ L(ED)ij 
For any point p LLS is calculated as a function of the LLSpj, for all points j=l to n on the 
map, so that 
LLSp~ (Sj~1..n Wpj (L(ED)pj)x LLSpj ) ! Sj~ 1..n Wpj, 
where W is the weight of a certain point as a function of the distance Lij between two 
points i and j, the average distance D around point p (D is defined in the computer 
algorithm as the average distance of the ten closest points to p) and the volume Vat end-
diastole. The weight is therefore function of the point density in a defined region, the 
volume of the heart and the distances between points at end-diastole. 
Definitions 
Point loop stability (PLS): measures the maximum of distances between the locations of the 
selected point in two consecutive heart cycles. Low PLS indicate a reproducible catheter 
movement trajectory. 
Cycle length (CL) stahility: the difference between the length of the current cycle and the 
average of the last 100 cycles recorded by the system. Number has to be as small as 
possible. 
Location stability: a measure of the variability in position of the catheter tip on the 
endocardial wall during two consecutive cardiac cycles. 
Comparison of angiographk and NEM data 
Although the NEM system allows for viewing the three-D images in any angle chosen by 
the operator, we analyzed the mapping data in the 30° RAO and 60° LAO views, in order 
to create comparable data sets. The respective angiographic segments related to the bull's 
eye map results were as follows: 
Angio 
Anterobasal segment 
Anterolateral 
Apical 
Inferior 
Bull's eye mapping 
Al 
A2,Ll, L2 
A3, L3, P3, S3 
P2 
(;7 
68 
(;ilc/;')/ j - Jia/ida/ioll oltlre /oCd/s/wrlellillg timc/ioll a,\' assessed by lI(mjlllol{)scopic ei{'('/mllu'('h(mica! mapping: 
Posterobasal 
Septal 
Posterolateral 
PI 
51,52 
P2, P3, L2, L3 
For every segment, the average local linear shortening was calculated. These results were 
compared to the regional wall motion changes in the same angiographic segments. 
Averages were not calculated if fewer than 5 points were obtained in anyone segment. 
In the second part of the study, we defined LLS values for normokinetic, hypo kinetic, 
akinetic and dyskinetic segments respectively. A segment was defined as normokinetic 
when the area change was > 40%, hypokinetic between 20 and 40%, akinetic between 
o and 20% and dyskinetic when <0%.6, 11 The change in angiographic RWM was 
compared to the corresponding L1,S of the predefined segments on the NEM bull's eye 
map. 
Statistics 
Statistical analysis was performed using SPSS, version 9.0 (SPSS Inc., Chicago, Illinois, 
USA). Data are expressed as mean ± SD. Correlations were performed using Pearson's 
test. Means of nominal values for LLS were compared between myocardial segments -with 
nonnokinetic, hypokinetic or akinetic wall motion by ANOVA. Intergroup comparison 
was made using Student's t-test with Bonferroni correction. A value of P<0.05 was 
considered statistically significant. 
RESULTS 
Between March 1998 and November 1999,26 patients were studied. In this study, male 
gender was predominant (23/26, 88%). Mean age was 61 ± 8 years. Twenty patients (77%) 
patients suffered a previous myocardial infarction. Nineteen (73%) had undergone 1 or 
more revascularisation procedures (CABG or PTCA). Five patients (19%) were in 
NYHA heart failure class II, 7 (27%) in NYHA class T, the remainder having no signs of 
heart failure. Reasons for referral for cardiac catheterization were stable angina (CCS class 
1 in 11 p'dtients (42%), CCS class 2 in 6 patients (23%), class 3 in 5 patients (2ook» or 
coronary assessment following myocardial infarction (4 patients, 15%). Of 30 patients 
initially screened, 4 were excluded (1 for atrial fibrillation, 1 for stable angina that became 
unstable during admission, 1 for aortic valve prosthesis, and 1 for unwillingness to sign an 
informed consent). Risk factors were hypercholesterolemia (18 patients, 69%), 
hypertension (13 patients, 50%), smoking history (16 patients, 62%), diabetes (5 patients, 
19%) and family history (9 patients, 35%). 
The average procedure time for the acquisition ofNElV1 maps was 41 ± 27 minutes. All 
patients remained in stable hemodynamic conditions during the respective procedures, as 
confirmed by continuous in-cathlab heart rate and blood pressure monitoring data. There 
were no procedural complications. In the first part of the study, 162 (out of 182, 89%) 
angiographic segments were analyzed. Twenty segments could not be compared due to 
insufficient (less than 5) number of points taken during the NEM procedure. The overall 
comparison of angiographic and NEM segments yielded a Pearson correlation coefficient 
of 0.67 (p,O.OOO5) (figure 4). 
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Figure 4 
Correlation between angiogmphic wall motion analysis per segment and the wrrespondillg local 
linear shortening (LLS) data. 
100 
80 
~ 60 
ill 
0> 
C 40 ro 
~ 
u 
ro 
~ 20 ro 
2' 
S 
'" 
0 
-20 
-40 
-20 -10 0 10 20 30 40 
LLS (%) 
69 
70 
L.'t';,,/,tc, .5 - Valida/io/l of IiiI' local shortening jimelioll liS IIssc,\'scd by llf!lljlll1Jl7!.l'copic e/l'cllOlllcc/wnica/ mopping: 
The Pearson correlation differed among segments, as shown in table 1. 
Table 1. Local linear shortening (IJ,S), average wall motiol1 change on angiography, Pearsall 
correlatioll and I-values if the dffferent segment;. SD= standard deviation. 
Angiographic Average LLS oj' Average Wall motion PearSOIl p-I'aiue 
Segment cOl'responding segment challge (%±SD) Correlatioll r 
(%±SD) 
Anterobasal 6.9+7.4 31.!±20.2 0.55 0.04 
(segmcnt 1) 
Anterolatcral 9.7±7.1 27.4±23.! 0.63 <0.001 
(segmcnt 2) 
Apical 7.9±7.2 30.4±!9.S 0.61 0.01 
(segmcnt 3) 
Infcrior 7.5±8.3 34.0±JS.7 0.54 0.02 
(segmcnt 4) 
Postcrobasal 8.7±9.2 33.!±!4.7 0.68 <0.001 
(segment 5) 
Posterolatcral 9.7+6.5 2S.4±!5.6 0.74 <0.0005 
(segment 6) 
Septal 8.2±7.7 29.2±17.4 0.72 <0.0005 
(segment 7) 
All segments 8.7...1:5.5 30.1±13.4 0.67 O.OOS 
From this table it is clear that correlation was best for septal and posterolateral segments 
(r=0.72 and 0.74 respectively), and worst for anterobasal and inferior segments (r=0.55 
and 0.54 respectively). However, all correlations reached statistical significance. 
In the second part of the study, we compared R\iVI'v1 ( assessed as normokinetic, 
hypokinetic, akinetic or dyskinetic) with the LLS value obtained for the same segments. 
Of the 162 segments, 18 were dyskinetic (LLS= -3.68% ± 8.86), 44 were akinetic 
(LLS~2.84% ± 3.96), 60 were hypokinetic (LLS= 9.35% ± 4.27) and 40 were 
normokinetic (LLS= 13.66% ± 7.98) (p,0.0005 by AN OVA, table 2). 
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Table 2. Mean local linear shortening (IJ,S) valueJ fOl" dyskinetic (-1), akinetic (0), hypokinetic (1) 
and normokinetic (2) segments. Number ifsegments (N), standard deviation, standard 
errOl; 95% COI!/£dC1lce interval and p-value for the overall analysis of variance are alro 
shown. 
Segmental N Mean LLS Std. Std. 95% Confidence Interval ANOVA 
motion (%) Deviation Error 
Lower Bound Upper Bound 
-1 18 -3.69 8.86 2.29 -8.59 1.23 
0 44 2.84 3.96 0.65 1.52 4.16 
60 9.35 4.27 0.60 8.13 10.56 P<0.0005 
2 40 13.66 7.98 1.33 10.96 16.36 
Total 162 7.31 8.10 0.69 5.95 8.68 
Table 3. Unpaired Student:, t-test with Bonferroni correction for the comparison if local linear 
shortening (LLS) values between r0IJkinetic (-1), akinetic (0), hypokinetic (1) and 
nonnokinetic (2) segments. Mean dijJerences, standard errOl; and statistical significance are 
shown. 
Comparison of dys-, 8-, hypo-, and normokinetic segments 
Segmental wall motion Mean difference Std Error p-value 
-1 (dyskinetic) 0 -6.52 1.83 0,003 
-13.03 1.76 <0.0005 
2 -17.34 1.84 <0.0005 
o (akinetic) -1 6.52 1.83 0.003 
-6.50 1.30 <0.0005 
2 -10.82 1.40 <0.0005 
1 (hypokinetic) -1 13.03 1.76 <0.0005 
0 6.50 1.30 <0.0005 
2 -4.31 1.31 0.007 
2 (normokinetic) -1 17.34 1.84 <0.0005 
0 10.82 1.40 <0.0005 
4.31 1.31 0.007 
Table 3 shows the results of the different unpaired t-tcsts with Bonfcrroni correction 
between LLS values for the different groups. 
71 
72 
('1,,'r,/>!" ; - j/(llidatioll oltire foctll shortening timctioll {I,\' (/.1'.1'1',1'.1'1'£1 hv n()J(fluomscopic eleclfOll1ec/w!lica/ II/appillf{' 
40 
30 1 0 =40 I 
20 
~ 
U) 10 
-1 
-1 
0 
1 0 =60 I 
1 0 =18 I EJ~, I 
I E? 
-10 
-20 --
-1.00 .00 1.00 2.00 
Segmental wall motion 
Figure 5 shows a box plot for comparison of LLS values for the different angiographic 
RvVIVl analyses. 
DISCUSSION 
Although the independent prognostic value on long-term outcome of indexes of regional 
function is still in debate/12) it remains important that reliable observer-independent 
information on regional myocardial function can be obtained. Nonfluoroscopic 
electromechanical mapping has been proposed for on-line in-cathlab detection of 
myocardial viabilityY) However, the LLS function of the NEM system had not yet been 
validated as compared to standard angiographic techniguesY' I, 'i) As NEM has been 
proposed for in-cathlab assessment of left ventricular function, we compared NEM data 
with RWM as assessed by computerized LVA. Our study showed that left ventricular 
regional wall motion measurements using NEl\1. provide information comparable with 
computerized LVA assessment. In addition we showed highly significant (overall 
ANOVA: 1'<0.0005) differences in LLS values for dyskinetic (LLS" -3.68% ± 8.86), 
akinetic (2.84% ± 3.96), hypokinetic (9.35% ± 4.27) and normoki.netic (13.66% ± 7.98) 
segments. The value of electromechanical mapping has been studied in the animal and in 
the human model. Kornowski et a1. showed impaired local shortening in the anterior wall 
in dogs after ligation of the left anterior descending artery.°) In the same study, the 
mapping data clearly delineated infarcted areas in patients) and a concordance of 78% 
between echocardiography and local shortening data was shown. The greatest discordance 
was seen in the posterior wall. Gepstein et a1. showed a high correlation between mapping 
Chl!!,!"'- 5 - \falidation oIrile loca! silo{lellillg/iIllClioll as assessed by lIolIJluomscopic e/eclfOlllec/wnicalmappillg: 
data and pathology-confirmed infarcted areas in the canine coronary occlusion modeL (4) 
Recently, a strong correlation berw-een radionuclide perfusion and local shortening values 
was demonstrated (5), where normal and infarcted segments showed average LLS of 12.5% 
± 2.8 and 3.4% ± 3.4 respectively. Our findings of LLS for normokinetic and akinetic 
segments (13.66% ± 7.98 and 2.84% ± 3.96 respectively) arc in close agreement with these 
results. 
The reason for some segments having better correlations (lateral and septal regions) than 
others is not clear. A possible explanation could be that effects such as differences in 
twisting motion and radial motion that have been described recently may not be 
demonstrated accurately by two-D left ventricular angiography of diseased left 
ventricles.(13,1-I) However, the number of points taken per segment may also have influenced 
these findings, as it indeed has been shown that a minimum number of points is 
mandatory to accurately assess segmental characteristics(2l. For this reason, areas with less 
than 5 points were omitted from our analysis. 
I,imitations. First, subjective interpretation of angiographic left ventricular regional wall 
motion is routinely performed with knowledge of the location and extent of coronary 
artery disease. Studies have shown that subjective interpretation of local wall motion may 
be biased through this ImowledgeY\") In our study, the observer who calculated 
angiographic local wall motion was blinded for CAD severity. Second, the ventriculogram 
is a two-D reconstruction of a three-D structure, and may therefore not constitute the 
optimal technique for wall motion abnormality detection. Also, the computer-assisted 
area method is subject to interobserver variability, as choosing of the respective digitized 
cine frames and manual tracing of the endocardial border is operator-dependent. Recently, 
Natarajan and coworkers have found a time-related dependence of wall motion 
abnormalities, suggesting that ischemic ventricular segments may seem hypokinetic on 
angiography, but in fact appear to have normal absolute shortening due to a contraction 
delay. (16) In the left ventricular angiograms this temporal consideration was not taken into 
account for the assessment of regional fimction. Also, in this study, patients with atrial 
fibrillation and excessive ventricular ectopia were excluded. Indeed, these situations do not 
allow for adequate cycle length stability and loop stability, and may therefore confound 
regional electromechanical properties. It is therefore impossible to make definite 
statements on the use of electromechanical mapping in these clinical settings. 
In conclusion, our study showed that LLS data arc significantly correlated with 
angiographic wall motion for comparable segments. In addition, LLS is a reliable 
parameter for the evaluation of regional wall motion. Thus, NEM is a suitable technique 
for invasive assessment of regional left ventricular function. 
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INTRODUCTION 
The quality of coronary collateral formation may decide on the amount of residual 
functional myocardium after coronary occlusion.{1} It has been shown that the presence of 
an efficient microvascular collateral network can maintain viability in the myocardial 
region previously perfused by the occluded coronary arteryY) Coronary angiography 
however only assesses the anatomical quality of these collaterals. (3) 
NEM is a novel technique for in-cathlab on-line assessment of the functional mechanical 
and electrical properties of the myocardium.(-I-lO) The electromechanical properties thus 
assessed may predict the presence of viability in previously injured segments, and may 
therefore reflect the functionality of the collateral formation. (R) 
We therefore assessed the correlation between the presence and the extent of coronary 
collaterals in patients with one native total coronary occlusion with the electromechanical 
properties of the target myocardium of the occluded coronary artery. 
METHODS 
Patients 
All consecutive patients that underwent NEM in our centers were entered in a database. 
Patients were elected for the present study if they met the following criteria: 
No more than one occluded native coronary artery, but at least one. 
Coronary angiography and biplane left ventriculogram during the index procedure 
No previous bypass surgery 
Successful NEM mapping 
Informed consent signed 
Coronary angiography and collateral grading 
Angiography was performed before NEM using the right femoral approach according to 
standard techniques. Left and right 6F diagnostic catheters were used to engage the 
coronary ostia, and all images were recorded on a digital recording system. Coronary 
collateral grading was performed by an investigator blinded for the mapping results. 
Collateral grading was scored according to the Rentrop classification (0= no opacification; 
1= filling of the side branches of the occluded artery without visualization of the epicardial 
segment; 2= partial filling of the epicardial segment but not up to the original occlusion; 
3= complete retrograde filling of the occluded coronary artery up to the original 
occlusion). 
left ventricle angiography 
Left ventricle (LV) angiography was performed with 5, 6 or 7F pigtail catheters, according 
to the preference of the operator. Angiograms were recorded in a 30° right anterior oblique 
and 600 left anterior oblique view. LV angiograms were made with the patient in a stable 
position and during maximal inspiration. The angiograms were analyzed on the CAAS II 
system (PIE medical, Maastricht, The Netherlands) by an independent investigator, who 
was blinded for the left ventricular mapping data. Calibration was performed using non 
contrast-filled catheters. The extent of the myocardial region originally perfused by the 
occluded artery was defined on a visual basis. The myocardium involved was then analyzed 
CA!!,!,,!" 6 - H/I'f'lmmec!lIlllical propl'rtics o!mvocardiulil supplicd hy i"rmmllfy collateml cir('lr/tllion 
using the centerline method, dividing the involved areas into normal, hypo kinetic or 
akinetic.(ll,l1} 
Nonfluoroscopic electromechanical mapping (NEM) 
The system and its various components have been described previously. In short, a low 
magnetic field (10-5 to 10 6 Tesla) is generated around the patient. A catheter securely 
taped to the patient's back is used as a reference to compensate for subject motion during 
the procedure. A 7 French catheter (NOGA-STARTM, Biosense-Webster, a 
Johnson&Johnson company) containing a locatable sensor and recording electrodes in its 
deflectable tip is inserted through an 8 F femoral sheath and is then dragged along the 
endocardium of the left ventricle. Acquired signals are then send through the catheter 
shaft and processed by the NOGA processing unit (Biosense-Webster). The system can 
determine the location (with accuracy of dmm) and orientation of the catheter in six 
degrees of freedom (x, y, z, roll, pitch, and yaw). Electromechanical information is 
obtained using a combination of data gathered by the electrodes and the location sensor. 
Thus unipolar (UPV) and bipolar (BPV) endocardial potentials and local linear 
shortening (LLS) data for every contact point are acquired, and can be displayed in bull's 
eye maps. Chamber geometry can then be accurately reconstructed using three-D 
endocavital information. 
Post-processing of data was performed to eliminate points suggestive for catheter tip 
instability, as evidenced by catheter point loop stability, cycle length stabiljty, local 
activation time and location stability data (see definition section). A triangle fill threshold 
of 40 mm was chosen for our data set. This setting allows the system to fill triangles 
between acquired points using an interpolation algorithm; distances between points larger 
than 40 mm were left blank until points in between were captured. 
Mter applying an inner point filtering by the computer algorithm, points were manually 
deleted when they did not fit standard stability criteria ( location stability <4mm, cycle 
length stability < 10% and loop stability <4mm), if they were taken during ST-segment 
elevation (suggestive for severe wall impression) and if the points were not related to the 
left ventricle (such as atrial location). 
Comparison of angiographic LV regions, coronary artery supply and NEM regions 
To ascertain that comparisons of the same areas on angiography and on NEM were 
obtained, the location of the mapping catheter was verified with angiography in a subset 
of five patients. l<or every point sampled with NEM, the location of the mapping catheter 
at the same time was recorded with biplane angiography (3000 RAO and 6000 LAO). 
Mter the procedure, locations of these points on the NEM bull's eye map were compared 
to the location of the mapping catheter on the recorded angiographic session according to 
the 7-segment division of the biplane LV angiogram. Correlations between the area 
supplied by the coronary artery under study and the myocardial region of interest was 
performed as described previously by Sheehan and coworkers(12-15}: 
LAD: anterobasal (segment 1), anterolateral (segment 2), apical (segment 3) and septal 
(segment 6)RCA: diaphragmatic (segment 4) and posterobasal (segment 5) 
CX: diaphragmatic (segment 4), posterobasal (segment 5) and posterolateral segment 
(segment 7) After defming which angiographic segment correlated to which 
nonfluoroscopic segment, we were able to define the relationship between each coronary 
79 
8U 
(j'dP,; C) - EiectlVllleclwlJiclI{ proper/ie.I' (!(myocmdiulI/ supplied bv (·orollm)' col/mend cirnr{(lfioll 
artery and the NEM segments perfused by it. We then assessed the average LLS, UPV 
and BPV of segments originally perfused by the occluded coronary artery and compared 
them to the respective parameters of segments that were perfused by a patent coronary 
artery. Also, we compared the different parameters between segments with good collateral 
flow (defined as having collateral flow grade 2 or 3) to those with poor collateral flow 
(defined as having collateral flow grade 0 or 1). 
Statistics: 
All data are reported as mean value ± SD. Parametric comparisons were performed using 
the unpaired Students' t-test, nonparametric comparisons with the Wilcoxon signed ranks 
test. Proportional data were analyzed by the chi-square test, with the Yates correction if 
one of the frequencies in the 2X2 contingency table was <5. Collateral index was 
compared using the Wilcoxon signed ranks test. A value of p<0.05 was considered 
significant. 
RESULTS 
One hundred twenty-two consecutive patients underwent NEM between June 1997 and 
May 2000. Of these, 67 had previous bypass surgery, 11 only had monoplane left ventricle 
angiography, 1 patient had 2 completely occluded coronary arteries and 5 patients had an 
incomplete data set. Finally, 38 (31%) patients were studied. Clinical parameters are 
shown in table 1. 
Poor collateral quality Good collateral quality p-
C collateral-.Erading = 0 or I} j(collaleral gradi l1g = 2 or 3) value 
N 13 24 
- -Age (years" SD) 59±10 61±12 NS 
Male n (%) 9 (69%) 22 (92%) NS 
PrevioLls PCI II (K5%) 18 (75%) NS 
Q-wave myocardial 9 (69%) 15 (63%) NS 
infarction 
II ypercholcsterolemia 10 (77%) 18 (75%) NS 
~rtension 8 (62%) 17 (71%) NS 
Smoking histQEY . 10 (77%) 16 (67%) NS 
Diabetes I (8%) 2(5%) NS 
Table .1 
Clinical rharacteristics. SD= standard deviation; PCl= percuttlneollJ coronmy intervention. 
The first part of the study involved the defining of the NEM segments that correlated 
with the respective coronary arteries. In 5 patients, 320 points were assessed through 
biplane angiography and consequently every catheter position was correlated with the 
point on the NOGA map that was taken at exactly the same time. The results are shown 
in table 2. 
('/.'-"/'1 ' Ii - Uectmmechwlica/ properTies oIl!I.I'oclirililllll.l'lIpplied by comlllll}' collateral cilnriarioll 
Aneioeraohic se!!ment NEM scerncnts 
~basal Al 
Anterolateral Ll,L2,P2 
~~al A3,L3,P3,S3 
Dianhra!!matie PI,P2,P3,S3 
Posterobasal Pl,P2,SI 
SeDtal SI,S2,S3 
Posterolateral Ll,L2,P2 
Table 2 
Correlalion between angiographic segments and segments defined by the non fluoroscopic 
electromechalliml mapping (NRM) system. The left column shows the respective 7-segment 
subdivision on angiography, the right column shows the respective segments derived/rom NEM, with 
A==anteriOli L==lateral, P==posteriOl; S==septal. 
Following the coronary artery distribution correlated to biplane angiography as previously 
described by Sheehan ct aI., we constructed a similar model for the NEM bull's eye map, 
as shown in table 3. 
_~oronarv artery NEM sevrnents involvcd 
LAD Al ,A2,A3,LI ,L2,L3,S3,P3 
RCA Al,PI,P2,S3,P3 
ex Ll,L2,PI,P2,P3,S3 
Table 3 
Correlation between roronmy arte}] and NRM-segments. 
The comparison for all patients of T LS, UPV and BPV between injured segments and 
segments remote from the injured myocardium is shown in table 4. 
Injured S~~),9Pts RemoLe sel!ments In-value 
~.('Y"±SOl 8.0 13.7 <0.0005 
UPV"(;nY + SD) 10.5 14.9 <0.0005 
BPY (mY ± SOl 2.8 4.9 <0.0005 
Table 4 
Average values for linear lowl shortening (LLS), lfnipolar (UPV) and bipolar voltages (BPV) for 
segments lowted in the initial target myocardial region 0/ the ocrllfded COl"Oll{ffY artery (i,?iured 
segments) as compared to the average values 0/ the mme parameters/or segments in the non-affected 
areas (remote segments)' 
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The results of the analysis of variance performed to detect differences between segments 
with good collateral perfll~ion and segment~ with poor collateral perfusion is shown in 
table 5. 
Poor collatcrals Good collaterals o-value 
LLS in'ured segments J.8±4.7 IO. 3±3.5 <0.0005 
LLS remote se~ments 11.9±2.6 14.7±4.S 0.07 
UPY injured segments 6.0±2.S 13.0±3A <0.0005 
UPV remote segments IJ . I±4.0 IS .8±J.7 0.07 
BPY inju red segments 1.6± 1.9 3.5± I. 7 <0.0005 
DPV remote segments J.8±1.9 S.4±2.2 0.06 
Table 5 
Compariwn of linear local.rhorlening (LLS), unipolar (UPV) and bipolar voltages (BPV) for 
regions both injured (injured segments) lind nOJ1~tifftcted (remote segmcnts) in velltricles without 
versus those wilh good collateral formation. 
Examples arc shown in figures 1 and 2. 
Figure 1 
Patient with previous inftroposterior myocardial 
infarction. A and B .rhow the righl anterior oblique 
(RAO) view rifthe left ventricle angiogram in end~ 
diastole and end-sptole re.;peclively. One can 
appreciate the inftrior infitrCtioll (arrowheadr in A 
altd B). C shows the occluded right corol1my mielY 
(arrow) in RAO, D shows the left anterior oblique 
view qf the left coronmy artelY tree. Collllterals 
(Rentrop class 3) call be clearly appreciated (arrow.r). 
E shows the RAG view (1' the 1I0lljluoroscopic 
unipolar voltage map. The arrow indicates the high 
voltages in the il1jf:rior region, suggesting viable 
liHue. Color grading shows voltagesfi"Ol1t velY high 
(> 14 mV) in pUlple, to velY low «6mV) i11 red. F 
depicis the linear local shortening map, with the 
arrowheads showing decreased regional functioning 
as JlIggesled by the red color. Color coding rtl11ges from 
high (>11%) in plllple, to VClY low «2%) ill red. 
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D ISCUSSION 
Figure 2 
Patient with previous infiroposterior l1Iyocmdial 
infarction due to an occlllded right corolllllY artelY. 
(a) shows the occluded RCA in the left anterior 
oblique (LAO) view, (b) shows the left COr011(11Y tree 
in LAO view. No collaterals are seen. (c) and (d) 
show unipolar voltage and linear local shortening 
maps ill RAO view; the arrows delineate the 
infiroposterior region 0/ low voltages (lnd decreased 
lima!' local shortening. 
The most important finding from our study is that electromechanical properties of 
myocardial segments of which the perfusing native coronary artery has occluded and that 
are supplied by coronary coUaterals of good quality, are better preserved than segments 
that do not have good coronary artery supply. From table 5 it becomes clear that in 
previously injured segments that are provided by a good collateral supply, higher LLS, 
UPV and BPV are found. On the other hand, remote segments ofventric1es with poor 
collateral supply do not show statistically significant differences in LLS, UPV as well as 
BPV. 
It has been previously shown that good collateral supply may be a sign of myocardial 
viabilityYl This finding can be supported by the current data set. 
Limitations: The model created through LV angiographic determination of coronary 
artery perfusion is not validated. Also, our model is based upon 5 patients in which the 
correlation between angiographic location and NEM location was made. Further study 
may be necessary on this issue. 
CONCLUSION 
Nonfluoroscopic mapping data of previously injured myocardial segments are significantly 
correlated with the quality of coUateral coronary artery supply to the target region of 
occluded coronary arteries. This furth er underscores the potential of nonfluoroscopic 
mapping in assessing myocardial viability. 
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STRUCTURED ABSTRACT 
Objectives. We sought to discriminate between normal, non viable and ischemic 
myocardium by comparing left ventricle (LV) electromechanical maps with redistribution 
perfusion thallium studies. 
Background. The Biosense Noga is a catheter-based system for electromechanical mapping 
which uses magnetic technology to localize a sensor tip catheter reconstructs the 3D 
geometry of LV in real time. 
Methods. In 29 patients with coronary artery disease, linear local shortening (LLS) and 
local intracardiac signals (unipolar voltage=UV) were compared with thallium 
redistribution images analyzed by single photon emission tomography, and myocardial 
regions were classified as normal eDlTI uptake> 75% of maximal), viable impaired (201TI 
uptake >50%) and non viable (201Tl uptake< 50%). 
Results. A total of280 LV segments had adequate scintigraphic and electromechanical data 
for comparison. Overall UV and LLS values were significantly lower (UV: 6.1±2.6 versus 
10.8±5.3 mY; p<O.OO1. LLS: 2.9±6.4 versus 6.5±5.8%; p<0.015) in regions with ).\llTI 
uptake<50% versus regions with impaired 201Tl uptake (50-75%), and higher in regions 
with normal )'(IITI uptake (>75%). (UV:13.8±6.1 mY) and LLS: 8.9±7.6%; p<0.001 and 
p=0.0032 respectively versus viable impaired). Based on these data the UV threshold to 
distinguish non-viable myocardium was 6.5 ill V) with a sensitivity of 68.2 (95% CI: 45.1 
- 86.1) and a specificity of 84.9 (95% CI: 79.9 - 89.9). 
Conclusions. Electromechanical maps distinguish normal, non viable and ischemic 
myocardium as assessed by thallium perfusion imaging studies. 
KEY WORDS 
Mapping, ischemia, ventricles) myocardium, viability, 
CONDENSED ABSTRACT 
The Biosense Noga is a catheter-based system for electro-mechanical mapping of the left 
ventricle (LV). 
In 29 patients linear local shortening (LLS) and unipolar voltage (UV) potentials 
measured by this new left ventricular mapping system were compared to redistribution 
thallium activity. Overall a significant difference in LLS and UV was found between 
normal, viable impaired and non-viable myocardium as assessed by thallium perfusion 
imaging studies. 
ABBREVIATIONS AND ACRONYMS 
BP: 
DMR: 
EMC: 
FI: 
LLS: 
LV: 
Bipolar Voltage 
Direct myocardial revascularization 
Electromechanical coupling 
Fragmentation Index 
Linear local shortening 
Left ventricle 
Cb.-I.!Y(>' ! - Lefi I'ellfrini/lir eiectrolllec/JmliclIl endocardia inwppillg to (lsses myocardial viahilifV 
MI: 
SPEeT: 
201Tl: 
UV: 
Myocardial infarction 
Single photon emission computed tomography 
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INTRODUCTION 
Diagnostic testing to evaluate the presence and the extent of viable, but dysfunctional 
myocardium has become an important component of the clinical assessment of patients 
with chronic coronary artery disease and left ventricular dysfunction. Several noninvasive 
methods arc currently used to identity physiological markers of myocardial viability in 
regions with contractile dysfunction) including PET imaging to assess myocardial 
metabolic activity) JI)ITI imaging to assess myocardial perfusion and membrane activity and 
dobutamine echocardiography to assess myocardial contractile reserve. Recently) a new 
non-fluoroscopic) catheter-based, mapping system (NOGA - Biosense) designed to 
acquire) analyze and display electro-anatomical maps of the human heart) has been 
developed and validated both in animal and human studies. Previous studies confirmed 
that such an LV mapping procedure in patients with myocardial ischemia allows to 
distinguish between infarcted, ischemic and normal myocardium according to the 
perfusion status in radionuclide SPECT imaging. 
The purpose of this study was to compare LV electromechanical mapping data with 2IJITI 
perfusion imaging studies in the aim of discriminating between normal, non viable and 
ischemic myocardium. In addition we sought to evaluate if electro-mechanical coupling as 
assessed by NOGA may enable differentiation of hypo contractile viable myocardium. 
METHODS 
Patients 
The study population is formed by 29 patients which underwent LV electromechanical 
assessment and JOlT1 perfusion imaging studies to detect myocardial viability as part of 
evaluation of chronic ischemic heart disease. Fourteen patient had a previous myocardial 
infarction. All the patients have significant coronary artery disease documented by 
coronary angiography. Informed consent was obtained from all patients before any 
diagnostic procedure. 
Electromechanical mapping system. The nonfluoroscopic electromechanical mapping system 
(Noga, Biosense) has been described elsewhere. Briefly it comprised an external ultralow 
magnetic field emitter located under the operating table (triangular location pad), a 7F 
deflectable-tip electrophisi010gical catheter which incorporates a miniature passive 
magnetic location sensor (NOGA-STAR, Cordis-Webster), and a workstation for 
information processing and 3-dimensional LV reconstruction and display (Silicon 
Graphics). 
Electromechanical mapping procedure. The fixed reference catheter was positioned under 
fluoroscopy externally on the back of the patients corresponding to the heart region. The 
accurate position (within 5 em of location pad center) was verified with the reference 
catheter location check on the NOGA system. It is used to detect small changes in 
intracardiac position due to respiration or movement of the patient. After cannulating the 
femoral artery with an 8F sheath, the mapping catheter was advanced under fluoroscopy 
guidance to the descending aorta, its tip deflected to form aJ shape, and introduced across 
the aortic valve. Once inside the LV cavity the catheter tip deflection was released and the 
first three points (apex, aortic outflow and mitral inflow) were acquired under fluoroscopic 
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guidance to generate the initial 3-D image of the LV. The "mapper" operator acquired 
subsequent points exploring different regions of the endocardium by dragging the catheter 
tip. The position of the catheter appears on the screen in real-time as an icon 
superimposed on the cardiac map being constructed. As the catheter moves on the 
endocardium, local electrograms and the catheter locations are reported simultaneously to 
the system which construct a 3-D geometrical representation of the cardiac LV chamber, 
using a triangular algorithm. Points were acquired as much homogeneously as possibly 
thorough the LV cavity, when the endocardial contact of the catheter tip was stable as 
evidenced by location stability, cycle length stability, local activation time stability, loop 
stability and good synchronization of the intracardiac electrograms of two consecutives 
heart cycles. The operator analyzed signals, and if the point based on the previous 
parameters is accepted as valid, it is brought into the 3-D map which is updated with every 
accepted point in real-time. A "triangle fill threshold" of 40 mm was chosen in order to 
provide a minimal level of points density at each mapped site. Validation of both 
intracardiac location accuracy and intracardiac signal recording have been previously 
established. 
The post - processing of the data points was done automatically using the moderate points 
filter provided by the system, which deletes points based on the inner points filter (cone 
angle < 25°; relative depth> 10%) and the points stability filter (location displacement> 
6 mm; trajectory instability> 6 mm; median cycle length ± 15%). Some more points were 
edited manually (visually inner points, points closer than 5 mm and points with prominent 
ST-segment elevation on the intracardiac electrogram), to assure a correct interpretation 
of the maps. Only segments with more than 3 sampled points were considered for the 
analysis. 
Electromechanical map data definition 
Unipolar voltage map: represents an electrical map displaying a map of maximum peak-to-
peak voltage of the intracardiac signal measured by mapping catheter tip. 
Bipolar voltage map: represents an electrical map displaying a map of maximum peak-to-
peak voltage of the intracardiac signal measured by the difference measured between two 
unipolar channel placed at the mapping catheter tip and ring respectively. 
Linear Local Shortening map: represents a mechanical map and displays the local shortening 
calculated on the linear distance from each point to its neighboring points. 
Fragmentation Index map: represents a map which displays an estimation of the QRS 
complex fragmentation. 
Electromechanical coupling: An estimate of EMC was provided based on LLS and UV 
values. A threshold of 6.5% for LLS for contractile myocardium derived from a 
compar.ison with left ventricular wall-motion at angiography and a threshold for UV of 
6.5 m V for viable myocardium derived from the comparisons with JOITt perfusion studies 
were used. Electromechanical coupling index was defined as LLS x IN. 
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Myocardial perfusion 201Thallium imaging 
All patients were injected with J01TI (1.5 MEq/Kg). 
Myocardial perfusion imaging was performed with a rotating 2-head gamma camera 
(SOPHY - DST) equipped with a low energy - High Resolution collimator and 
interfaced to a computer (SOPI-IA - Vision). Images were acquired with patient in prone 
position on a special dedicated scinti-bed. 32 projections (matrix 64*64; 40 seconds per 
projection) were acquired from 45° right anterior oblique view to 45 D left posterior oblique 
view. Tomographic reconstruction was performed by standard filtered back projection with 
a hamming-Hann filter to generate transaxial tomograms. Reconstructed 6.4 mm slices 
were summed and reoriented in standard short axis, horizontal long-axis and vertical long-
axis for visual analysis. For quantitative analysis, 2 consecutive short axis thick slices were 
considered from base to apex and sectorial profiles were generated using the John 
Hopkins/Frankfurt protocol. Apex was analyzed on long-axis slices and profiles were 
generated using the same protocol. 
A ten segments model was used for this study: the short axis tomograms were divided into 
four segments representing the anterior, antero-septal, infero-posterior and lateral wall. 
The apex was divided into tvvo regions: antero-septal and infero-lateral. 
To asses myocardial viability in segments with fixed perfusion or partially reversible defect, 
the redistribution perfusion images were analyzed after nitrate administration and J01Tl 
reinjection; myocardial regions were classified as normal (viable and not impaired) when 
20lTI uptake> 75% of maximal, viable impaired with 101Tl uptake of 50% to 75% and non 
viable when J01TI uptake was < 50%. In addition the regions with very low 20lTI uptake 
« 50%) were subdivided in segments non viable with 10lTl activity < 20% and regions with 
a 20lTl fixation between 20 and 50%. 
Statistical analysis 
In the Tables and in the body of the text, continuous variables are expressed as mean ± 
standard deviation. Categorical var.iables are expressed as absolute or relative frequencies. 
Means of nominal values of LLS and UV were compared betvveen myocardial segments 
non-viable, viable impaired and normal as assessed by rest/redistribution J01Tl perfusion 
imaging by the non-parametric test of Kruskal-Wallis. Intergroup comparisons was made 
by Wilcoxon (Mann-Whitney test) with Eonferroni correction. A p value < 0.05 has been 
considered statistically significant. Statistical analysis was performed using Stata 6.0 for 
Windows (StataCorp, College Station, TX). 
RESULTS 
Clinical patients' characteristics are shown in Table 1. 
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TaMe.1. Patient clinical and angiographic characteristics 
Age (yrs) 
Female gender 
Ejection fraction (%) 
Multivessel disease 
Previous MI 
Previous PTCA 
Previous CABG 
MI: myocardial infarction 
PTCA : percutaneous transiliminal coronary angioplasty. 
CABG: corollmy artel} bypa.u graft. 
63 (52-68) 
3 (15.8 %) 
55.8 ± 14.7 
26 (89.6 %) 
16 
15 
10 
The study population comprises 29 patients (3 females, mean age 61 ± 9.5 years) with 
documented coronary artery disease. No procedural complications were observed during 
or after the mapping procedure. The mean acquisition time was 53.2 ± 12.4 min, and 111 
± 23 data points (74 ± 16 after automatic post-processing and 56 ± 13 after manual 
editing) were obtained per patient. 
Comparisons of electromechanical maps with redistribution thallium perfusion 
imaging 
A total of 280 segments had adequate scintigraphic and NOGA electromechanical data 
for comparison. The distribution of mean ± SD LLS, UV, BP, FI values according to 
thallium activity is reported in Table 2. 
Table 2. Distribution c:fmwn ± SD loeallinear shortening, unipolar voltage, bipolar voltage and 
fragmentation index values according fo redisfribution 2m TI activity. 
Normal Viable impaired Non~viablc P valuc* 
N~192 N~6X N~20 
LLS (%) 8.9 ± 7.6 6.5 ± 5.X 2.9 ± 6.4 0.0021 
UV (mV) 13.8 :l6.1 10.S±5.3 6.1 ±2.6 <0.0001 
BP (mV) 3.88 ± 2.4 3.03 ± 2.15 1.7 ± 1.36 0.0001 
1'1 1.41 + 0.5 1.64 + 0.5 l.X3 + 0.7 0.1054 
*Lincar model with Huber-White robust standard error. 
LLS: loeallinear shortening. UV: unipolar voltage. BP: bipolar voltage. J-ti :fragmentation index. 
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Unipolar Voltage Map 
Overall UV correlated significantly with 20iTl activity and particularly the 
electromechanical maps could distinguish segments with normal (> 75%) and impaired 
(50-75%) ""TI uptake (UV: 13.8 ± 6.1 versus 10.8 ± 5.3; p , 0.001), and viable impaited 
regions and non-viable (UV: 10.8 ± 5.3 versus 6.1 ± 2.6; p< 0.001). In addition among the 
segments classified as non-viable with a 2!llthallium uptake < 50% a trend toward lower UV 
values was observed in the segments with a fixation < 20% compared to segments with 
2!llthallium uptake between 20% and 50% (UV : 4.64 ± 1.29 versus 6.91 ± 2.88; 
p = 0.084). 
Based on these data the lower limit for UV to discriminate normal myocardium was 10.3 
m V, with a sensitivity of67.9 (95% CI: 60.8 -74.4) and a specificity of 62.1 (95% CI: 51.0 
- 72.3). The UV threshold to distinguish non-viable myocardium was 6.5 m V, with a 
sensitivity of68.2 (95% CI: 45.1- 86.1) and a specificity of 84.9 (95% CI: 79.9 - 89.9). 
Linear Local Shortening Map 
Overall LLS correlated significantly with 20lTl activity and particularly the maps could 
distinguish segments with normal (>75%) and impaired (50-75%) 201Tl uptake (LLS: 8.9 
± 7.6 versus 6.5 ± 5.8; p=0.0032), and viable impaired regions and non-viable (LLS: 6.5 ± 
5.8 versus 2.9 ± 6.4; p' 0.015). 
Bipolar Voltages map 
Overall BP correlated significantly with 201TI activity (p=O.OOOl) and particularly the could 
distinguish segments with normal (>75%) and impaired (50-75%) 201Tl uptake (BP: 3.88 
± 2.36 versus 3.03 ± 2.15; p < 0.01), and between viable impaired regions and non-viable 
(BP: 3.03 ± 2.15 versus 1.70 ± 1.36; p' 0.0001). 
Fragmentation index 
Overall the fragmentation index was not significantly correlated to redistribution 20iTI 
activity (Table 3: p = 0.10), but the small number of data and the scattered distribution, 
results in insufficient statistical power to find a correlation between FI values and SPECT 
data. 
Electromechanical maps values according to myocardial regions 
Overall a significant difference was observed between the UV, LLS, and BP values in the 
basilar in comparisons to the mid-ventricular regions (UV: 9.65 ± 4.85 mV versus 14.49 
± 5.82 m V; p , 0.0001. LLS: 5.97 ± 7.15% versus 9.17 ± 6.03%; p , 0.0002. BP: 3.07 ± 
2.31 mV versus 3.88 ± 2.79; p = 0.039). Nevertheless the ability of these parameters to 
distinguish between infarcted, ischemic and normal myocardium according to the 
perfusion status in radionuclide SPECT imaging is not different among the basilar and 
the mid-ventricular segments (Interaction mid-ventricle versus basilar for LLS) UV and 
BP p = NS). The average LLS values, UV and BP potentials were higher in regions with 
normal 201 t hallium uptake and lower in regions with 20lthallium activity < 50%. The 
segments with 201thallium uptake between 50% and 75% showed intermediate values 
(Figure 1). 
e/y!!"-,, :;- - Leji I'enlricu/ar e/eclmmcc/wnicu/ eni/onm/itl imapping to (lsses myocardia! 1'iabifity 
J-i'igllre 1 
Local linear shortening, Unipolar voltages and Bipolar voltages according to thallium activity in 
basal and mid-ventrirular regions 
Basilnr ,'lid-
,'enlricular 
Basil1'r i\lid-
venlrirulH 
IIllsilar ;\Iid 
__________ ~·~~nl_rirnh". 
LLS-locallinear shortening, UV- lInipolar voltage, BP- bipolar voltage. 
III Non-Viah!e 
0Viable Impaired 
o Normal 
Overall a sigllifhallt dijJerence was observed between the UV; LLS and PB values in the basal as 
(Ompared to the mid-·ventriw/ar region., (UV:p<O.OOOJ, LLS :p<0.0002, BP :p<0.039). 
The ability (:fthese parameters to distinguish between irifarderl, ischemic and normal myocardium 
according to Thallium petfltSion studies is preserved (interaction mid-ventricle verJlls basal for LLS, 
Uv, Bl' = NS). 
Electromechanical coupling assessment 
Overall the distribution of the electromechanical coupling index values correlates with 
redistribution thallium activity (p <0.0001). Significantly lower values ofEMC index were 
found in non viable segments compared with viable impaired (25.18 :!: 60.5 versus 86.8 ± 
95.6; p = 0.003) and normal regions (25.18 ± 60.5 versus 138.4 ± 137.7 P , 0.0001). LLS 
and UV were combined to provide an estimate of electromechanical coupling (EMC) 
which significantly correlates with redistribution thallium uptake as shown in Table 3. 
95 
96 
(j'd!,!.·, 7 - Leli l'elllriculu{ electromechanical elldocardiu illlu{Jpillf! to asses lIIyocardiall'iuhilily 
Table 3 
Distribution o/'estimate if EMC according to redistribution rlj2VlT/ activity. 
EMC Normal Viable impaired Non-viable P value 
N~192 N~68 N~20 
LLS < 6.5%, UY < 6.5 mY 14 14 11 
LLS < 6.5%, UV:c 6.5 mV 45 21 3 
LLS:c 6.5%, UV:c 6.5 mV 124 31 3 
LLS > 6.5%, UV < 6.5 mV 9 2 3 < 0.001 
LLS: loeallinear shortening. UV: unipolar voltage. EMC: electromechanical coupling. 
Automatic and manual editing 
The Lin's concordance correlation coefficient for agreement between the automated 
edited maps and the manual edited maps was 0.72 (p<O.OOl) for the LLS and 0.95 
(p<O.OOl) for UV respectively. Overall both LLS and IN maps automatically and 
manually edited could discriminate between normal, viable impaired and non-viable 
myocardium as assessed by perfusion studies (LLS automated edited: 10.7 ± 7.1 versus 9.4 
± 6.8 versus 7.3 ± 6.8; p= 0.044. UV automated edited: 13.8 ± 6.1 versus 10.7 ± 5.3 versus 
7.8 ± 4.1; p ~ 0.0001). 
Intra-patients reproducibility 
The intra-patient reproducibility of the NOGA map's data has been evaluated in five 
patients in whom the NOGA study was performed in two times (as a clinical assessment 
and as part of a DMR protocol) few weeks apart without any revascularization procedure 
between. The LIN's concordance correlation coefficient rho of 0.61 (p<O.OOl) was 
observed for the UV data. The relatively small number of segments results in insufficient 
statistical power to raise any definitive conclusion for the intra-patient reproducibility of 
NOGA myocardial assessment. 
DISCUSSION 
The Biosense electromechanical mapping system has been proved in animal studies and 
in preliminary clinical experience to distinguish infarcted from healthy myocardium by a 
reduction in both electrical voltage and mechanical activity. In these preliminary studies 
local endocardial shortening "lN3S significantly impaired in MI zones compared with 
controls and significant electrical impairment was observed in the infarct zones. 
Kornowski, observed that segments with reversible perfusion defects at the 99m 
Tc-sestamibi after adenosine stress scintigraphy, have a moderate reduction (15%) in 
endocardial potentials and mechanical function, while segments with fixed perfusion 
defects showed a profound electromechanical impairement. In our study comparing 
redistribution thallium images with Noga parameters, we could discriminate between 
ischemic but viable and non viable myocardium. Interestingly among the segments with a 
thallium uptake < 50% of maximal, unipolar voltages show a trend toward higher values 
in the regions with a thallium uptake between 20% and 50% compared to regions with 
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thallium activity < 20% (p=0.08). This observation raises the question of whether a regions 
of patchy ischemia within fibrotic areas still retain some electrical activity and possibly 
myocardial viability which should be accurately detect -with endocardial mapping. 
Mechanical dysfuction could indicate irreversible myocardial necrosis as well as restorable 
ischemic or hibernating myocardium, and Kornowski suggested that the existance of 
electromechanical uncoupling (impaired mechanical activity with preserved electrical 
activity) migth signify retained myocardial viability. This issue has been addressed by Koch 
who evaluates myocardial viability in hypocontractile and underperfused myocardium, 
comparing the endocardial electrical signals with F-18 FDG uptake at PET and Tc-99m 
sestamibi at SPECT studies respectively. In this study electrical unipolar signals using 
6 m V as threshold amplitude correctly identifies scar areas from areas with preserved 
viability and may predict improvement in wall motion abnormalities six months after 
successful revascularization. 
Concordantly -with the series of van Dahl we found an overall threshold for the UV of 
6.5 mV defining viable tissue, while a threshold of 10.3 mV characterizes the normal 
viable tissue. This is consistent with the average unipolar voltages observed by Van 
Langenhove in segments with or without improvement at low dose dobutamine stress 
echocardiography (10.2,5.7 mV and 6.9,3.1 mV respectively). 
In our series significant lower values of LLS and of UV were observed in the basal 
myocardial regions versus the mid ventricle. At the regional level, there appears to be 
remarkably spatial heterogeneity of myocardial deformation. Midwall segment shortening 
is higher at the apex than at the base of the LV, and circumferential shortening is higher 
in the anterior than in the posterior left ventricular wall. The presence of the valve 
apparatus (electrically inactive) should possibly explain the lower average voltages values 
recorded basilar regions. Nevertheless despite different absolute values, within the 
midventricular and the basilar regions the UV accurately detect viable from non viable 
myocardium, with possibly a somewhat more overlapping in the mitral anulius area as 
ahoeady observed by Kornowski. These observations raises the issue of possibly different 
threshold according to LV regions for a better definition of the myocardial viability status. 
In our study an estimate of the electromechanical coupling and the electromechanical 
index appear to significantly correlate with redistribution thallium perfusion, but with a 
not negligeable overlapping between non-viable, viable impaired and normal myocardium. 
This is possibly due to the limit of using a standard segmentation of endocardial surface 
and average values of data points. 
Overall higher fragmentation index values compared to those reported by Keck, were 
observed in our series (1.41 ± 0.5 versus 1.15 ± 0.18 and 1.83 ± 0.7 versus 1.28 ± 0.23 in 
normal and non viable segment respectively), but the difference between normal, viable 
imapired and scar areas was not statistically significative probably due to an excessive 
scattering of the signal in our maps. More sophisticated signal analysis and algorithms 
could better define the fragmentation phenomena in the aim of a precise detection of 
viable myocardium. 
The correct interpretation and clinical significance of the obtained data are totally 
dependent by the quality of the acquired points. The system provides an automatic editing 
of the undesired points. From our data the automated postprocessing appears to be as 
accurate as the manual editing for the UV maps and slightly less precise for the LLS 
interpretation based on the version 2. of the sofware, possibly due to the weight of the 
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unedited inner points and the clustered points on mathematical function which calculated 
the LLS. The clinical relevance of these observation implies a reliability of the 
interpretation of the voltages data even in presence of "bad" points) for the detection of 
normal, ischemic and non viable myocardium. 
Moreover it appears that the electrical information is reproducible over the time in the 
same patients not treated by any revascularization procedure. This implies a reliability of 
the UV maps interpretation and permits to utilize the NOGA myocardial assesment to 
define changes in viability status after different revascular.ization procedures. 
Study Limitations 
As all comparative studies, there is the potential for anatomic misalignment, because the 
orientation of the heart is inherently different between the techniques. Particularly with 
NOGA the reconstruction of the chamber is sequential and irregular and the 3-D 
geometry of the chamber depends on the number of point sampled. Hence the temporal 
resolution of the method is limited and failure to collect data points homogeneously from 
the entire ventricle results in underestimation of the true LV chamber. 
The mechanical function derived from the by use of local endocardial shortening for each 
endocardial site is the average from all the neighboring points and this may result in 
reduction of the reduced LLS area. 
Unipolar voltage measurements may potentially be affected by Eu-field potentials which 
could decrease the amplitude of the unipolar electrograms at infarcted region. 
Bipolar electro grams with the actual mapping catheter have certain limitations because of 
changes in the electrode orientation relative to the activation wave front. These limits 
should be overwhelmed with the splitted tip mapping catheter. 
A mathematical algorithm provides a reliable estimation of the QRS complex 
fragmentation) but the real intracardiac signals are cont·aminated with noise and other 
small disturbances which could affect the level of fragmentation and may result in 
reduction of the ability to detect viable tissue within a scar. 
Clinical implication 
Electromechanical mapping could provide new intriguing insight in the comprehension 
of myocardial ischemia and of myocardial viability. The possibility of discriminate viable 
myocardium should have an importance in the revascularization decision-making directly 
in the cath-lab. The ability of navigating into the left ventricle permits the guidance of 
catheters for direct myocardial revascularization both by laser energy and gene transfer. 
The on-line assessment of myocardial viability should be advantageous both for targeting 
the treatment zone and avoiding the laser energy delivery within then scar. 
CONCLUSIONS 
Electromechanical maps distinguish normal) non viable and ischemic myocardium as 
assessed thallium perfusion imaging studies. 
The electromechanical assessment could enable the discrimination of hypo contractile) but 
still viable myocardium. The myocardial viability status as assessed by the unipolar voltage 
appears to be reproducible over the time. 
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ABSTRACT 
Background 
Nonfluoroscopic electromechanical mapping (NEM) has recently emerged as a novel in-
cathlab method to assess electromechanical functioning of the myocardium and to detect 
myocardial viability. Up to now) no comparison with dobutamine stress echocardiography 
has been reported. We therefore compared the results of NEM to those of DSE for the 
detection of myocardial viability in a subset of patients with severe coronary artery disease. 
Methods and Results 
Myocardial viability was assessed through both DSE and NEM in 30 patients, a majority 
of whom suffered a previous myocardial infarction (83%). A segment-to-segment 
comparison was made in 324/360 segments (90%). Logistic regression and receiver 
operator characteristics (ROC) curve analysis revealed highly significant predictive values 
for both linear local shortening (LLS) and unipolar voltages (UPV) : area under the curve 
was 68% and 74% respectively (p<0.0005 for both). ROC curve analysis revealed LLS= 
7.2% and UPV =8.2 m V as optimal cut-off values to define viability. The combination of 
both parameters proved to be the strongest predictor for viability (RR;;:6.5 ,CI 3.0-13.9, 
p,O.0005). 
Conclusion 
NEM can predict recovery in previously injured myocardium when compared to DSE. 
Both LLS and UPV have added value in the assessment of viability. Strongly significant 
cut-off values for both LLS (7.2%) and urv (8.2 m V) were found. 
Condensed abstract 
Nonfluoroscopic electromechanical mapping (NEM) has recently emerged as a novel 
technique for in-catlliab assessment of myocardial viability. We compared the findings of 
NEM in 30 patients with the results of dobutamine stress echocardiography. We found 
highly significant cut-off values for both linear local shortening and unipolar voltages for 
the detection of viable myocardium. Moreover) the combination of both parameters has 
the highest value in predicting recovery of previously injured myocardium. 
List of Key Words 
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Ventricles 
Stress Echocardiography 
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INTRODUCTION 
Assessment of viability in patients that previously suffered myocardial injury remains a 
challenge in clinical cardiology, as revascularization of viable myocardial segments may 
improve prognosisY,2) DSE is a widely accepted method to define the presence of 
myocardial viability,(J,'I) and has been found superior to information obtained solely from 
coronary anatomy at cardiac catheterization. (5) DSE however is not easy to apply inside the 
cathlab, and is usually performed with a certain time delay from the index diagnostic 
catheterization. 
Nonfluoroscopic mapping has recently emerged as a novel in-cathlab method to assess 
electromechanical functioning of the myocardium. 'This system allows measurement of 
local electrical (unipolar voltage, UPV) and mechanical (local linear shortening, LLS) 
properties of the left ventricle.(Wfhese properties have been implied in the assessment of 
potentially recoverable myocardium post-infarctionY'~) Kornowski et al. recently described 
the value of nonfluoroscopic electromechanical mapping (NEM) in the detection of 
reversible perfusion defects as compared to radionuclide perfusion imaging.(9) Up to now, 
no comparison with DSE has been reported. 
We therefore, for the first time, compared the results of NEM to those of DSE for the 
detection of myocardial viability in a subset of patients with severe coronary artery disease 
and defined cut-off values for electrical (UPV) and mechanical (LLS) parameters for 
viable myocardial tissue. 
METHODS 
Study population 
We studied 30 patients with severe chronic coronary artery disease. Mean age was 61 :!: 8 
years. Twenty-seven (90%) were male. Twenty-five patients (83%) previously suffered a 
myocardial infarction, 16 (53%) had a Q:wave on the ECG. Twenty-seven patients (90%) 
underwent one or multiple revascularization procedures. All patients had stable anginal 
complaints (7 patients in CCS class 1, 11 in CCS class 2, 6 in CCS class 3, and 6 in CCS 
class 4). The study was approved by the respective medical ethical committees, and all 
subjects gave informed consent. 
Nonfluoroscopic electromechanical mapping 
The components of the system and the technique have been described extensively.(n.ll l In 
short, the NEM system (NOGATM, Biosense-Webster, Cordis, Johnson & Johnson) is 
able to acquire electromechanical data from the endoluminal surface of the left ventricle 
through the use of a 7 French catheter with a locatable tip placed in the left ventricle. A 
low magnetic field surrounding the patient enables the system to threedimensionally 
locate the catheter tip at all times. The tip of the catheter also contains electrodes to 
acquire local electrophysiological voltage data. Thus uni- (UPV) and bipolar voltages and 
linear local shortening (LLS) data of the left ventricle endoluminal surface can be 
assessedY,-ll) Presuming that in healthy myocardium any two points move closer to each 
other during contraction, the LLS assessment as measurement of distances between 
neighboring points is therefore the basis for calculation of myocardial shortening. The 
computer algorithm takes into account the density of points around a point p, and gives a 
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negligible weight to points too close (sampling noise) and points too far (of no influence 
as they provide non-local information). The algorithm for LLS is calculated as follows (Ill: 
for any two points on the map, i and j, LLS is calculated as the change in distance between 
these two points from end-diastole to end-systole, normalized for the length at end 
diastole: 
I LS-- ~ (L(ED) - - L(ES)--)/ L(ED)--
--'lJ 1J IJ 1J 
For any point p LLS is calculated as a function of the LLSpj, for all points j""l to n on the 
map, so that 
LLSp~ (SH __ n Wpj (L(ED)pj)x LLSpj ) / Sj~l..n Wpj, 
where W is the weight of a certain point as a function of the distance Lij between two 
points i and j, the average distance D around point p (D is defined in the computer 
algorithm as the average distance of the ten closest points to p) and the volume V at end-
diastole. The weight is therefore function of the point density in a defined region, the 
volume of the heart and the distances between points at end-diastole.(12) 
To ensure maximum validity of the data obtained, we applied an intense filtering 
mechanism. First, an inner points filtering was applied. This computer algorithm removes 
points that arc located deep within the reconstructed left ventricle. Therefore, the cone 
angle (the angle of the cone formed around a line connecting the investigated point and 
the center, defining the closest vicinity of a neighboring point) was set at 20%, whereas the 
relative depth percentage was set at 20%) meaning elimination of points located 20% 
deeper than neighboring points. Maximum location displacement of the catheter tip was 
set at 4 mm, trajectOlY instability was maximum 4 mm, and median cycle length was set 
at 10%, thus deleting all points which cycle length differed more than 10% from the preset 
values. After this thorough editing, local trajectories were examined for points with 
questionable behavior (which could imply loss of contact with the ventricular wall), 
endocardial ST segment elevation was evaluated for marked elevations (caused by intense 
impression by the mapping catheter), and ECG tracings were evaluated to ensure that 
data were not obtained during or immediately after an extrasystole. 
We considered a map successful when more than 40 points throughout the ventr.icle were 
acquired, and when no procedural complications occurred. Segments were evaluated only 
if at least three points per segment were acquired. 
Dobutamine stress echocardiography 
Dobutamine stress echocardiography (DSE) using a standard protocol was performed 
prior to the mapping procedure.(lJ,l-!) For wall motion analysis, we used a 16-segment 
subdivision as described prevlouslY1ll. These 16 different segments were analyzed by an 
operator blinded for the mapping results. Segments were evaluated using the 5-point 
scoring system according to the American Society for Echocardiography (1 ""normal, 
2""hypokinetic, 3""akinetic) 4""dyskinetic, and 5""aneurysmal) at rest, during low dose 
(10 mg/kg/min) and high dose dobutamine (up to 40 mg/kg/min, and additional atropine 
until maximum heart rates were obtained). 
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Segments were than qualified as worsened, unchanged or improved, depending on their 
change in score on the 5 point ranking. These results were than compared to the average 
local linear shortening (LLS, mm) and the unipolar voltages (UP, m V) of the same 
segments obtained during the NOGATM procedure. 
As standard echocardiography techniques divide the left ventricle into 16 segments, we 
had to imply a reduction to 12 segments to produce a comparable data set with the 12 
segments provided by the NEM bull's eye view. The validity of this comparison has been 
shown previously.{161The basal, mid and apical anterior segment were taken from the apical 
two-chamber view; the basal, mid and apical lateral segment from the apical four-chamber 
view, and the basal, mid and apical posterior segment from the apical long-axis view 
(figure i), 
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Comparison if NOGATM segments and erhocardiographic segments. The central square illustrates the 
bum: eye view qf the l~ft ventricle map as provided by the NOGA'flH system. Clockwise from upper 
right A (anteriOl), L (lateral), P (posteriOl) and S (septal) divisiollS are shown. From the center to 
the aliter part they are divided into apical, mid and baJal JegmentJ. The arrows Jhow the comparable 
segments 011 echocardiography. AP2C '" apical2-chamber view; AP4C"" apical 4-chamber view; 
APLAX== apical long axis view; /)'AX= parasternal short axiJ view; PLAX= pamsternallong axis 
View. 
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The apical septal segment was taken from the apical four-chamber view, whereas the mid 
septal segment was derived from the mid posterior and mid anterior septal segments on 
the parasternal short axis view, and the basal septal segment from the basal posterior 
(apical four-chamber view) and basal anterior septal segments (parasternal long axis view) 
(figure 1). When there was disagreement on the scoring of one of these combined DSE 
segments, the worst score was chosen. 
Statistics: Correlation was measured using Pearson's test. Means of values were compared 
using the unpaired Student's t-test. Multivariate logistic regression (forward stepwise) 
analysis was used to determine independent predictors of viability. Receiver operator 
characteristic (ROC) analyses were applied to determine the optimal cut-off values for 
LLS and UPV to predict viability, so that any value above that point would be considered 
as positive (ie predictive for viability), and any value below as negative. Sensitivity, 
specificity, and positive and negative predictive values were calculated at each threshold. 
We defined the best threshold of a significant predictive variable to de the cut-off point 
where sensitivity equals specificity, defining the point with the highest diagnostic accuracy. 
Using this threshold, the population was divided in two times two categories. The 
frequency of viability in all categories was determined, and differences were evaluated by 
chi-square analysis. Relative risks were calculated. A p-value <0.05 was considered 
significant. 
RESULTS 
All mapping procedures and dobutamine stress echo cardiograms were successful. No 
complications were seen. An example is shown in figure 2. 
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Figure 2 
NOGAl.,.' map and dobutamine stress echoctlrdiogram sequence of the same patient. The upper panel 
demollStmles the NOGATM map from a sllperior view ( apex of the left ventricle is shown 01 the top 
of the picture, basis at the bOllom) to facilitate comparisons with the dobl/lall/ille stress echo images. A 
shows the unipolar voltage (UPV. 111 V) maps in the .{tIme view, (111(1 its respective bull's eye view(A'). 
B shows the linear loenl shortening (LLS, %) map, with its respective bull's eye view. Color codes are 
shown to Ihe right oflhe maps (UPV fiwn red «6m/l) to plilple (>14mV), alld LLSfrom red «2%) 
10 purple (>11%)). The nrrows in A and B show (/ region wilh high UPV alld low LLS, sllggeSl111g 
myocmdial viability ;11 the affected basal, mid, and apicolateral segments (llId ill the mid allterior 
segment. The absolute values can be appreciated il1 the bull's eye maps. Dobutamine stress 
echocardiogrnphic apical 4 chamber images orc shown at Ihe boltom of the figure. (a) shows akinesia 
of the b(lsal, mid (lnd (lpimllateral segment.r (It rest, (b) find (c) reveal viability with low and high 
dose dobulamine respectively, (d) .rhows the image during IwovelY. 
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In 30 patients, 324 ( of 360, 90%) segments were compared. Twenty-four segments (7%) 
could not be compared due to insufficient amount of points acquired during NEM, 12 
segments (3%) could not be analyzed due to insufficient echocardiographic image quality. 
Of these 324 segments, DSE showed that 100 (31%) were "truly" normal (normal at rest 
and normal during dobutamine infusion), 75 segments (23%) showed no viability, and 149 
(46%) segments were viable. UPV for normal versus all other segments was 14.9 m V ± 5.7 
versus 9.0 mV ± 4.3, respectively. LLS was 12.8% ± 6.1 versus 6.9% ± 6.6, respectively 
(p,O.OOS for both comparisons). 
Of the 100 normal segments, 15 showed ischemia and 85 did not. UPV did not differ 
significantly amongst the two groups ( 14.2 m V ± 5.7 versus 14.9 m V ± 8.1 ,respectively, 
p=0.70). The difference in LLS for the ischemic segments (8.7% ± 8.2) versus the non-
ischemic segments (12.8% ± 6.1) was borderline significant (p=0.047). Hypokinetic 
segments (n=79) showed ischemia in 21 segments (27%) and no ischemia in 58 segments 
(73%). UPV was higher in the ischemic segments (11.5 m V ± 5.3) than in the non-
ischemic segments ( 8.7 mV ± 3.1) (p=0.004). LLS however, did not differ significantly 
between both groups ( 8.2% ± 6.5 vs. 8.5% ± Sol, respectively, p=0.87). 
The correlation between UPV and LLS for all segments is shown in figure 3. 
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Correlation be/ween unipolar voltages (UPf/; m V) and linear local shortening (LLS, %) for the same 
segments. 
Although only moderate (r=0.49), the correlation proved highly significant (p,O.OOOS). 
For the further analysis on viability, only the segments that were not normal were used. 
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Table 1 
Logistic regression and receiver operator characteristin (ROC) curve analysis if /,LS and UPV for 
detecting viable myocardium. 
Variable Cut-off ROC area P (multivariable) Sens, % Spec, % PPV,% NPV,% 
(95% el) 
LLS-% 7.2 68 (61-75) <0.0005 64 68 80 48 
UPV-mV 8.2 74 (67-80) <0.0005 70 77 85 61 
Scm= semitivi!y, ~pec= jpecificity, PPV= positive predictive vallie, NPV= negative predictive vallie, 
LLS= local linear shortening, ROC= recti·va operator characteristics, C,Y= canidmer interval. 
Table 1 shows the results of the logistic regression and the ROC analyses. 
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Receiver operator characteristics (ROC) C/fr·ve jOr upv. The graph demonstrates the optimal cut-off 
value for UPVas the optimal semitivity and specificityJor detecting myocardial viability. 
Figure 4 shows the ROC curve for UPV. LLS has a moderate prognostic value in the 
prediction of viability (ROC area 6891), p<O.0005); the optimal cut-off value for LLS was 
7.2%. UPV had a stronger prognostic value in predicting viability ( ROC area 74%, 
p<O.0005); the optimal cut-off value for urv was 8.2 m V. The multivariate logistic 
regression analysis showed that both LLS and urv were highly significant independent 
parameters to predict viability. 
According to these cut-off values, we then stratified segments into four subsets according 
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to low (,7.2%) versus high (,7.2%) LLS and low (,8.2m V) versus high (,8.2m V) upv. 
The segments that were most likely to be viable had LLS> 7.2% and UPV>8.2mV (group 1). 
Conversely, the segments that were least likely to be viable had LLS<7.2% and 
UPV<8.2mV (group 4). The segments with either LLS>7.2% or UPV>8.2mV had 
intermediate likelihood of viability (group 2 and 3, see figure 5). 
Divisioll of segments into jOllr 
categories according to the optimal 
wt-r:!fva/ues ifUPV= 8.2 mV and 
LLS= 7.2%. Group .1 represents 
segments that have both optimal 
UPV as well aJ f.LS. Group 4 
represents segments thai have both 
decreased UPV and LLS. Groups 2 
and 3 represent groups with high 
LLS and low UPV; and vice versa. 
The closed squares represent 11011-
viaNe segmenls; the open squares 
represenl viable :;egments. 
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'The result of this division into 4 subgroups according to the presence of viability is also 
shown in figure 6. 
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In this figure) the segments viable on DSE are depicted as open circles, whereas solid 
points represent those that were not viable. The right upper quadrant contains most of the 
segments that were viable on DSE, whereas segments that did not show viability are 
abundant in the left lower quadrant. 
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The optimal cut-off criteria of the combined categorical variables were subsequently used 
to establish the relative "risk" (RR) of the presence of viability (sec table 2). 
Segments in group 1 (LLS:;' 7.2% and UPV:;, 8.2 m V) had a 6.5 times higher probability 
of being viable than segments in group 4 (LLS < 7.2% and UPV < 8.2 m V). 
DISCUSSION 
The most important finding of this study is the high predictive value of nonfluoroscopic 
mapping as a tool for in-cathlab assessment of viability. We have - for the first time-
identified strong threshold values of LLS (7.2%) and UPV (8.2 mY) that characterize a 
subgroup of hibernating myocardial segments that are likely to be viable. Although the 
risk analysis showed that both LLS (RR 2.4) and UPV (RR 4.5) were independently 
predictive of viability, a combination of both parameters showed an even stronger 
predictive value (RR 6.5). 
This is the first study that demonstrates the possibilities of electromechanical mapping as 
compared to dobutamine stress echo cardiography to predict recovery of injured 
myocardial segments. The correlation of NEM with radionuc1ide testing in the detection 
of reversible perfilsion defects is well established.(R.9) Recent studies however have 
suggested a preference for dobutamine stress echocardiography for viability assessment 
when compared to radionuclide techniques.(J7 I~) Indeed, Arnese et a!. comprehensively 
demonstrated that a specificity of 48% with poststress reinjection !_OITI single-photon 
emission computed tomography (SPECT) before surgery induced a significant amount of 
unnecessary grafting procedures to segments that were deemed viable, but proved not to 
be when reassessed after bypass surgery. (IR) A comparison with DSE may therefore be of 
added value to the ongoing search for cut-off values in the electromechanical assessment 
of myocardial viability. 
The results of our study are somewhat discordant with previously published reports.{~) 
Kornowski et a1. comprehensively demonstrated that in their population of 18 patients 
with symptomatic chronic angina, reversible perfusion defects showed LLS and lJPV 
values of 10.3% ± 3.7 and 12.0 m V ± 2.8, respectively.(~) This discordance may be induced 
by the difference in study population, the small amount of patient.s in both studies or the 
differences in sensitivity and specificity between DSE and radionuc1ide scanningYo 2l) 
Although the electromechanical mapping technique is not readily available in every 
cathlab and is not easy to master, some advantages can be put forward. 1) The 
interobserver disagreement in stress echocardiography and radionuclide scintigraphic 
techniques may reach up to 20%(23); the NEM technique is not based on interpretation, but 
puts forward clear values of electromechanical properties and may therefore have better 
reproducibility and may provide a more straightforward interpretation. Others have 
suggested that radionuclide techniques may over- as well as underestimate the amount of 
possibly recoverable myocardial tissue.{2W) 
In this study, we found significant differences in electromechanical parameters in ischemic 
versus non-ischemic segments that showed a normal baseline contraction pattern on 
echocardiography. The fact that LLS showed a borderline significant lower value in 
segments that proved to be ischemic during dobutamine infusion, could reflect the 
minimal changes in regional contraction of the jeopardized myocardium that cannot be 
seen using echocardiography but become apparent with NEM. In segments that show 
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hypokinesia on baseline echocardiography, UPV was higher in segments that were 
ischemic during DSE. This may reflect the viability that is still present in these segments. 
Limitations 
The small number of patients limits us in drawing final conclusions about true cut-off 
values for viable and non-viable segments. Also, it may be of importance that in the group 
with both low LLS as and low UPV, DSE suggested still 40% of the segments to be viable. 
This issue is addressed in the forthcoming DINO study, which will evaluate the 
assessment of NEM for predicting recovery of injured myocardial segments as compared 
to true recovery after bypass surgery. Last, 40 points may not be enough to adequately map 
all myocardial regions. 
Conclusion 
NEM can predict recovery in injured myocardium when compared to DSE. Both LLS 
and UPV have added value in the assessment of viability. Strongly significant cut-off 
values for both UPV (8.2 ill V) and LLS (7.2%) are set forward. 
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Summary 
Direct myocardial revascularization (DMR) has been proposed to treat patients with 
severe coronary artery disease who are not amenable for classical revascularization 
techniques such as percutaneous coronary intervention (PCI) or bypass surgery (CABG). 
Although recent reports suggest its benefit in alleviating the patients' complaints in the 
long term) there is still a paucity of data on the immediate impact on regional and global 
myocardial functioning following this treatment. In this overview we discuss our own 
experience and provide a summary of other data currently available. 
('h~" ;,) ij -Acute changes (!(glo!;alwld regioJlal feji l'clllriclllal"jilllclioll ill/Illcdiately after (/iree! myomrdial rel'(lsculariwtioll 
Text 
Introduction 
Direct myocardial revascularization (DMR) has been proposed to treat patients with 
severe coronary artery disease who arc ineligible for classical revascularization techniques 
due to inappropriate coronary anatomy or due to highly increased risk for re-operationY--1! 
The principle of DMR is based on the direct treatment of the myocardial muscle by 
creating channels within the myocardium by mechanic or by thermic injury. Since the very 
first experimental application, the technology has been continuously improved. Modern 
systems for clinical application create channels by use of laser energy. Currently, two 
methods are available: the surgical transmyocardial approach{j,6), and the percutaneous 
catheter-based technique(7,~!. Although recent data suggest the benefit of both techniques 
in alleviating the patients' complaints/~' 11)) information on the immediate impact on 
myocardial functioning is still lacking. Indeed, most studies provide data on the effect on 
left ventricular (LV) function 3 (l1-11! or 6 months after the index procedure.(9, LI! The acute 
effects on LV function however remain unclear. Perioperative morbidity and mortality 
after surgical transmyocardial revascularization range up to 50 and 20% respectively, 
including a high incidence of congestive heart failure(14). Also, there is no conformity on 
the inclusion of severely diseased left ventricles: where in some studies patients were 
included with LV ejection fraction (LVEF) as low as 2091() (Y! or 25%011,141, others used 30%(15) 
as cut-off to include patients. In most trials, average LVEF on inclusion was quite high, 
ranging between 50 and 60%(H. 16, 17), suggesting the inclusion of patients with relatively 
good LV function in these trials. For the above-mentioned reasons we felt it important to 
unravel some of the mechanisms that lead to these early failures. This overview will 
therefore mainly focus on acute effects of DMR on the LV function. In addition, we 
provide the Thoraxcenter data on the acute effects on the left ventricu1tr function before 
and immediately after percutaneous DMR in 15 patients treated in our institution. 
Thoraxcenter experience 
Patients with medically refractory angina and coronary artery disease that could not be 
treated with percutaneous or surgical revascularization were assigned to undergo 
percutaneous DMR. They all suffered severe and diffuse coronary artery disease or did not 
have a target vessel or conduit suitable for bypass grafting. All had reversible ischemia as 
demonstrated by dobutamine stress testing or radio nuclide perfusion imaging. The only 
exclusion criterion was a left ventricular ejection fraction lower than 3091). The ShIdy was 
approved by the Erasmus University Hospital medical ethics committee, and all patients 
signed an informed consent. 
l<ollowing a diagnostic angiogram, a DMR procedure was performed. According to the 
preference of the investigator, one of two available systems was used. The Cardiogenesis 
system (CardioGenesis, CA, USA) uses biplane fluoroscopy for navigation. The system is 
made up by an Axcis aligning 9 F catheter and a Holmium (HO): yttrium-aluminum-
garnet (YAG) single fiber 330? laser catheter incorporating a tip lens for controlled laser 
energy deliveryY,l) The catheter has nitinol pedals ncar its tip to prevent deep penetration 
into the myocardium. The energy delivered is 2 Joules (]) per pulse for 4 pulses. The 
Biosense system (Biosense-Webster, Cordis, a Johnson & Johnson Company) uses a 
recently developed nonfluoroscopic 3-dimensional electromechanical mapping technique 
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that has been described previously. (l~-ll) In short, the system is composed of a miniature 
passive magnetic field sensor incorporated in a catheter, an external magnetic field emitter 
(location pad), and a processing unit. The deflectable-tip catheter contains both a location 
sensor proximal to its tip, and standard electrodes that allow recording of unipolar (UPV) 
and bipolar (BPV) electrical signals. The locator pad placed beneath the operating table 
consists of three radiators that generate magnetic fields (5xl0-6 to 5xl0-5 Tesla) that 
contain the information necessary to resolve the location and orientation of the sensor in 
6 degrees of freedom. As the catheter tip is dragged over the LV endocardial surface) the 
system continuously analyzes its location in 3-dimensional space without the use of 
fluoroscopy. Chamber geometry is then reconstructed, in real time, using the set of 
sampled location points. The system thus allows for 3-dimensional guiding of the laser 
catheter to the region of interest. The laser system is a Ho:YAG single-fibre 300? laser 
catheter that delivers energy at 2 J per pulse.(22) 
LVA's in RAO 300 and LAO 600 were performed using standard techniques(2J), before and 
immediately after the DMR procedure. We assessed regional myocardial function using 
the area-length method and the Slager method(23) and compared treated and non-treated 
segments. 
Between October 1998 and September 1999) 15 patients were included. Seven patients 
were treated with the Cardiogenesis system, and 8 with the Biosense system. Eighty-seven 
percent (13/15) of patients were male. Average age was 60 ± 9 years. Twelve patients 
(80%) were in stable angina class CCS 3 or 4 while 3 patients were unstable. On average, 
20 ± 5 channels were created, in an average procedure time of 96 minutes ± 31. All 
procedures were successful, and no complications occurred. The relative decrease in LVEF 
was 18% ± 10 after DMR, the relative decrease in regional wall motion was 9% ± 18 for 
the non-treated and 26% ± 17 for the treated regions. Further results are shown in the 
table. 
Table 
Numhe, LVEF LVEF RMW treated RMW treated area RMW non-treated RMW non-lre"lc<.l 
of before{%) ~fler(%) are" before before area before area after 
Ch"nnel, DMR(%) DMR(%) DMR(%) DMR (%) 
(n±SD) 
Average 2. 65 53 19.80 14.60 16.90 15.60 
±5 ±11 ±1' ± 6.40 ±5.40 ±6.60 ±6.10 
Wilcoxon P 0.001 L-_ P 0.001 P 0.031 
signed 
ranI,s test 
The table shows the average number C!f channels created per patient, the overall lift ventricular 
function (LVEF) and the regional (RT1Ilv1) myocardial function if treated and non-treated areas. 
SD: standard deviation; LV},'P' I~ft ventricular ejectio11.Faction; RWM: regional wall motion; 
DMR: direct myocardial revascularizatioll. 
(,'/"I}'I<'I' ~ - Acute c/ranges o{global (lnd regional {eli vclllriclI/arlilllclioll immediately ajier direCllllyocardia/ rel'tlsntlllri;:.uliol! 
Effects of Catheter-Based Direct Laser Myocardial Revascularization on Regional 
and Global LV Function: The U.S Experience 
Transthoracic echocardiography was performed within 24 hours before left ventricular 
(LV) mapping guided DMR, within 24 hours after the procedure and again at one month 
in 77 patients enrolled into the Biosense'I'M DMR phase 1 safety and feasibility study 
conducted in the U.S. There was no change in average measured LV ejection fraction after 
DMR or dur.ing follow up (48±12% post procedure, 46±11% at one month vs. 48±11 % at 
baseline, P=NS for both comparisons).{]'!) Regional wall motion was assessed by 
transesophageal echocardiography (TEE) in a sub-study that included 10 patients 
undergoing catheter-based DMR using a Ho:YAG laser before and immediately after the 
procedureY'l Mild deterioration in wall motion score occurred in only 31160 (1.9%) 
segments carefully assessed by TEE and did not induce clinical heart failure. Overall, there 
was no change in wall motion score index after laser myocardial revascularization 
(0.74±0.98 before versus 0.76±0.98 after DMR, p"0.3)Y" 
DISCUSSION 
Our experience suggests that myocardial function immediately following DMR is 
impaired, causing a decrease in LVEE These data arc consistent with findings of animal 
studies that clearly show an acutely reduced global LV function after DMRyr,.27J GassIer 
et a1. showed that transmyocardiallaser revascuIarization causes acute irreversible damage 
of tissue surrounding the laser channels, creating necrosis up to 2 mm from the laser 
application site(2~). Even beyond this zone, irreversible damage may occur. (28) The damage 
thus incurred may in part explain for the decrease in local myocardial function. 
Data on the immediate impact of surgical and percutaneous DMR are scarce. Recently, 
Hughes et al. reported the incidence and spectrum of peri operative morbidity and 
mortality in 34 patients treated with surgical DMR.(29) In their study, baseline LVEFwas 
50 ± 9% (assessed with radionuclide techniques). Perioperative morbidity was 47%, 
perioperative mortality 6%. No immediate post-intervention assessment of LVEF was 
performed, but the authors carefully examined all adverse events in the postoperative 
period. Two patients died as a result of perioperative myocardial infarction. It is however 
of interest that 29% of the patient population suffered an episode of congestive heart 
failure (CHF) in the immediate postoperative period. Preoperative presence of unstable 
angina was the only predictor for perioperative death, while lack of experience and the 
absence of furosemide infusion were the sole predictors of morbidity. The authors suggest 
that the use of IV furosemide in the immediate postoperative period might reduce the 
incidence of myocardial edema caused by laser injury of the myocardium, thus reducing 
the incidence of diastolic failure and CHF.(29) The same group very recently reported on 
the acute effects of surgical DMR using holmium:YAG and carbon dioxide laser in the 
swine. They comprehensively demonstrated the increase in myocardial water content and 
thus impaired diastolic relaxation possibilities of lased myocardial regions, suggesting a 
possible mechanism of increased incidence of perioperative morbidity following DMR.(30) 
Aaberge et al. recently reported an incidence of CHF of 35% after surgical DMR. At 3 
and 12 months however, no significant change in LVEF was reported. Lutter et al. 
reported on 7 patients with LVEF <35% treated with surgical DMR. Swan Ganz catheter 
examinations showed deterioration of LV-function after laser revascularisation 
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intraoperatively and improvement after 2 h and further after 6 h. (31) In this study, final 
outcome was favorable possibly due to the use of intraaortic balloon pumping, as 
suggested by the authorsY ll 
Although our preliminary findings suggest no acute beneficial effect on LV function, 
myocardial laser revascularization has shown to improve anginal status in a subgroup of 
patients that were not amenable for classical revascularization procedures.!9, 10, 1-1, 16, JJ.. H) 
Recently, three randomized trials showed improvement in clinical status in DMR-treated 
patients six to twelve months after the index procedure(~' 10). Whether this treatment also 
improves myocardial perfusion, or global LV function, however remains to be proven. 
Current literature shows conflicting reports; while some authors suggest increase in LV 
functiod.l'll, others have found no changd17) or even decrease(.J5, 36) in the long mil.. These 
discrepancies may be explained by differences in duration of follow-up, in LV assessment 
methods,(J7) differences in LV function assessment or differences in baseline LVEE Nagele 
et al. recently showed that patients with lower LVEF at baseline had worse long-term 
outcome after laser revascularizationPhl• Our results may ~ for the first time ~ elucidate the 
basis for these findings. The decrease of LV function immediately following DMR may 
well be the pathophysiological basis for the high incidence of CHF in the periprocedural 
era. Indeed, if an acute decrease in left ventricular performance immediately following 
DMR is to be expected, one can appreciate the reluctance one has to generate in treating 
patients with low baseline LVEE On the other hand, recent data on percutaneous 
catheter-based DMR suggest no detrimental immediate effect on the left ventricleY·I,25) 
Conclusion 
Although DMR can causes acute decrease of the LV function, most studies suggest that 
there is no detrimental effect in the long term. Also, recent data from other centers suggest 
that percutaneous DMR may not be so detrimental in the acute phase as the findings in 
our patient group suggest. It however remains troublesome that up to 45% of patients may 
experience an adverse event in the immediate post-intervention era. Therefore, one must 
be careful when performing myocardial laser revascularization in patients with a low 
(<30%) baseline LVEE Prolonged observation in a coronary or intensive care unit, the use 
of intraaortic balloon pumping and the use of high dose IV furosemide may be warranted. 
Whether percutaneous DMR will prove to be safer than surgical DMR, remains to be 
shown. 
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A 60-year-old man was referred to our intervention laboratory for direct myocardial 
revascularization (DMR). He had received maximal medical therapy and had undergone 
coronary bypass surgery 10 years earlier, and his peripheral coronary anatomy was now 
found to be unsuited for surgical revasculariza tion. In addition, the lesions on coronary 
angiography proved to be unfit for percutaneous revascularization. Consequently, a DMR 
procedure was performed. We used the NOGA nonfluoroscopic electromechanical 
mapping system (Biosense-Webster) as a guidance tool to deliver laser energy at the exact 
target locations. The system has been described previouslyY.1) 
In the Figure, A shows the local linear shortening (LLS) map in the left an terior oblique 
view and its corresponding bull's eye view (A9) at baseline. The map is color-coded (see 
color bar in B), ranging from red (LLS, 2%) to purple (LLS. 11%), with red zones thought 
to delineate akinetic zones and purple normokinetic zones YJ The bull 's eye view shows 
basal (outer circle), mid, and apical (inner circle) regions of (clockwise from top) the 
an terior (small A), lateral (L), posterior (P), and septal (S) segments. ]n the picture, the 
low LLS values in the basal and mid portions of the posterior and lateral segments can be 
seen (21.4%, 22.5%, 2.2%, and 4.1%, respectively). Because the unipolar voltage map 
suggested viability, these regions were thought to be eligible for DMR. Band B9 show the 
LLS map afte r the DMR procedures, with the brown tags showing the precise locations 
of the laser energy app lications. Similar LLS values in this region support the belief that 
regional wall motion improvement can b~ expected only after a certain time delay and not 
immediately after DMR. The control map taken at 6 months is shown in C and C9. The 
improvement of regional waIJ motion can easily be appreciated in C. Indeed, the 
posterolateral zone, formerly colored red, is now green~blue, suggesting increased LLS 
and thus improved wall motion. The hull's eye shows increases in 1....1....S of 2.9%, 7.1%, 
4.3%, and 7.2% for basal and mid portions of the posterior and lateral segments, 
respectively (average increase, 4.8±3.3%). This case suggests, for the first time, a local 
shortening increase as a function of left ventricular wall motion improvement 6 months 
after a DMR procedure. 
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ABSTRACT 
Backgrolfnd. Percutaneous transendomyocardial injection with an injection catheter is a 
new drug delivery method for e.g. therapeutic angiogenesis. Little is lmown about the 
efficacy of this drug delivery technique. We studied efficiency and retention of 
transendomyocardial injections with a NOGA guided injection catheter system by using 
scintigraphy w.ith radio-labeled model drugs. 
Methods. Ten non-ischemic landrace pigs were used. In each animal 2-3 
transendomyocardial injections were performed using a 3-D mapping based catheter 
system called NOGA. As a model for proteins like angiogenic growth factors or particles 
like microspheres or adenovirus we used 99mTc labeled albumin and 99mTc labeled 
colloid albumin, respectively. Efficiency of the injections and retention of the 
transendomyocardial deposited substance was evaluated by a gamma camera during and 
after injection of 0.1 or 0.2 ml. 
Re,wlts. All 29 injections showed scintigraphic proof of intramyocardial deposition. The 
average injection efficiency of all 29 injection was 26 ± 23%. 'I'he average injection 
efficiency of 0.1 and 0.2 ml injections were 33 ± 30% (n=8) and 24 ± 20% (n=21), 
respectively (p=0.33). Intramyocardial retention curve of albumin showed a rapid wash-
out within the first 2 hours of the injection, whereas the retention of colloid albumin 
showed no decrease. 
In conclusion, transendomyocardial delivery of proteins and particles with an injection 
catheter show favourable efficiency rates, however the retention time of intramyocardial 
deposited small proteins like albumin is short. This may indicate the need for sustained 
release systems of angiogenic growth factors for intramyocardal injection in therapeutic 
angiogenesis. 
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INTRODUCTION 
Chronic myocardial ischemia caused by coronary artery stenosis or occlusion has been 
shown to increase g-rowth of the coronary collateral circulation. Vascular growth factors, 
like some isoforms of Vascular Endothelial Growth Factor (VEGF), Fibroblast Growth 
Factor (FGF) or Platelet-derived Growth Factor (PDGF) arc important modulators in 
the complex process of collateral artery formation.(H) Animal stud.ies have proven the 
feasibility of enhancing collateral function by delivery of these angiogenic factors 
(cytokines) to the myocardiumY':;). Currently, therapy by applying vascular growth factors 
or genetic material that encodes for these angiogenic factors (therapeutic angiogenesis) is 
under clinical evaluation. Besides the method of delivery i.e.: growth factors, naked DNA 
(plasmids) or viral transfection of genetic material, also duration and route of 
administration of the angiogenic factors are important variables for the efficiency, efficacy 
and safety of the therapy. (6) 
lntramyocardial delivery of angiogenic drugs by transendomyocardial injection with an 
injection catheter is a novel administration route. Little is lrnown about the efficiency of 
this percutaneous transendomyocardial injection technique as well as the retention time of 
the injected substance in the myocardium. Therefore, we investigated the efficiency and 
the retention time of percutaneous intramyocardial injected radio-labeled proteins with a 
new injection catheter system. 
METHODS 
Animak Ten landrace pigs (weight 36-62 kg) were pre-medicated with Ketamine (25 
mg/kg i.m.), anesthetized with pentobarbital (10 mg/kg per hour i.v.) and ventilated with 
a nitrous oxide/ oxygen mixture (2:1). Catheterization was performed through a 8 F 
sheath in the right femoral artery. During the procedure arterial blood pressure and ECG 
were monitored. All experiments were performed in accordance with the "Guiding 
Principles in the Care and Use of Laboratory Animals, as approved by the American 
Physiological Society and with prior approval of the Animal Care Committee of the 
Erasmus University Rotterdam. 
Material. Analog to the local drug delivery studies in the coronary artery by our group(?'~) 
we investigated the efficiency and retention time of intramyocardial injected drugs with 
scintigraphy. As a model for vascular growth factors we used human serum albumin 
(lISA) coupled to Technetium (99mTc), using the TcchneScanR HSA kit (Mallinckrodt 
Medical BV, Petten, The Netherlands). Albumin is like the vascular growth factors a 
protein with a comparable molecular size (Albumin 69 blodalton (kDa), VEGF165 49 
Jilla, FGF-2 between 18-24 Jilla and PDGF bctween 28-34 lilla). Furthermore, as a 
model for much larger molecules (macroaggregates of growth factors) or particles 
(microspheres or adenovirus) we used human albumin microcolloidal particles (ALBU-
RESR, Amersham Sarin S.r.l. Saluggia, Italy) coupled to Technetium (99mTc). The size 
of the microcolloidal particles range between of 0.1 - 3.0 micrometer, whereas the size of 
an adenovirus is 0.13 micrometer and microspheres can range between 1.0-10 micrometer. 
Labeling procedure. 99mTc-HSA and 99mTc-colloid albumin were prepared by adding 
2 ml 0.9% NaCI with 99mTc of 92.5 MBq/ml (Mallinckrodt Medical, Petten, The 
Netherlands) to the TechneScanR HSA-bt or the ALBU-RESR kit, respectively. After 
the substance was homogenized, labeling efficiency of 99mTc-HSA ar 99mTc-colloid 
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albumin complex was measured using the I nstant Thin Layer C hromatography (ITLC) 
method (Gelman Sciences, Ann Arbor, Michigan, USA). Activity was measured by a 
Veenstra eRC- lOO dosiscalibrator (Veenstra Instruments BV, Leeuwarden, The 
Netherlands). The average labeling effic iency of all labeling procedures was 98.3 ± 2.3%. 
Injection procedure. After a left ventricle angiogram. a NOGA map of the left ventricle was 
obtained with an electromechanical mapping system (Biosense-Webster, Waterloo, 
Belgium). As described previousltY.lIJ, the electromechanical mapping system uses (1) a 
triangular location pad with 3 coils generating ultralow magnetic field energy, (2) a 
stationary reference catheter with a miniature magnetic field sensor located on the back of 
the animal, (3) a naviga tion sensor mapping catheter (7F) with a deflectable tip and 
electrodes providing endocardial signals and (4) a workstation (Silicon Graphics, 
Cal ifornia, USA) fo r information processing and 3-dimensional LV reconstruction. After 
the N OGA map, the 7 F mapping catheter was changed for an 8 F injection catheter 
(Biosense-Websrer, Waterloo, Belgium). The injection catheter consisted of a 
combinarion of an electro-mechanical mapping catheter and needle injection catherer 
(figure 1). 
B 
A 
figure 1/1 & B 
ThisJigllre represents the l1iosense injectioll calheter (Aj and mtheter lip (Bj. The mtheter has tI 7 F 
shaft with a dislal active de.flectable tip 0/ 8 F. The tip consists 0/ (111 electromagnetic sens01; a ring 
and tip electrode and the housing of a 0.014 x 0.009 inch extendable "itinol needle. At the proximal 
end 0/ the catheter the l1it;1101 Jhafl is connected with a luer lock fittil1gfor a syringe. 
T hrough a nirinol rubing, thar was connected with an extendable and retractable needle 
at the distal end of the catheter, drugs could be administered. The injection catheters used 
had a fixed needle lengrh of 4.5 mm. 
The NOGA map served as a guide for positioning the injection catheter perpendicular 
against the endomyocardium at differenr locations in the left ventricle (figure 2). 
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Figure 2 
E XlImple of NOGAl'A' catheter position perpmdicular to the bllslIl anferior of the left ventricle wall 
(white arrowhead). The figure shows the right SlIperior oblique (A) and the left anterior oblique (B) 
view of the left ventricle in a unipolar voltage map. The color coding to the right shows the vollage 
range: bluc-purple indicates 1Iormal myocardium (high 'Voltage, > 14 mV); red il1dicnles infimted 
lisJUe (low voltage, <6 I11V). 
The endomyocardial voltage signal indicated endomyocardial contact and location 
stabili ty and loop stability of the NOGA system 11 ind icated a stable position of the 
catheter tip against the endomyocardium during the cardiac cycles. In order to ensure that 
all individual injections were done at a single site, a four step injection protocol was used. 
1. After a stable catheter position against the target zone was obtained a NOGA point 
was taken and tagged. 
2. Afte r extension of the needle a second NOGA point was taken and tagged. 
3. After injection, a third NOGA point was taken and tagged. 
4. Finally, after retraction of the needle location of the cathetertip was identified by a 
tagged NOGA point. 
During aU injection procedures, the endomyocardial position of the cathetertip remained 
unchanged. Figure 3 illustrates the injection sites and tagged NOGA points during the 
injection procedure. 
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Figure 3 
Figures A and B represent the NOGA local activation map of the lift ventricle of one of the pigs in 
frontlll find right oblique view. respectively. The three fIreos with the colored dots indicate the three 
injectio'l sites. Each iujec/ion site has four colored riots accordi11g to the used injection procedure. No 
shift il1 endomyocardial pOJitioll 0/ the injection cathetertip WfIJ noted during the injection procedure. 
All injection catheters were pre-loaded with the 99mTc-H SA or 99mTc-colloid albumin 
with a 1 ml syringe with a luer lock fitting attached to the injection port of the injection 
catheter. Mter the pre-loading procedure, the distal end of the catheter was cleaned in 
order to prevent contamination of 99mTc outside the injection compartment. After 
positioning of the catheter at the injection si te, 0.1 or 0.2 ml 99mTc-HSA or 99mTc-
colloid albumin was manually injected in 20 seconds. After each injection procedure the 
catheter was retracted and the needle injection system cleaned and checked. Thereafter, 
the catheter was advanced and positioned in the left ventricle again for another injection 
at a different site. 
Scallning procedure. Before injection the radioactive activity of the syringe with the injected 
substance was measured on the gamma camera (t=O) in order to recalculate the activity in 
time during the experimencs. During and 2-4 hours after the injection counts per region 
were acquired by the mobile gamma camera (Cardiac, Siemens, Erlangen, Germany) close 
above the chest in an anterior-posterior projection. Scintigraphic data was stored on a 
PDP 11/34 computer system (Digital). During the injections, dynamic scans of 60 frames 
per 2 seconds were obtained in order to visualize direct systemic loss of the injected 
substance. After the injection at regular intervals 1 minute scans were acqui red. At the end 
of the experiment a scan after thoracotomy was performed in order to calculate the 
attenuation by the anterior chest wall (see appendix). The ave rage attenuation correction 
factor was 1.36 ± 0.18. 
After the animals were sacrificed, the hearts were excised and inspected macroscopically. 
The injection regions were easily identified as "hot spots" on the gamma camera. 
Definition . Efficiency of the injection was defined as the percentage of the amount injected 
that showed an intramyocardial deposition at 1 minute after the injection. The efficiency 
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was calculated by measuring the counts of the "hot spot" on the gamma camera during the 
first minute after the injection and dividing this by the expected counts of the total 
injected substance (0.1 or 0.2 ml) for that time period. Retention was defined as the 
percentage of the intramyocardial deposition in time. The retention was calculated as the 
counts of the "hot spot" on the gamma camera in time and compared to the counts of the 
"hot spot" at one minute after the injection. Efficiency and retention of all injections were 
corrected for the decay of the 99mTc in time and the attenuation of the anterior chest wall 
(see appendix). 
Statistics. All values are presented as mean ± standard deviation. Comparison of efficiency 
between the 0.2 and 0.1 ml injections was done with a double-sided student-t test. A p 
value less than 0.05 was considered statistically significant. 
RESULTS 
A total of 29 injections were done in 10 animals. All 29 injections showed scintigraphic 
proof of intramyocardial deposition. T'he average injection efficiency of all 29 injection 
was 26 ± 23%. The average injection efficiency of 0.1 and 0.2 ml injections were 33 ± 309,'0 
(n=S) and 24 ± 20% (n=2l), respectively (p=0.33)(figure 4). 
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This figure represents the percentage efficiency if the 0.2 and 0.1 m! injections. The 0.2 and 0.1 lit! 
injectiom had an average injection efficiency of24 ± 20% and 33 ± 30%, respectively. 
The injection efficiencies between albumin and colloid albumin injections were 23 ± 19% 
and 30 ± 30% (p=0.46). 
Intramyocardial retention of albumin showed a rapid wash-out within the first 2 hours of 
the injection, whereas the retention of albumin-colloid showed no decrease after a small 
initial drop-off (figure 5). 
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Figure 5 
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Th;sjigllre represents the retention time r:lthe intramyocardial deposited 99mTr-albumin (v) and 
99mTc-colloid albumin (I). After 2 hOllr.'i 23 ± 9% and 82 ± 10% if the initial deposited amollnt r:l 
99mTc-albumin and 99mTc-colloid albumin, rejpectively, waJ still present at the il1je[t;011 site. 
During 8 injection procedures, a backflow of injected substance could be ident.ified on the 
dynamic acquisition scan (figure 6). 
Figure 6 
Thisjigure represenl.'i 16/iwlles if2 serond'i each during the dynamic scan acquisition at the time r:l 
011e if the injections. At frame Illl1l1her 9 a ''hot spot" emerged, indirating all il1tramyomrdial 
deposition (wwll arrow). From jh!1lle 9 to fiwne 14 bacliflow if the injected suhstance during the 
injalioll procedure is noted inlo the left velltricle cavity (arrow heads). Simultaneollsly, background 
activity increa.'ied during and after this injettion. 
In all these 8 cases the injection efficiency rates were less than 30% and were mainly 
observed in the 0.2 ml injections (n=7). 
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No sustained ventricular rhythm disturbances or other hemodynamic changes occurred 
during or after the injections. Furthermore, myocardial perforation was not noted either 
scintigraphically or macroscopically. 
DISCUSSION 
This study reports on the efficacy of a novel intramyocardial drug delivery method, using 
a non-fluoroscopic guided transendomyocardial injection catheter system. Analog to a 
previously described scintigraphic method(7,8\ our study shows that the average efficiency 
of an transendomyocardial injection with this catheter system is 26 ± 23%. Furthermore, 
we show that intramyocardial retention after transendomyocardial injection of small 
proteins like albumin is short compared to the stable retention rates of small particles like 
colloid-albumin. 
The obtained efficiency rates in this study seem to be better compared to the low 
myocardial recovery rates of 0.5 and 3-5% that were obtained after intravenous or 
intracoronary administration of 1251 labeled basic FG F as shown by Lazarous et aL (12) 
using an autoradiography method. 
In our study, we noted a wide range in efficiency of the injections. Although our injection 
protocol showed that during the injection procedure the cathetertip did not change its 
endomyocardial position, still a large variation in injection efficiency existed behveen 
2 and 93%. This was probably caused by insufficient penetration of the needle into the 
myocardium or by rapid loss of injected substance out of the injection site. As shown in 
fi,gure 6, in 28% of the injections we observed a backftow of the injected substance during 
the injection. This backflow was probably along the needle shaft into the left ventricle 
cavity, as only low injection efficiency rates and increase of background activity were noted 
together with this observat.ion. This phenomenon is likely to occur whenever the pressure 
at the deposition region is high for instance after a high volume dose injection and perhaps 
at regions with non-compliant tissue characteristics like a scar. Furthermore, rapid loss 
from the injection site may also be augmented by the myocardial contractions. 
Another observation in our shldy was the difference in retention between albumin as 
model for small proteins like growth factors and colloid-albumin as model for small 
particles, like adenovirus or n1icrospheres. The consistent intramyocardial retention of 
colloid albumin, in contrast to the rapid wash out of albumin, is probably explained by the 
physical properties of the colloidal particles. Due to their sizes, the colloidal particles are 
likely to be lodged be!\vecn the myocardial muscle cells, whereas small proteins like 
albumin are likely to dissolve quickly into the cxtracel1ulair fluid compartment. Another 
possible explanation for the difference in the retention time is the gradual loss of substance 
through the neck of the injection channel, which is likely to be faster with small proteins. 
We noted some helpful properties of the NOGA system during the injection experiments. 
1. The 3~D NOGA map functioned as a cast of the left ventricle and gave an indication 
whether the cathetertip was in endomyocardial contact. 
2. Firm endomyocardial contact was conf-irmed by the endomyocardial ECG signal from 
the cathetertip electrode. 
3. Perpendicular positioning of the cathetertip against the endomyocardium was assessed 
by looking at the NOGA map from different angles. 
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4. The system allowed accurate spatial positioning and tagging of the injection sites with 
no or little use of fluoroscopy. Apart from the above mentioned procedural advantages, 
the electro-mechanical assessment of the left ventricle by the NOGA system has also 
the potential to direct the injection therapy towards on-line identified viable myocardial 
regions(Hl) . 
All the injections showed scintigraphic proof of intramyocardial deposition without any 
adversary event. This is consistent with the observations of Kornowski(Ll) and also of Vale 
et a1. (14) that this percutaneous transendomyocardial injection technique is a safe and a 
reliable drug delivery method. 
Limitations: First, a major llimitation of the shldy is the use of a model drug for evaluation 
of the intramyocardial retention. The model drugs used in our study disregard the cell 
receptor binding capacity of angiogenic growth factors. Therefore, it is likely that the use 
of receptor binding cytokines will show a longer retention time. Second, the needle length 
of the injection catheters in our study was fixed at 4.5 mm. We noted a gradual decrease 
(0.5-1.0 mm) in needle length after one or more injections. Although, little is lmown 
about the influence of the needle length for intramyocardial drug dclivery, we believe that 
a needle length of less than 4.5 mm results in less efficient injections. Therefore, new 
injection catheters were used for each animal and when the needle length was less than 
3.5 mm. Probably, the small variation in needle length can also explain in part the 
variation in efficiency of the different injections. Third, scanning with the gamma camera 
was done in one plane (anterior-posterior), therefor scintigraphic evidence of back flow of 
the injected substance during the injection could have been missed when the catheter tip 
was coaxial towards the scanning plane. 
In conclusion, transendomyocardial delivery of proteins and particles with an injection 
catheter show favourable efficiency rates, however the retention time of intramyocardial 
deposited small proteins like albumin is short. This may indicate the need for sustained 
release systems of angiogenic growth factors for intramyocardal injection in therapeutic 
angIogenesIs. 
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Appendix 
Activity at time (x) was calculated according to the following formula: 
A(x)=A( 0) .e-[0,693 -t{x)! ,(112)??","]'c] 
A(x) = Activity at time x minutes after calibration 
A(O) = Activity at time of calibration 
t(x) = time in minutes after calibration 
t(1/2)?9n'Tc = halflife time of9~mTechnetium (360 minutes) 
Attenuation of the anterior chest wall was calculated according to the following formula: 
A(x) corrected" A(x) . [A(x2) open chest / A(xl) closed chest] 
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INTRODUCTION 
Nonfluoroscopic electromechanical mapping (NOGAfM, Biosense-Webster, a Johnson & 
Johnson Company) is a recently developed technique that enables the acquisition of on-
line information on electrical and mechanical endoventricular functioning of myocardial 
tissue!' T'he rationale of this new technique is of two kinds. First, no currently available 
in-cathlab method can distinguish viable from non-viable myocardium. Accepted 
techniques as radionuclide scintigraphy and dobutamine stress echocardiography may not 
be readily available, and can only be performed out of the cathlab. Second, applications 
such as myocardial laser revascularization or intramyocardial gene-injection may prove 
cumbersome when performed using echocardiography or fluoroscopy with only two-
dimensional projections available on-line1. A major pitfall in these is indeed the inability 
to accurately associate the two-dimensional positioning with a specific endocardial site. It 
has been shown previously that localization of the recording sites with fluoroscopy is 
inaccurate, cumbersome, and associated with high x-ray exposure for both the patient and 
the physicianUl• Although clinical application of on-line 3D echocardiography and 
magnetic resonance imaging are underway, until recently no technique for real-time three-
dimensional guiding of intervention tools and assessment of myocardial electromechanical 
functioning was available. Indeed, nonfluoroscopic electromechanical mapping has 
become the first navigation technique to accurately determine the trajectory of a tool 
inside the human heart, to guide the interventional device to a specific site, and to 
meticulously couple functional and anatomical properties(l). 
In this overview, we shall describe the NOGATM system components, the left ventricular 
mapping technique, the current experimental and clinical data available, the ongoing trials 
and the possible future applications of this technique. 
The system 
The system exists of a mapping catheter, a magnetic field emitter, a data acquisition unit 
and a workstation. The deflectable-tip catheter (NOGA-STARTM, Biosense-Webster, A 
Johnson &}ohnson company) contains both a location sensor just proximal to its tip, and 
standard electrodes that allow recording of unipolar (unipolar voltages, UPV) and bipolar 
(BPV) electrical signals. 
The locator pad placed beneath the operating table consists of three radiators that 
generate low magnetic field energy (5xl0-1 to 5xl0 6 Tesla). This way, the system is 
provided with the information necessary to resolve the location and orientation of the 
catheter-sensor in 6 degrees of freedom (figure 1). 
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Figure 1 
Close-up o/Ihe calheler tip (left). The exact 
10mliol1 in three different degrees if freedom 
pitch, roll and yaw) tan be appreciated 
througholll Ihe procedure; at the starl if the 
procedure, a 'calibration" has 10 be pelformed 
in order to know Ihe color coding of Ihe 
different orientaliom of the cothelel: In the 
figure (right), for instance, the green color 
could be the upper side if the cathetet: 
The amplitude, phase and frequency of the emi tted magnetic signals recorded by the 
location sensor allow the computer algorithm to solve a number of complicated algebraic 
equations yielding the location (x , y and z) and orientation (roll , pitch and yaw) of the 
sensor. T he NOGATM processing unit consists of a computer that updates the acquired 
information in real-time, and a Silicon Graphics work station that displays the 3D left 
ventricular endocardial reconstruction (figure 2). 
Figure 2 
The system's components. (A) shows the different components a/the work slalioll, with the Silicon 
graphics compllier and the monitor displaying a NOGATM map. (B) shows the system incorporated in 
f1 moveable cart, with all Ihe right a enrt with the cable connecting hoard visible underneath Ihe 
monilol: 
The operator chooses whatever view he wishes to work with during point acquisition, can 
add a second view in a separate window, and can change views whenever he wishes to do 
so, during the mapping procedure. Besides electrical activation maps, minimum voltage 
maps (showing uni- or bipolar voltages) , local shorten ing maps, and bull 's eyes views, a 
variety of other fea tures are provided by the system. A full length description however 
would lead us to far. 
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Definitions and acronyms 
Point loop stability: measures the maximum of distances between the locations of the 
selected point in two consecutive heart cycles. Low point loop stability indicate a 
reproducible catheter movement trajectory. 
Cycle length (CL) stability: the difference between the length of the current cycle and the 
average of the last 100 cycles recorded. 
Local activatioll time (UT) stability: measure of how stable the LAT is between cycles. 
Reliable points show a LAT variation of dms. 
Location stability: a measure of the variability in position of the catheter tip on the 
endoventricular wall during two consecutive cardiac cycles. 
Triangle jill threshold: by setting a "triangle fill threshold" value, the operator chooses the 
minimum triangle size for which the program will close a face on the reconstructed 
chamber. This feature allows the operator to determine the degree to which the system 
will interpolate between actual data points and will ensure that a minimal level of point 
density will be met at each mapped region. Usually an interpolation threshold of 30 mm 
between adjacent points is taken(1 ). 
Inner pointsjiltering: computer algorithm that removes points thought to be located inside 
the ventricular lumen (and not on the ventricular wall) or on a papillary muscle. The 
algorithm calculates relative position of points as compared to at least three neighboring 
ones and is therefore able to remove these contending points. 
Local linear shortening (LLS): The local linear shortening assessment is based on the 
assumption that in healthy myocardium any two points move closer to each other during 
contraction. Measurement of distances between neighboring points is therefore the basis 
for calculation of myocardial shortening. The computer algorithm takes into account the 
density of points around a point p, and gives a negligible weight to points too close 
(sampling noise) and points too far (of no influence as they provide non-local 
information). 'The algorithm for regional linear shortening is calculated as follows: for any 
two points on the map, i and j, LLS is calculated as the change in distance between these 
two points from end-diastole to end-systole, normalized for the length at end diastole: 
LLSij ~ (L(ED)ij - L(ES)ij)/ L(ED)ij 
t<or any point p LLS is calculated as a function of the LLSpj, for all points j=l to n on the 
map, so that 
LLSp~ (Sj~l..n Wpj (L(ED)pj)x LLSpj ) / Sj~l..n Wpj, 
where W is the weight of a certain point as a function of the distance Lij between two 
points i and j, the average distance D around point p (D is defined in the computer 
algorithm as the average distance of the ten closest points to p) (figure 4) and the volume 
V at end-diastole. The weight is therefore function of the point density in a defined 
region, the volume of the heart and the distances between points at end-diastole. 
Unipolar Voltages (UPY): The maximum peak-to-peak voltage (expressed in m V) of the 
intracardiac signal measured at the tip of the mapping catheter. This unipolar recording 
may identifY subtle changes in the local myocardial voltages. 
Bipolar Voltages (SPY): Maximum peak-to-peak voltage of the cardiac signal measured 
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at the catheter tip and the catheter ring (located more proximally). AJthough it has been 
hypothesized that BPV, as it is less likely to be influenced by contact stability and "far-
field" potentials, may be more accurate than UPV, only UPV is currently being used in tlle 
electromechanical assessment of the left ventricle. Possibly, future studies can elucidate the 
importance of BPV measun:ments. 
The 3D mapping procedure 
The mapping catheter is introduced through a 7F or 8F femoral sheath. Prior to the actual 
mapping procedure, heparin is given intravenously (5 to 10,000 IU); additional heparin is 
given to maintain an activated clotting time (ACT) above 200s. A reference catheter is 
applied to the back of the patient. A mapping catheter is then inserted into the left 
ventricle. The location of the tip of the mapping catheter while inside the heart is gated 
to end diastole and is recorded relative to the fixed reference catheter, thus compensating 
for subject motionw. 
As the catheter tip is dragged over the LV endocardial surface, the system continuously 
analyzes its location in 3-dimensional space without the use of Auoroscopy. The set of 
points thus coUected comprises an irregularly sampled data set of location points that arc 
members of the endocardial surface. Chamber geometry is then reconstructed, in real 
time, using the set of sampled location points (figure 3). 
Figure 3 
Dragging 0/ the catheter (Cnth) 
throughout the ventricle with 
acquisition of electromechanical 
information. The mapping 
information is superimposed 011 
anatomical information in this 
figure. Ao denotes the mccllding 
aorta, AoV is the aortic valve, LV 
is the left venh·icle, PapM is a 
papillary lIluscle. and Ap is the 
apex 0/ the left ventricle. 
The endocardial surface is presented as a set of polygons (triangles) whose ve rtices are the 
sampled points. The local activation time (LAT) at each site is determined as the time 
difference between a selected fiducial point on the body-surface ECG and the steepest 
negative intrinsic deflection in the unipolar intracardiac electrogram (filtered at 0.5 to 
400 Hz) recorded from the tip of the mapping catheter. The activation map is color coded 
and superimposed on the 3D chamber geometry. The center of mass of the reconstructed 
chamber is automatically calculated from the set of the surface points. The volume of the 
chamber can be calculated from the sum of the volumes of all tetrahedrons constructed 
when connecting the center of mass to all triangles forming the reconstructed surface(l). 
Thus, left ventricular end-diastolic (LVEDV) and end-systolic (LVESV) vo lumes, stroke 
volume (LVEDV-LVESV) and ejection fraction (LVE~~ SV/LVEDV) can be calculated 
and displayed (figure 4). 
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Figure 4 
Example of a normal map. (A) demonstrates the maximum voltage 111ap (UPV) ill the right allterior 
oblique (RAO) position. The color bar on the righl shows the color coding rtlllgillgfrom red (-::;' 6.0 m V) 
to blue-pUlple (214.0 m V). (B) shows the lowllinear shorlel1il1g (I...I...S) map ill the same RAO view. 
The color bar ral1gesfiwlI red (LLS:O::; 2.0%) 10 bllIe-pUlple ("'211.0%). (C) shows Ihe bull's eye view 
of the IInipolar voltage map aJ displayed by the system. The numbers displayed are the absolute UPV 
vtlilles, with the percentages if Ihe moximum values in brackets. Four regions (clockwise from top: 
anterior (A), lateral (L), posterior (P) and septal (S)) are each subdivided in J segments (apical, mid 
and basal), dividing the whole 1110P ill Iwc/ve segmenls. (D) shows {he bultr eye view 0/ the LLS 
map. (E) and (}i') show the bipolar map tllld its hultr eye view, respectively. (G) shows the volume-
time curve, with the bille markers denoting minimum lind maximum voillmes. (/-I) shows the loop 
stability histograms; Ihe average value 0/ 1.27 111171 indiwtes a reproducible C(ltheter movement 
tmjeelOlY· 
The stability of the catheter-to-wall contact is evaluated at every site in real time, and 
points can be manually deleted from the map if 1 of the following criteria is met: 
(1) a premature beat or a beat after a premature beat; 
(2) location stab il.i ty, defined as a difference of >4 mm in end-diastolic location of the 
catheter at 2 sequential heartbeats; 
(3) loop stability, defined as an average distance of >4 mm between the location of the 
catheter at 2 consecut ive beMs at corresponding time intervals in the cardiac cycle 
(figure 4); 
(4) cycle length that deviated> 10% from the median cycle length; 
(5) different morphologies of the local ECG at 2 consecutive beats, or severe ST-elevation 
of the intrac<lrdiac electrogram depicting excess ive myocardial impression by the 
mapping catheter; 
(6) local activation time differences of >3 ms between 2 consecutive beatsj 
(7) different QRS morphologies of cl,e body slirface ECG; 
(8) inner point location j 
(9) adjacent points closer than 5 mm; 
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(10) points not related to the left ventricle (such as atriallocationY3). 
The moderate filtering algorithm incorporated in the system covers most of these issues. 
A normal map is shown in figure 4. 
Experimental and clinical studies 
The initial validation studies of the mapping system were reported by Gepstein et a1. (~) 
These authors first tested the in vitro accuracy of the locatable-catheter capabilities. By 
using a test jig with several holes at precise known distances from each other, they showed 
that repeated measurements of the location of one specific site differed 0.16 mm 
maximally, and that distances between specific points were equally highly reproducible 
(mean error 0.42 mm). Also, the intracardiac electr.ical signal from the locatable catheter 
was found to correlate highly with the signal acquired using a standard nonlocatable 
electrophysiological catheter placed in the immediate vicinity of the mapping catheter 
(cross-correlation"" 0.96 ± 0,01). In the same study, they tested the reproducibility of 
measurements performed on the beating pig's heart. Again, standard deviation (SD) for 
measurements at the same site were low (0.74 ± 0.13 mm), and the overall mean error of 
distances measured inside the body (through the use of a long sheath with markers every 
10 mm) proved to be low (0.73 ± 0.03 mmY4). Furthermore, Gepstein and colleagues found 
a consistent activation pattern of the left ventricle in pigs. During ventricular pacing, the 
earliest site of activation was at the site of pacing. During sinus rhythm, the earliest site 
of activation was on the superior part of the septum. Invariably, the latest site of activation 
in both rhythms was on the left lateral wall close to the mitral valve annulus. The total 
activation time of the left ventricle varied between 40 and 80 illS during sinus rhythm and 
between 57 and 87 ms during paced rhythm(". 
In a second series of validation studies by the same group, volumetric measurements of test 
jigs and pig ventricles were analyzed(1). Phantom objects with known volumes showed that 
the measured volumes were very close to the actual volumes, with an average deviation of 
about 2.7%. Measurements of LV casts (with a more difficult anatomy) showed an average 
deviation of 9.6%. , with a correlation r",,0.94 with the actual volumes. Measurements of 
volumes in a dynamic test jig showed high accuracy with lmown volumes, deviating only 
1.4,0.7,6.0 and 5.2% for maximal volume, minimal volume, SV and EF respectivelym. In 
12 pigs tested in this study, the intra- and interobserver variability proved to be very low. 
Also, SV measurements acquired with the mapping system proved to be highly correlated 
with thermodilution cardiac output measurements (see also figure 7, chapter 1)(2). 
As further validation of the system as a tool for the assessment of local left ventricular 
function, Gepstein et al. acquired the left ventricular electromechanical regional properties 
in 11 dogs with chronic infarction (4 weeks after ligation of the proximal LAD) and 
6 controls and compared them to the pathology results. Average endocardial local 
shortening (LS, measured at end systole and normalized to end diastole) and intracardiac 
bipolar electrogram amplitude were quantified at 13 LV regions. Endocardial LS was 
significantly lower at the infarcted area (1.2+/-0.9%, P<O.Ol) compared with the 
noninfarcted regions (7.2+/-1.1% to 13. 5+/-1.5%) and with the same area in controls 
(15.5+/-1.2%, P<O.Ol). Average bipolar amplitude was also significantly lower at the 
infarcted zone (2.3+/-0.2 m V, P<O.Ol) compared with the same region in controls 
(10.3+/-1.3 III V) and with the noninfarcted regions (4. 0+/-0.7 to 10.2+/-1.5 III V, P,O.Ol) 
in the infarcted group. Also, the electrical maps could accurately delineate both the 
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location and extent of the infarc t, as demonstrated by the high correlation with pathology 
(Pearson's correlation coefficient=O.90) and by the precise identification of the infarct 
border. The authors concluded that chronic myocardial infarcted tissue could be accurately 
characterized and quantified by abnormal regional mechanical and electrical functions(.I) . 
T he firs t human studies with the NOGATM system were reported by Kornowski et al. (3} Tn 
24 patients (12 patients with prior myocardial infarction (Ml ) and 12 control patients) LV 
endocardial mapping was performed to assess electromechanical funct ion in infarcted 
versus healthy myocardial tissue. In patients with prior M I, the average voltage was 7.2+1 
-2.7 mV (UPV)/1.4+/-0.7 mV (BPV) in MI regions, 17.8+/-4.6 mV (UPV)/4.5+/-1.1 
mV (BPV) in healthy znnes remote from MI, and 19.7+/-4.4 mV (UPV)/S.8+/-1.0 mV 
(DPV) in control patien ts without prior MJ (P <O.OOI for M J value~ versus remote zone~ 
or control patients). They clearly showed tha t both UPV and local endocardial shor tening 
were significantly impaired in MI zones compared with controls. Also, concordance with 
echocardiographic wall motion analysis was goodol. An example is given in figure 5. 
}</gllre 5 
Example if an e/ectromechrmiwl assessment 
map ill a patient with n mid allterior 
descending artery oCc/lIJiol1 {md a JIIbseqllent 
apicoposteroseptal infarction. (A) shows the 
unipolar voltage (UPV) map and (B) the 
lillear local shortening (LLS) map ill the 
right anterior oblique view. (C) and (D) 
show the respeClive bulls eye views. The 
Jllla/! arrows in (A) fllld (B) delineate the 
il?farctioll zone, wbich call be clearly 
appreciated from the red areas. The 
nrrowheadJ in (J)) show the negt/tive LLS 
vaille.r, suggestive for dYJkineJia ill the 
npical, septal aud posterior regiom. The 
larger arrow ill (A) .wgge.r/J a region if 
moderate UPV (corresponding with tJ zone if 
low LLS), sllgge.rtive lor viability 
(''elertromechallhallllismfltch',). 
Kornow~ki et al. later repor ted on a comparison between NOGAJ"M mapping and 
radionuclidc perfusion imaging!6}. T hey showed that UPV (14.0+/-2.0 m V) and LLS 
values (12.5+/ -2.8%) were highest when measured in myocardial segments (n=56) with 
normal perfusion and lowest (7.5+1-3.4 mV and 3.4+/-3.4%) when measured in 
myocardial segments with fixed perfu~ion defects (n=20) (PO.0001) on single photon 
emission computed tomography imaging studies using 10ITI at rest and 99mTc-sestamibi 
after adeno~ine stress. A significant difference in UPV and LLS values was found between 
groups (P <O.OOI for each comparison by ANOVA). Myocardial segments with reve rsible 
perfusion defects (n=66) had intermediate UPV (12.0+1-2.8 m V, P=0.048 versus normal 
and P=0.005 versus fixed segments) and LLS values (10.3+1-3 .7%, P=0.067 versus norma.l 
and P=0.001 ve rsus fixed segments). From these results it was concluded that NOCA™ 
mapping might allow the detection of myocardial viability. 
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Van Langenhove et al. compared enddiastolic (EDV) and end systolic volumes (ESV), 
stroke volume (SV) and ejection fraction in 44 patients with both LV angiogram and 
NOCATM mapping. Although a strong correlation (r=0.78, p<O.OOl) fo r EF measurement 
between the two techniques was found, the Bland-Altman analysis (figure 11) 
demonstrates the disagreement and the absence of interchangeability between both 
methods. Indeed, on average, a difference of about 30% in LVEF was found (1). We also 
compared local linear shortening assessed with non fluoroscopic electromechanical 
mapping (NEM) as a function of regional wall motion with echocardiographic data in a 
subset of 40 patients with severe coronary artery disease and subsequently decreased left 
ventricular function. Our study showed that NEM mapping can accurately assess regional 
wall motion. In addition, this study showed a significant decrease in unipolar voltages 
amongst segments with declining regional function.(~) 
The same authors described significant correlations between regional wall motion 
assessment llsing LV angiography as compared to LLS data acquired in the same 
segments(p<0.001)(9I, see figure 6 . 
. 0 
A I~) 
Figure 6 
Left ventriCIIlar angiogram ill RAO (A-B) alld LAO (e-D) views in respettively md-diastole (A-
C) alld end-systole (B-D). Corresponding linear local shortening (LLS) map ill the stUlle view.f (A'-
D,). The arrows ill (A-IJ) are suggestive if apienl akinesia, the arrowheads in (e-D) show akinesia 
ill the septal regioll. The arrows ill (A'-B') show the red ZOI1C ill the apical region; low LLS values 
lire also suggested il1 [he septal regiol1 ( red z,ol1e ill septal tlre(l ill (A '-B') alld red-yellow-green zone 
il1 (C'-D: arrowheads). 
Finally, dobutamine stress echo was compared to LLS and UPV data for comparable 
segments in patients with a previous myocardial infarction. ROC cun'es showed 
significant cu t-off values for myocardial viabil ity of UPV=9.0 m V (sens 56%, spec 81%, 
1' <0.0001) and LLS=6.8% (sens 56%, spec 92%, p<0.0001 )""' H' (scc also figure 5). 
Fuchs et aJ. assessed in-vivo electromechanical changes following gradual coronary artery 
occlusion in a pig ameroid constrictor model using NOGATM(l21, UPV and LLS were 
measured in the ischemic lateral and non-ischemic anterior zones in animals at rest (n = 9) 
and 5 weeks after the implantation of ameroid constrictors around the left circumflex 
artery. Echocardiography was used to assess regional contractility (% myocardial 
thickening), and an echo-contrast perfusion study was performed using acoustic 
densitometry methods. The ischemic lateral zone showed reduced myocard ial perfusion at 
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rest (peak intensity; 3.4 +1- 1.7 versus 20.7 +1- 14.8, P = 0.005), impaired mechanical 
function (percentage wall thickening 22 +1- 19% versus 40 +/- 11%, P = 0.03; local 
endocardial shortening 2.9 +/- 5.5% versus 11.7 +1- 2.1%, P = 0.002), and preserved 
electrical activity (unipolar voltage 12.4 +/ - 4.7 versus 14.4 +/- 1.9 m V, P = 0.25; bipolar 
voltage 4.1 +/- 1.1 versus 3.8 +/- 1.5 mY, P = 0.62), compared with the anterior region. 
The authors concluded that gradual coronary artery occlusion resulting in regional 
reduced perfusion and function at rest (i.e. hibernating myocardium) is characterized by 
preserved electrical activity. Electromechanical left ventricular mapping may be of 
diagnostic value for identifYing the hibernating myocardium(12). Botker et a1. compared the 
findings of FDG-positron emission tomography (PET) with data derived from NOGATM 
mapping and found that segments with reversible perfusion defects had UPY /LLS of 
7.3 ± 3.1 mY and 4.0 ± 2.4% respectively. Normal segments showed UPV 11.5 ± 3.7 mV, 
LLS 7.7 ± 3.3%. Infarcted areas with irreversible perfusion defects showed UPY 4.8 ± 2.2 
mY, LLS 2.9 ± 2.8%.0)) 
Kornowski et al. recently presented preliminary results on the first NOGATM-guided 
direct myocardial revascularization (DMR) studyY4) They showed that DMR using this 
technique was safe and feasible, that in 77 patients no deaths occurred, and that early 
efficacy endpoints showed an improvement in anginal status, and a prolonged exercise 
capacity 6 months after the index procedure. Laham et al. reported on improvement in 
regional wall motion score and collateralization in a subgroup of 15 patients also treated 
with laser-DMR. (15) Some caution however may be appropriate. As previous studies had 
shown a substantial amount of patients suffering an episode of heart failure following 
transmyocardiallaser revascularization(16, 17) we sought to determine the acute effects on the 
left ventricular function. We found that in 15 patients, where we performed a left 
ventricular angiogram before and immediately after the DMR procedure, that the relative 
decrease in LVEFwas 18% ± 10 after DMR, and that the relative decrease in regional wall 
motion was 9% ± 18 for the non-treated and 26% ± 17 for the treated regions. From this 
study, we concluded that the physician should be cautious when performing myocardial 
laser revascularization in patients with a low «30%) baseline LVEF.(JS) 
Recently, Vale et a1. showed feasibility and safety of percutaneous, catheter-based, 
nonfluoroscopic mapping guided myocardial gene transfer(19). In six pigs in which the 
injection catheter was used to deliver plasmid using cytomegalovirus promoter/enhancer, 
encoding nuclear-specific LacZ gene (pCMV-nlsLacZ) (50 microg/ml) to a single LV 
myocardial region, peak beta-galactosidase activity after five days was documented in the 
target area of myocardial injection in each pig. As all pigs survived until sacrifice, and no 
complications were observed with either the mapping or the injection procedures, the 
authors concluded that percutaneous myocardial gene transfer can be successfully achieved 
in normal and ischemic myocardium without significant morbidity or mortalit)l19). It is 
furthermore important to underline the importance of the 3D mapping technique for 
gene application procedures, as exact delineation of the area to be treated seems 
mandatory. To test the feasibility of myocardial angiogenic gene expression, through 
endocardial transfection of adenovirus vascular endothelial growth factor-121 using the 
NOGA ™ system as a guidance, Kornowski et al. transfected transgeoes into designated 
myocardial sites of the pig model. They demonstrated that this less invasive catheter-based 
system offers a similar gene delivery efficiency and, thus, may have clear advantages 
compared with the surgically-based transepicardial injection approach.(20) 10 a recent study, 
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our group demonstrated in a pig model that the average efficiency of an endomyocardial 
catheter injection using the NOGATM system as a guidance is 26 ± 23%. Also, we showed 
that intramyocardial retention after endomyocardial injection of small proteins like 
albumin is short compared to the stable retention rates of small particles like colloid-
albuminYI) An injection catheter is shown in figure 7. 
A B 
Figure 7 
Thisjigllre rejJresents the B iosel1se injection catheter (AJ and catheter tip (13). The calheler has a 7 F 
shalt wilh a dislal aaive dif/eclab/e lip oj 8 F. The lip consists ojan electromagnetic se1lSOI~ a ring 
alit! tip electrode and the hOl/sing if a 0.014 x 0.009 illch extendable nitinolneedle (E). At the 
proximal end q/the catheter the nitinol shaft is cOImected with a Iller lock jittingfor a syringe, that 
may cOlltain injectable substallces. 
Ongoing and clinical investigations 
Some burning questions related to the clinical usability of the NOGAl'M mapping system 
in clinical practice still need to be addressed. Up to now, no clear evidence has shown that 
the local shortening function really is a reflection of the local wall motion. We do not 
know if assessment of bipolar voltages could further improve the performance of the 
system. Also, we do not know if the system is able to detect true viability. It also needs 
further investigation whether there need for this expensive technique for in-cathlab 
detection of viability/ischemia - when other techniques have already proven their value. It 
also needs further investigation whether direct myocardial revascularization, for which this 
system seems to be an ideal guiding tool, really improves the clinical status of the patient. 
It is also unclear if local gene application, again for which this system seems an optimal 
platform, is going to be applied c1inicaIly. 
Some of these questions will be answered by ongoing investigations. The DIRECT and 
EURO-DlRECT trials are currently enrolling patients in the USA and Europe 
respectively; these trials (single blinded, randomized NOGATM mapping without ve rsus 
with DMR in patients not suitable for classical revascularization) are aiming to answer the 
question if the presumed benefit with DMR is simply a placebo effect, or docs really 
improve the patient's clinical and functional status. The DIRECT trial has included 300 
patients and the first results will be available by the end of september 2000. The EURO-
DIRECT is aiming at 200 patients. Studies assessing "true viability" in patients scheduled 
for bypass surgery will answer the question if NOGA'fM can predict recuperation of 
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myocardial segments with wall motion abnormalities after revascularization. The DINO 
study is currently enrolling patients; goal of this trial is to assess the possibilities of the 
NOGATM system to accurately determine viability in hibernating myocardial segments, as 
compared to stress echocardiography, radionuelide pcrfusion scintigraphy and 
angiography performed before and 6 months after coronary bypass surgery. A study 
assessing the possible additional benefit of low-dose dobutamine during NOGATM 
mapping is currently pcrformed at the Thoraxcenter. Future investigations will evaluate 
the possible value of adenosine in the detection of ischemic segments, the diagnostic value 
ofNOGATM mapping as compared to magnetic resonance imaging (MRl) in myocardial 
viability, the efficacy of growth factors to induce myocardial angiogenesis and additional 
comparisons with radionuclide perfusion imaging studies(H-1I,21.Hl. Also, the possibility of 
the pericardial approach to acquire electromechanical mapping information and the 
intrapcricardial delivery of angiogenic factors may offer a theoretical advantage of 
prolonged exposure of either coronary or myocardial tissue to the administered drug as 
result of a reservoir function of the pericardium, and is currently undcr investigationY4l 
Investigations to shorten the mapping time, to acquire multiple point information 
through a multi-sensor catheter, and to incorporate fluoroscopic information into the 
NOGATM system, are underway. 
Conclusions 
Lcft endoventricular 3D re,J-time electromechanical mapping is a new, intriguing 
technique for in-cathlab assessment of mechanical and electrical functioning of the left 
ventricle. Although initial snldies have shown safety, feasibility and reproducibility of this 
techniquc, and havc provided similar results as compared to established techniques in the 
quest for viability, data on the additional clinical value of the system are still scarce. 
Ongoing trials on the prediction of viability, the benefit of DMR and intramyocardial 
gene injection, may definitely establish its place among currently used techniques in 
interventional cardiology. 
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Summary l/Illl C,mriwiolls 
Nonfluoroscopic electromechanical real-time on-line 3-dimensional mapping using the 
NOGATM device broadens our insights into left ventricular functioning. 
The thesis exists of three parts. In dle first part of th is thesis (chapters 1-5) we compare 
the NOGATM technique to established methods for evaluating left ventricular function 
and wall motion. In Chapter 1 we explain the technique and its physical basis. In chapter 
2 we evaluate NOGATM maps in patients without previous myocardial infarction and with 
normal ventricles on contrast angiogram. In this study, we show that although unipolar 
and bipolar voltages and linear local shortening tend to be consistently high throughout 
the left ventricle in subjects with normal left ventricular functioning on angiography, basal 
septal and posterior areas of the left ventricle do have lower values, probably due to the 
presence of the mitral annulus. Also, large variations in absolute values of unipolar 
voltages and linear local shortening can be appreciated amongst patients and amongst 
segments in the same patients. In chapter 3 we compare volumetric measurements and left 
ventricular ejection fraction assessment as provided by the NOGATM system to the 
standard in-cathlab technique to produce these measurements, i.e. contrast 
ventriculography. We show that - although the data provided by the NOGATM system are 
strongly correlated to those given by computerized ventriculography- the absolute values 
of both volumetric measurements and ejection fraction calculation are clinically not 
interchangeable. Differences up to 30-40% in left ventricular ejection fraction are shown. 
Although the new software version (NOGATM 4.0) reduces these differences (chapter 2), 
they still mount up to ± 20%. In chapter 4 we compare the linear local shortening function 
as assessed w.ith NOGArM as a function of regional wall motion with echocardiographic 
data in a subset of patients with severe coronary artery disease and subsequently decreased 
left ventricular function. We show that NOGATM accurately assesses regional wall motion 
and that myocardial segments with declining regional function also show decrease in 
unipolar voltages. In chapter 5 we compare linear local shortening data to dedicated area 
analyses using computerized left ventricular angiography. The per-segment analysis shows 
that linear local shortening data are significantly correlated with area data derived from 
the ventriculogram. Moreover, it becomes clear that linear local shortening is a reliable 
parameter for the evaluation of regional left ventricular wall motion. 
In the second part of the thesis (chapters 6-8), we evaluate the ability of the NOGATM 
system to detect viable myocardium. In chapter 6 we analyze electromechanical properties 
of target myocardial regions of occluded coronary arteries. We show that the 
electromechanical properties of previously injured myocardial segments are significantly 
correlated with the quality of collateral coronary artery supply to the target region of 
occluded coronary arteries. This further underscores the potential of nonfiuoroscopic 
mapping in assessing myocardial viability. In chapter 7 we demonstrate that - as compared 
to radionuclide scanning techniques- NOGATM is able to differentiate myocardial scar 
tissue from regions that are still viable. A value of unipolar voltage of 6.5 m V is set forward 
as the optimal cut-off to suggest viability in a defined region. In chapter 8 we compare 
data on myocardial viability assessment derived from dobutamine stress echocardiography 
with NOGATM mapping data of the same patient cohort. We conclude that NOGA™ can 
predict recovery in injured myocardium when compared to dobutamine stress 
echocardiography. In this study we demonstrate that both linear local shortening as well 
as unipolar voltages have added value in the assessment of viability. Receiver operator 
characteristics analyses revealed 8.2 m V for unipolar voltage and 7.2% for linear local 
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shortening as the optimal cut-off values to distinguish non-viable from potentially 
recoverable myocardium. 
In the third part of the thesis (chapters 9-12\ we evaluate novel techniques that usc 
nonfluoroscopic 3-dimensional electromechanical mapping as a vehicle to deliver 
respective therapies. In chapter 9 we provide an overview of currently available 
information on the evolution of left ventricular function after direct myocardial 
revascularization. We show that -although in the acute phase following therapy, a decrease 
in LV function can be seen - in the long-term, recovery is to be expected. We also provide 
data from our center showing that direct myocardial revasculari%<1tion may cause acute 
deterioration of the left ventricular function and that hence one has to refrain from 
performing myocardial laser revascularization in patients with a low baseline left 
ventricular ejection fraction. In chapter 10 we provide the first follow-up NOGATM 
images 6 months after direct myocardial revascularization. Improvement in regional 
functioning of the treated areas is clearly shown. In chapter 11 we describe the efficiency 
of percutaneous intramyocardial injections of albumin and albumin microcolloidal 
particles in animals as possible future carriers of drugs for direct myocardial injection 
therapy. We show that the technique of intramyocardial injection is feasible, that the 
efficiency is around 25%, and that small proteins as albumin have a shorter retention time 
than small particles such as the microcolloids we used. In chapter 12 we reflect on the 
possible future diagnostic and therapeutic applications of the NOGAfM system. 
In conclusion, the NOGATM system is a safe and feasible technique that, when in 
experienced hands, provides reliable data on the electromechanical functioning of the 
myocardium. The system is able to detect viability and may therefore be of added value in 
the assessment of revascularization strategies. Also, the technique is a strong vehicle to 
deliver specific intramyocardial therapeutic measures, through its ability to accurately 
define regions of interest in 3-dimensional space. 
Some questions however remain unanswered: What is the cause of discordance in 
volumetric measurements when compared to other techniques? Is linear local shortening-
a parameter that describes tangential movement of myocardial points during contraction-
really comparable to the well-accepted myocardial thickening or perpendicular wall 
motion? Is the accuracy of viability detection high enough to warrant the adaptation of 
this system as the golden standard? Is there need for an expensive, not easy-to-master, 
technique for in-cathlab detection of viability and/or ischemia, when other validated, 
accepted, less expensive, easily applicable techniques already have proven their value? Docs 
direct myocardial revascularization, for which the system seems to be an ideal guiding tool, 
really improve the clinical status of the patient? Is local gene application, again, for which 
this system seems an optimal platform, going to be applied clinically? Forthcoming 
multicenter randomizcd trials will answcr some of these issues. 
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SamclI1JtlttillKt'1I COIlr/lI\iCI 
Zonder rontgendoorlichting in real-time 3-dimensioneel evalueren van de electromecha-
nische eigenschappen van het hart verbreedt onze kijk op het functioneren van de linker 
kamer. 
Deze thesis is opgebouwd uit drie delen. In het eerste deel van de thesis (hoofdstukken i-
S) vergelijken we gegevens gegenereerd door het NOGATM systeem met technieken 
erkend voor de evaluatie van de linker kamerfunktie en de lokale beweging van de 
hartspier. In hoofdstuk 1 beschrijven we de techniek en zijn f)rsische basis. In hoofdstuk 2 
evalueren we de NOGATM techniek bij patienten zonder voorgeschiedenis van 
myocardschade en bij wie gedurende contrast ventriculografie een normale linker ventrikel 
contractiliteit is gezien. In deze studie tonen we dat, hoewel uni-(UPV) en bipolaire 
voltages (BPV) en local linear shortening (LLS) meestal hoge waarden tonen in deze 
normale linker ventrikels, er duidelijk lagere waarden worden gezien in het posteroseptale 
gebied, waarschijnlijk ten gevolge van de aanwezigheid van de mitralisklepring aldaar. 
Ook zien we grate variaties in absolute waarden voor zowel UPV ais I.LS. In hoofdstuk 3 
vergelijken we volume-metingen en ejectiefraktiebepalingen gemeten met de NOGATM 
techniek met de meest gebruikte standaardtechniek, n<lmel~jk contrast ventriculografie. 
We toneo aan dat, hoewcl beide meettechnieken sterk gerelateerde resultaten geven, de 
technieken klinisch niet uitwisselbaar zijn, m.a.w. dat men niet de ene keer de 
ejectiefraktie kan meten met de ene techniek, en de volgende keer met de andere. 
Verschi1len tot 30-40% worden gezien. Ondanks dat de nieuw ontwikkclde software deze 
verschillen kleiner maakt, bedragen ze toch nog om en bij de 20% ( Hoofdstuk 2) In 
hoofdstuk 4 vergelijken we de LLS aIs ceo graadmeter voor lokale wandbeweging van het 
myocard met echocardiografie gegevens in een subgroep van paticntcn met ernstig 
coronairlijden en -als gcvolg daarvan- verminderde linker ventrikcl funktie. We tonen aan 
dat NOGATM op betrouwbare wijze de regionale wandbeweging van het hart visualiseert, 
en dat naargelang de regionale funktie vermindcrt, ook de absolute waarden van de 
unipolaire voltages afnemen. In hoofdstuk 5 vergelijken we LLS gegevens met precieze 
bepalingen van de regionale fllnktie van het myocard d.m.v. gecomputerizeerde linker 
ventr.ikel angiografie. De segment-per-segment analyse toont dat LLS data significant 
gecorreleerd zijn aan de gegevens betreffende de lokale wandbeweging afgelcid uit het 
contrast ventriculogram.Hieruit wordt duidc1ijk dat LLS een goede parameter is om de 
locoregionale myocardfunktie te bestuderen. 
In het tweede deel van de thesis (hoofdstukken 6-8), evalueren we de moge1ijkheid om aan 
de hand van de NOGArM techniek viabe1 myocard te onderscheiden. In hoofdstuk 6 
analyzeren we de clectromechanische eigenschappen van hartspierweefse1 dat voorheen 
door een nu geoccludeerde coronaire arterie werd bevloeid. We tonen aan dat de 
electromechanische eigenschappen, en -hieruit afgeleid- mogelijks de hoevec1heid 
leefbaar hartspierweefscl bepaald worden door de kwaliteit van de collateraalcirculatie die 
deze regio's van bioed voorzien. Dit onderlijnt de moge1ijkheid om viabiliteit te detecteren 
aan de hand van de NOGA'rM techniek. In hoofdstuk 7 tonen we dat ~ in vergclijking 
met nucleaire viabiliteitsdetectie- NOGArM de mogelijkheid biedt een onderscheid te 
maken tussen littckenweefsel in de hartspier en weefscl dat reversibele schade heeft 
opgelopen. Een absolute waardc van het unipolaire voltage van 6.5 m V wordt 
vooropgeste1d als de optimale cut-off waarde om viabel van nict-viabel weefsel te 
onderscheiden. In hoofdstuk 8 vergc1ijken we data afkomstig van dobutamine stress 
echocardiografie met gegevens afkomstig van NOGATM om hartspierviabiliteit te 
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definieren. We tonen dat NOGATM accuraat reversibiliteit van hartspierbeschadiging kan 
voorspcllen, wanneer vergeleken met dobutamine stress echo. In deze stu die zien we dat 
zowel LLS als UPY additicve waardc hebben in het vaststellen van reversibiliteit van de 
hartspierbeschadiging. Receiver operator characteristics (ROC) analyses tonen 8.2 m V 
voor UPY en 7.2% voor LLS ais de optimale cut-off waarden om non-viabel (oflitteken) 
weefsel te onderscheiden van potentiecl recupereerbaar myocard. 
In het derde deel van de thesis (hoofdstukl(en 9-12), bekijken we innoverende therapiecn 
die NOGA ™ gebruiken aIs vehikel om respectievelijke therapeutische akties te 
ondernemen. Zo is er in hoofdstuk 9 een overzicht van de informatie beschikbaar over de 
effekten van percutane direct revascularisatie van het myocard (DMR) d.m.v. laser. Wij 
beschrijven dat -ondanks dat een acute deterioratie van de myocardfunktie kan optreden 
onmiddellijk na de laserbehandeling- er een trend tot volledig herstellijkt te zijn. Onze 
data leren dat gezien de mogelijklleid van acute deterioratie van de linker ventrikcl 
funktie, DMR bij patienten met een zeer slechte linker kamerfunktie weloverwogen dient 
te gebeuren. In hoofdshlk 10 zien we het verbeteren van de regionale myocardfunktie 6 
maaml na een DMR procedure. In hoofdstuk 11 beschrijven we de efficientie van 
percutane intramyocardiale injecties van aibumine en albumine microcolloida1c deeltjes in 
proefdieren; deze substanties fungeren als mogclijke toekomstige vehikels voor het 
transporteren van geneesmiddelen of andere faktoren voor directe intramyocardialc 
injectie. We tonen aan dat de tech nick haalbaar is, dat de efficientie om en bij de 25% 
bedraagt en dat ldeinere molecules zoais album inc een kortere retentietijd hebben dan 
grotere, z-oals de microcolloidale partikels. In hoofdstuk 12 rcflecteren we over de 
mogelijke toekomstige diagnostische en therapeutische implicaties van het NOGATM 
systccm. 
Samengevat, is NOGATM een veilige techniek die, in geoefende handen, betrouwbare 
gegevens verschaft over het clectromechanisch funktioneren van de linker hartbmer. Aan 
de hand van deze techniek is het mogc1ijk viabiliteit te detecteren, hetgeen van bclang kan 
z~jn bij het bcpalen van de revascularisatiestrategie bij de individuele patient. Ook is de 
techniek een bclangrijk vehikel om specifieke intramyocardialc therapicen ter plaatse te 
brengen, door de mogclijkheid van het systeem interessegebieden in een 3-dimensionele 
ruimte te definieren en weer te geven. 
Een aantal vragcn blijft echter onbeantwoord: wat is de rcdcn van de discordantie in de 
volume-bepalingen wannecr deze techniek met andere wordt vcrgc1ekcn? Is LLS - een 
parameter die een tangentiele beweging van de cathetertip tijdens hartspiercontractie 
beschrijft- wcl te vergelijken met geacceptecrde evaluaties van locoregionale 
wandbeweging z-oals hartspicrverdikking of perpendiculaire beweging van de cathetertip 
t.o.v. de wand? Is de accuraatheid van de viabiliteitsdetectie groot genoeg om dit systeem 
als de nieuwc gouden standaard aan te nemen? Wat is de noodzaak voor een dure, niet 
makl(elijk te beheersen in-cathlab techniek voor de detectie van viabiliteit wanneer andere, 
gcaccepteerde, eenvoudige, goedkope technieken reeds hun waarde bewezen hebben? 
Verbetert DMR, waarvoor dit systeem de idealc methode lijkt, daadwerke4ik de klinische 
status van de patient? Zal10kale gentherapie, waarvoor deze techniek -opnieuw- een 
ideaal platform is, gebruikt worden in de klinische praktijk? Een aantal geplande studies 
zal proberen op minstens een deel van deze vragcn een antwoord te geven. 
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First of all, I want to thank the Rotterdam POllce force, for having made my stay in 
Rotterdam as an unforgettable joy. For instance the time when my car was stolen, and I 
went to the Rotterdam Police Department to report the theft. The officer on call said 
{( there's really no use, your car is probably crossing the East German border as we speak I). 
Mter insisting, he- very against his will- finally wrote a report. My repeated calls one, two, 
three and four days following the event were consistently answered with : ~( do you think 
we have nothing better to do than to search for your car? )) Later I learned that indeed they 
had something better to do: writing tickets. Big was my surprise when 14 days later I got 
a letter from -yes- the Rotterdam Police Department, stating that my car had been towed 
away as a preventive measure to keep it from being stolen, as somebody had crashed the 
window to steal the car stereo. The letter said that I could pick up the car at the Rotterdam 
Police Parking Lot. Even bigger was my amazement when I arrived there, and they told me 
I had to pay 800 Dutch guilders for « parking costs )). I thought that they had checked the 
oil and cleaned it for that price, but nothing was less true. I then learned that shouting and 
being impolite does actually help: 1 didn't pay for the parking costs. One week later, I was 
driving back to my apartment around 12 p.m., when I noticed a Police car following me. I 
checked my lights, slowed down to 40 km/h, locked my seat belt and drove on. Suddenly, 
after turning a few corners, I was blocked by two Police cars in front, and two in the back. 
The Policemen howled through a megaphone « LEAVE THE CAR AND PUT YOUR 
HANDS V\THERE WE CAN SEE THEM )). I sat in amazement for a few seconds, when 
they repeated their demands, angrier than the first time. I did what I was ordered, and 
immediately two cops jumped upon me, and handcuffed me firmly. When I urged them to 
be careful, because I suffered from recurrent shoulder luxations, they looked at me as if I 
was coming from another planet, not understanding one word of what I said. When I told 
them that I was willing to write it down, but that it was useless because they probably didn't 
learn how to read anyway, they got really angry. By the time I asked them what would be 
the fine to call them a .. holes (censored), they fulminated, pulled me by the hair, and threw 
me into the police cae When I said they were making a big mistake, they laughed, saying 
everybody they arrested said the same thing. When T asked them what T was arrested for, 
they shouted "YOU STOLE THIS CAR", They didn't understand my outburst of 
laughter. The two hours T spend at the office downtown were unforgettable. I knew I could 
curse them as much as I wanted, because they were bound to discover their mistake sooner 
or later. And -I must admit- it's great to be able to say to policemen things like "where did 
they find such a bunch of dumb people?","do you guys actually get paid for this?" or "why 
do they forbid lQj; above 100 in the Rotterdam Police Department?", when you lmow 
you're not going to be punished for it. Anyway, after two hours they realized their huge 
mistake, blamed it all on the computer system, and overloaded me with excuses. Thanks 
again guys for letting me have so much fun. 
Also, many thanks to the several Parking supervisors to provide me with lots of parking 
tickets, and helping me in trying to abide by the Parking Rules. You've really been a great 
help. Forgive me for not paying you, but it's difficult to find a medical company to fund 
this. 
Many thanks also to the people of "Stadswonen", one of the housing companies in 
Rotterdam. I really appreciated your help when I came into your office naked, only covered 
with a far too small towel, asking for a spare key as I locked myself out of my room when 
going to the shower, and you people told me to wait in line as everybody else. It is true 
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that being naked docs not free you from having to wait for your turn. I also understand 
your refusal to give me the spare key because I couldn't pay the 25 guilders bail. 
Unfortunately I do not know the people who helped mc in getting rid of four car stereos. 
Thcrcfore, I cannot thank them personally. I really apologize for always locking the doors, 
so that each time you had to crush the windows. To the guy who stole my laptop in the 
Hospital while I was on the toilet: thank you very much, you really helped me in rewriting 
part of this thesis (former versions arc on your hard disk, call me if you want the latest 
version). 
I sincerely apologize for bcing such a bad customer to all the nice people who -almost on 
a daily basis- offered me a variety of goods to buy, like cocaine, heroin, crack, marihuana, 
and so on, 
My infinite thanks also goes to Mrs. £.S" former manager at the Thoraxcenter for saying 
no to every request I made (I'm not mentioning difficult things like a parking card or so). 
You've initiated my self-sustaining policy. 
The first time I met Patrick W Serruys in the Thoraxccnter, I caught him on a bad day. 
Something went wrong somewhere, and the first person he caught sight of, was me. 
"YOU'RE NOT GOING TO GET ANYWHERE SIPPING COFFEE" he shouted. 
It was the last coffee I drank in the hall next to his officc. Later, I came to realize the 
importance of the man for the Thoraxcenter and for Interventional Cardiology in general. 
His tremendous working force, his immense and seemingly unlimited knowledge, his 
insights into the world of interventional cardiology but also into the people surrounding 
him, his ubiquitous availability, his willingness to take risks, his dedication and 
professionalism, are a true example to whomever wants to succeed in the international 
academic medical field, or a warning to whomever wants a life. Which brings us to his 
wife, Danielle, It really needs a great woman to build the foundation under a big man. As 
most of the time he forgets to tell her this himself, he pays the fellows to write it in their 
theses. Additional funding by PW Scrruys is herewith gratefully acknowledged. I would 
however like to thank Danielle personally for the food, the winc, the coffee, and for telling 
me the score in Turkey-Belgium during EURO 2000, when Patrick confiscated me while 
I actually wanted to see the gamc. 
I would like to express my thanks to the members of thc promotion committee for their 
time and support: Prof Victor Legrand, Prof Shlomo Ben-Haim, Prof Ad Bogers, Dr. 
Geert Gijsbers, Dr. Pieter Smits, Prof Ivan de Scheerder and Prof Luc Jordaens. 
Thanks also to Pim de Feyter, another stronghold of the Thoraxcenter, for telling mc that 
having a life outside of the cathlab is also nice. Sorry Pim for not listening enough to you. 
Thanks to David Foley for cleaning up my mess and for the beers, to Benno Rensing and 
Jeroen Vos for always being in a good mood (don't ever loose that!), to Marcel van den 
Brand, Wim van der Giessen and Stephane Carlier, to Jaap Hamburger and Pieter Smits 
for helping me in writing parts of this thesis. My infinite gratitude also gocs to Anja, for 
not being on my back all of the timc; thanks for helping me with a lot of stuff, somctimes 
until late at night! Thanks to Claudia, for always offering me tea ("Would you like 
something? Coffee? Tea? Me?"), to Titia for always being ready to arrange things, to Arita 
and Willeke for taking care of some financial and secretarial concerns, and to Helen for 
keeping the place together. 
The Thoraxcenter would not be what it is today without the outstanding group of 
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technicians and nurses that it's lucky to have. It's mostly through their friendliness and 
support that one forgets the hardships and suffers from a long stay abroad. I had a closer 
relationship with Jurgen Ligthart, who taught me the basis of IVUS, and Emile 
Onderwater, who initiated me in NOGA. 
I want to express my thanks to the people of the Hemodynamics Department on the 23th 
floor of the Erasmus University. Especially Rob Krams, Yolanda Wentzell and Cees Slager 
initiated me into the interesting world of coronary blood velocity patterns, wall thickness 
and shear stress in the coronary artery, and were always willing to lend me their ears. Thanks 
also to Serge Trines, for helping me in all the pig stuff I hope you have a great career. 
In every situation in life, one tends to seek comfort in the group of people that suffers the 
same fate. In my case, this was the group of the fellows. The first one I met was Michael 
Kutryk (Winnipeg, Canada). I really hope that his stay was rewarding and that he finally 
got out of the dark and found a life in Canada. Manel Sabate (Barcelona, Spain) was an 
example to all of us: hard working, friendly, integer, honest and always ready to help. 
Mariano Albertal (Buenos Aires, Argentina) was my roommate in room H556. He 
initiated me in some of the most forcefull Hispanic statements as "no me inches las 
pelotas", "la concha de tu madre" and "la puta que te parillo". I do not want to translate 
these. Thanks my friend, for being there, and for making me laugh (although you didn't 
have to eat that 1 kg steak to show me that you're a real man). Pedro Serrano (Zaragoza, 
Spain) revealed me the possibilities of imaging and taught me all about statistics. Thanks 
Pedro, have a good life and congratulations for both the wedding and your appointment. 
Pavel Cervinca (Prague, Tsjechia) convinced me that a lot ofbeautiflll women reside in his 
country. Invite me again next year, Pavel! Marco "Circulation 99" Costa (Sao Paulo, Brazil) 
showed me that pushability is not a property solely of merallic stents. I really enjoyed our 
Belgian team beating the "world selection" in soccer on the beach in California. 
Congratulations also to you, to Erica and to the real father of the kid that's going to join 
your little family soon (I don't know where you would have found the time to do it). Ken 
Kozuma (Tokyo, Japan) is a wonderful guy never to tired to help you with anything. 
Evelyn Regar (Munchen, Germany)(I know a woman has to be twice as good as a man to 
accomplish the same), Attila Thury (Budapest, Hungary)(Don't get to shear stressed with 
all the situations) and Nestor (Medellin, Columbia)(l don't know who you'll have to talk 
to at 2 a.m. when I'm gone) are the latest acquisitions into this strong team. 
One day last February I met Leonidas Diamantopoulos. Until this time, I though that 
scientists that cover the whole spectrum, no longer existed. But when he showed me his 
skills in interventional cardiology, revealed me his correspondence with the space 
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In-hospital Complications. XII th Practical Course in Interventional Cardiology, Madrid, 
Spain, July 8-10, 1998. 
A Comparison between elective and ad hoc procedures in 3478 consecutive balloon 
angioplasties. A retrospective analysis. XII th Practical Course in Intcrventional 
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